CAS No.: 150399-23-8
培美曲塞二钠盐 Catalog No. CSN16714
Synonyms: 培美曲塞二钠盐;LY231514 disodium
Pemetrexed Disodium is an antifolate and antimetabolite for TS, DHFR and GARFT with Ki of 1.3 nM, 7.2 nM and 65 nM, respectively.
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
靶点 DHFR
Ki:7.2nMGARFT
Ki:65nMThymidylate Synthase
Ki:1.3nM- 描述
- 细胞研究
- Cell Data
- 更多
- 临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点 NCT01064648 Epithelioid Mesothelioma ... more >> Pleural Malignant Mesothelioma Recurrent Malignant Mesothelioma Sarcomatoid Mesothelioma Collapse << Phase 1 Phase 2 Active, not recruiting - - NCT00227565 Lung Cancer Phase 2 Completed - - NCT00702299 Fallopian Tube Cancer ... more >> Ovarian Cancer Peritoneal Cavity Cancer Collapse << Phase 1 Completed - United States, Arizona ... more >> Arizona Oncology - Scottsdale Scottsdale, Arizona, United States, 85258 Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724-5024 Collapse << - 更多
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 150399-23-8 | 储存条件 |
|
|||||
| 分子式 | C20H19N5Na2O6 | 运输 | 蓝冰 | |||||
| 分子量 | 471.37 | 别名 | 培美曲塞二钠盐;LY231514 disodium | |||||
| 溶解度 |
|
动物实验配方 |
| Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
|---|
| 211H | - | Growth Inhibition Assay | - | IC50=0.07±0.01 μM | 24714722 |
| A459 | 1/2/4 μM | Function Assay | 24/48 h | induces G1 phase arrest in dose- and time dependent manner | 25743822 |
| A459 | 1/2/4 μM | Function Assay | 48 h | decreases the levels of p-Akt | 25743822 |
| A459 | 4μM | Apoptosis Assay | 48 h | induces apoptosis | 25743822 |
| A549 | 1 μM | Cell Viability Assay | 48 h | enhances simvastatin inhibited viability | 26334320 |
| A549 | 1 μM | Function Assay | 24 h | enhances autophagy cotreated with simvastatin | 26334320 |
| A549 | 1 μM | Apoptosis Assay | 24 h | induces apoptosis cotreated with simvastatin | 26334320 |
| A549 | 1 μM | Function Assay | 48 h | increases AMPK phosphorylation and a concomitant decrease in AKT and mTOR phosphorylation cotreated with simvastatin | 26334320 |
| A549 | 0.234 mM | Growth Inhibition Assay | 24 h | growth inhibition=10﹪ | 25975637 |
| A549 | 0.234 mM | Growth Inhibition Assay | 48 h | growth inhibition=30﹪ | 25975637 |
| A549 | 0.234 mM | Growth Inhibition Assay | 72 h | growth inhibition=50﹪ | 25975637 |
| A549 | 1-1000 nM | Cell Viability Assay | 72 h | IC50=137 nM | 25145669 |
| A549 | 1 μM | Cell Viability Assay | 48 h | produces a synergistic inhibitory effect on the cell growth combined with simvastatin | 25096993 |
| A549 | 1 μM | Apoptosis Assay | 48 h | enhances caspase-dependent apoptosis combined with simvastatin | 25096993 |
| A549 | 1 μM | Function Assay | 48 h | enhances intracellular ROS production combined with simvastatin | 25096993 |
| A549 | 1 μM | Function Assay | 48 h | leads to mitochondrial dysfunction combined with simvastatin | 25096993 |
| A549 | 2.5/5/10 μM | Function Assay | 48 h | increases Noxa expression significantly | 24991768 |
| A549 | 2.5 μM | Function Assay | 48 h | induces caspase-9, caspase-3 and poly (ADP-ribose) polymerase (PARP) cleavage | 24991768 |
| A549 | 2.5/5/10 μM | Function Assay | 48 h | downregulates Mcl-1 | 24991768 |
| A549 | 2.5 μM | Apoptosis Assay | 48 h | induces apoptosis | 24991768 |
| A549 | 5 μM | Function Assay | 8 h | increases Mcl-1 ubiquitination levels | 24991768 |
| A549 | 1 µM | Function Assay | 4/8/12/24/48 h | increases the level of phosphorylated Akt in a time dependent manner | 24847863 |
| A549 | 0.1/0.3/1 μM | Function Assay | 48 h | increases the level of phosphorylated Akt in a dose dependent manner | 24847863 |
| A549 | 0.1/0.3/1 μM | Apoptosis Assay | 48 h | induces apoptosis in a dose dependent manner | 24847863 |
| A549 | 0.1/0.3/1 μM | Function Assay | 48 h | increases the ratio of S-phase population | 24847863 |
| A549 | 0.1/0.3/0.5/1 μM | Cell Viability Assay | 24/48 h | inhibits cell viability dose and time dependently | 24626722 |
| A549 | 0.1/0.3/0.5/1 μM | Function Assay | 24/48 h | produces the formation of AVOs in a dose-dependent manner | 24626722 |
| A549 | - | Growth Inhibition Assay | 96 h | IC50=1.35 μM | 24348854 |
| A549/PEM-1.6 | - | Growth Inhibition Assay | 96 h | IC50=5.03 μM | 24348854 |
| A549/PEM-16 | - | Growth Inhibition Assay | 96 h | IC50=51.45 μM | 24348854 |
| A549/PEM-6.4 | - | Growth Inhibition Assay | 96 h | IC50=23.39 μM | 24348854 |
| BXPC-3 | - | Growth Inhibition Assay | - | IC50=39.86±1.68 μM | 22977607 |
| BXPC-3 | 39.86 μM | Function Assay | 24 h | induces S arrest (P<0.05) and decreases the number of cells in the G2/M phase | 22977607 |
| BXPC-3 | 39.86 μM | Function Assay | 24 h | enhances EGFR phosphorylated levels, and the protein levels | 22977607 |
| BXPC-3 | 39.86 μM | Function Assay | 24 h | enhances EGFR, HER3 and AKT phosphorylation levels | 22977607 |
| DM-3 | - | Growth Inhibition Assay | 48 h | proportion of live cells=101.3±2.8 % | 23840376 |
| H1299 | 1-1000 nM | Cell Viability Assay | 72 h | IC50=178 nM | 25145669 |
| H1299 | - | Growth Inhibition Assay | - | IC50=1.84 μM | 24418519 |
| H1792 | 2.5/5/10 μM | Function Assay | 48 h | increases Noxa expression significantly | 24991768 |
| H1792 | 2.5 μM | Function Assay | 48 h | induces caspase-9, caspase-3 and poly (ADP-ribose) polymerase (PARP) cleavage | 24991768 |
| H1792 | 2.5/5/10 μM | Function Assay | 48 h | downregulates Mcl-1 | 24991768 |
| H1993 | - | Growth Inhibition Assay | - | IC50=0.17 μM | 24418519 |
| H2052 | - | Growth Inhibition Assay | - | IC50=0.57±0.34 μM | 24714722 |
| H226 | 1-10 μg/ml | Cell Viability Assay | 72 h | IC50>10 μg/ml | 24378576 |
| H2452 | - | Growth Inhibition Assay | - | IC50＞100 μM | 24714722 |
| H28 | - | Growth Inhibition Assay | - | IC50=0.07±0.02 μM | 24714722 |
| H290 | 1-10 μg/ml | Cell Viability Assay | 72 h | IC50>10 μg/ml | 24378576 |
| HCT116 | - | Growth Inhibition Assay | 72 h | IC50=0.049 ± 0.013 μM | 23959460 |
| HeLa | 0.234 mM | Growth Inhibition Assay | 24 h | growth inhibition=5﹪ | 25975637 |
| HeLa | 0.234 mM | Growth Inhibition Assay | 48 h | growth inhibition=10﹪ | 25975637 |
| HeLa | 0.234 mM | Growth Inhibition Assay | 72 h | growth inhibition=20﹪ | 25975637 |
| HepG2 | 0.1–100 μM | Cell Viability Assay | 72 h | high concentrations of pemetrexed at (10/100 μM) only slightly inhibits HepG2 cell survival | 25446102 |
| HepG2 | 0.1–100 μM | Apoptosis Assay | 72 h | induces apoptosis slightly at high concerntration | 25446102 |
| HepG3 | 0.1–100 μM | Function Assay | 48 h | induces p62 downregulation as well as Beclin-1 and LC3B-II upregulation | 25446102 |
| HepG3 | 0.1–100 μM | Function Assay | 48 h | activates cyto-protective autophagy | 25446102 |
| HepG3 | 10 μM | Function Assay | 48 h | upregulates phosphorylated (p-) MEK1/2 (Ser217/221) and p-ERK1/2 (Thr202/Tyr204) | 25446102 |
| HT-29 | - | Growth Inhibition Assay | 72 h | IC50=10.07 ± 0.94 μM | 23959460 |
| HT-29 | 0.05 μM | Function Assay | 72 h | increases the percentage of cells in the S phase | 23959460 |
| JL-1 | - | Growth Inhibition Assay | 48 h | proportion of live cells=98.2±2.2 % | 23840376 |
| Jurkat | - | Growth Inhibition Assay | 48 h | proportion of live cells=76.7±4.3 % | 23840376 |
| LoVo | - | Growth Inhibition Assay | 72 h | IC50=0.032 ± 0.002 μM | 23959460 |
| LoVo | 0.05 μM | Function Assay | 72 h | increases the percentage of cells in the S phase | 23959460 |
| M-14-K | - | Growth Inhibition Assay | 48 h | proportion of live cells=81.8±12.9 % | 23840376 |
| MES01 | - | Growth Inhibition Assay | - | IC50＞100 μM | 24714722 |
| MES04 | - | Growth Inhibition Assay | - | IC50＞100 μM | 24714722 |
| MG-63 | 0.01-100 μM | Cell Viability Assay | 72 h | inhibits cell viability dosedependently | 25152399 |
| MSTO-211 | 1 μM | Cell Viability Assay | 48 h | produces a synergistic inhibitory effect on the cell growth combined with simvastatin | 25096993 |
| MSTO-211 | 1 μM | Apoptosis Assay | 48 h | enhances caspase-dependent apoptosis combined with simvastatin | 25096993 |
| MSTO-211 | 1 μM | Function Assay | 48 h | enhances intracellular ROS production combined with simvastatin | 25096993 |
| MSTO-211 | 1 μM | Function Assay | 48 h | leads to mitochondrial dysfunction combined with simvastatin | 25096993 |
| MSTO-211H | 1 μM | Cell Viability Assay | 48 h | enhances simvastatin inhibited viability | 26334320 |
| MSTO-211H | 1 μM | Function Assay | 24 h | enhances autophagy cotreated with simvastatin | 26334320 |
| MSTO-211H | 1 μM | Apoptosis Assay | 24 h | induces apoptosis cotreated with simvastatin | 26334320 |
| MSTO-211H | 1 μM | Function Assay | 48 h | increases AMPK phosphorylation and a concomitant decrease in AKT and mTOR phosphorylation cotreated with simvastatin | 26334320 |
| MSTO-211H | 1-10 μg/ml | Cell Viability Assay | 72 h | IC50~0.04 μg/ml | 24378576 |
| PANC-1 | - | Growth Inhibition Assay | - | IC50=83.76±0.19 μM | 22977607 |
| PANC-1 | 84 μM | Function Assay | 24 h | enhances EGFR phosphorylated levels, and the protein levels | 22977607 |
| PANC-1 | 84 μM | Function Assay | 24 h | enhances EGFR, HER3 and AKT phosphorylation levels | 22977607 |
| PC9 | - | Growth Inhibition Assay | 72 h | IC50=16.05±1.85 nM | 24840891 |
| PC9 | 16 nM | Function Assay | 72 h | induces S-phase arrest | 24840891 |
| PC9 | 16 nM | Apoptosis Assay | 72 h | induces 14.54﹪ apoptosis | 24840891 |
| PC9/GR | - | Growth Inhibition Assay | 72 h | IC50=4.94±0.440 μM | 24840891 |
| PC9/GR | 4.94 μM | Function Assay | 72 h | induces S-phase arrest | 24840891 |
| PC9/GR | 4.94 μM | Apoptosis Assay | 72 h | induces 19.54﹪ apoptosis | 24840891 |
| PC9/GR | 4.94 μM | Function Assay | 72 h | increases p-ERK levels | 24840891 |
| PC9/GR | 4.94 μM | Function Assay | 72 h | increases p-AKT levels | 24840891 |
| STAV-AB | - | Growth Inhibition Assay | 48 h | proportion of live cells=64.4±21.8 % | 23840376 |
| STAV-FCS | - | Growth Inhibition Assay | 48 h | proportion of live cells=88.1±8.9 % | 23840376 |
| SW1116 | - | Growth Inhibition Assay | 72 h | IC50=1.70 ± 0.03 μM | 23959460 |
| SW620 | - | Growth Inhibition Assay | 72 h | IC50=1.09 ± 0.01 μM | 23959460 |
| T47D | 0.234 mM | Growth Inhibition Assay | 24 h | growth inhibition=10﹪ | 25975637 |
| T47D | 0.234 mM | Growth Inhibition Assay | 48 h | growth inhibition=20﹪ | 25975637 |
| T47D | 0.234 mM | Growth Inhibition Assay | 72 h | growth inhibition=30﹪ | 25975637 |
| U20S | 0.01-100 μM | Cell Viability Assay | 72 h | inhibits cell viability dosedependently | 25152399 |
| Vero | 0.234 mM | Growth Inhibition Assay | 24 h | growth inhibition=5﹪ | 25975637 |
| Vero | 0.234 mM | Growth Inhibition Assay | 48 h | growth inhibition=10﹪ | 25975637 |
| Vero | 0.234 mM | Growth Inhibition Assay | 72 h | growth inhibition=20﹪ | 25975637 |
| WiDr | - | Growth Inhibition Assay | 72 h | IC50=0.019 ± 0.002 μM | 23959460 |
| Y-meso14 | 1-10 μg/ml | Cell Viability Assay | 72 h | IC50>10 μg/ml | 24378576 |
| ZL-34 | - | Growth Inhibition Assay | 48 h | proportion of live cells=95.7±6.5 % | 23840376 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
|---|
| NCT01064648 | Epithelioid Mesothelioma ... more >> Pleural Malignant Mesothelioma Recurrent Malignant Mesothelioma Sarcomatoid Mesothelioma Collapse << | Phase 1 Phase 2 | Active, not recruiting | - | - |
| NCT00227565 | Lung Cancer | Phase 2 | Completed | - | - |
| NCT00702299 | Fallopian Tube Cancer ... more >> Ovarian Cancer Peritoneal Cavity Cancer Collapse << | Phase 1 | Completed | - | United States, Arizona ... more >> Arizona Oncology - Scottsdale Scottsdale, Arizona, United States, 85258 Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724-5024 Collapse << |
| NCT01593293 | Non-small Cell Lung Cancer | Phase 3 | Unknown | November 2015 | Korea, Republic of ... more >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Sang-We Kim, M.D. 82-2-3010-3215 swkim@amc.seoul.kr Collapse << |
| NCT01313663 | Lung Cancer, Small Cell | Phase 2 | Terminated | - | - |
| NCT00807573 | - | - | Completed | - | - |
| NCT01313663 | - | - | Terminated | - | - |
| NCT00059865 | Extrahepatic Bile Duct Cancer ... more >> Gallbladder Cancer Liver Cancer Collapse << | Phase 1 Phase 2 | Completed | - | - |
| NCT00807573 | Lung Cancer | Phase 2 | Completed | - | United States, New Jersey ... more >> Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital Sleepy Hollow, New York, United States Collapse << |
| NCT00614822 | Non Small Cell Lung Cancer | Phase 2 | Completed | - | - |
| NCT02725918 | Non-small Cell Lung Cancer | Phase 2 | Recruiting | June 2020 | China, Guangdong ... more >> Guangdong Lung cancer institute Recruiting Guangzhou, Guangdong, China, 510080 Contact: Qing Zhou, MD 86 13544561166 gzzhouqing@126.com Collapse << |
| NCT00744900 | Lung Cancer | Phase 2 | Completed | - | France ... more >> Centre Hôspitalier du Pays d'Aix, Service des Maladies Respiratoires Aix En Provence, France, 13616 CHU d'Angers, Service de Pneumologie Angers, France, 49033 Médecine 4, C.H.G. de la Fontonne Antibes Antibes, France, 06606 CHU brest, institut de cancérologie et d'hématologie Brest, France, 29200 Centre François Baclesse Caen, France, 14000 Centre Hospitalier René Dubos - Pontoise, Service d'Oncologie - Hématologie Clinique Cergy Pontoise, France, 95303 Centre Hospitalier, Service de Pneumologie Charleville, France, 08 000 CHI, Service de Pneumologie Creteil, France, 94010 Pneumologie, Centre hôspitalier, DRAGUIGNAN Draguignan, France, 83300 CH GAP GAP, France, 05000 Centre Hospitalier Départemental, Service de Pneumologie, La Roche Sur Yon, France, 85000 Hôpital A. Mignot, Service de Pneumologie Le Chesnay, France, 78157 Hopital de la Croix Rousse Lyon, France, 69317 Centre Hôspitalier, Service de Pneumo-Neuro Mantes La Jolie, France, 78200 Hôpital Sainte Margueritte Marseilles, France, 13274 Serv. de Pneumo-Allergo, CH de Martigues Martigues, France, 13695 Serv. de Pneumo - Hôpital St Antoine Paris, France, 75571 Service Pneumologie, Pavillon 1A, CH de Lyon-Sud Pierre-benite, France, 69495 Hôpital Pontchailloux, Service de Pneumologie. Rennes, France, 35033 CHG, Service de Pneumologie Roanne, France, 42300 Luc THIBERVILLE Rouen, France, 76031 CHU de ROUEN, Hôpital Bois Guillaume, Serv. de Pneumo. Rouen, France, 76233 Institut de Cancérologie de la Loire Saint-Priest en Jarez Cedex, France, 42271 CHU, Service du Pr. Carles Toulouse, France, 31059 Pneumologie, Centre Hospitalier VILLEFRANCHE sur SAONE, France, 69655 Collapse << |
| NCT02974933 | Nonsmall Cell Lung Cancer | Phase 2 | Recruiting | November 2018 | China, Hubei ... more >> Ou wuling Recruiting Wuhan, Hubei, China, 430079 Contact: Ou Wu ling, 40 13469989766 ext 86 609700817@qq.com Collapse << |
| NCT03086538 | Colo-rectal Cancer | Phase 2 | Recruiting | December 2018 | Korea, Republic of ... more >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 06351 Contact: seungtae kim, MD,PhD Collapse << |
| NCT01565538 | Lung Cancer | Phase 2 | Completed | - | China, Guangdong ... more >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Collapse << |
| NCT02723578 | Metastatic Colorectal Cancer | Phase 2 | Active, not recruiting | November 2018 | Korea, Republic of ... more >> Yonsei University Health System, Severance Hospital Seoul, Korea, Republic of, 03722 Collapse << |
| NCT03700333 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Not yet recruiting | October 20, 2019 | - |
| NCT00864513 | Pancreas Cancer | Phase 2 | Terminated(At interim analysis... more >> the study did not meet the response criteria to continue) Collapse << | - | United States, District of Col... more >>umbia Georgetown University Hospital/Lombardi Cancer Center Washington, District of Columbia, United States, 20007 Collapse << |
| NCT00702299 | - | - | Completed | - | - |
| NCT00461786 | Ovarian Cancer ... more >> Peritoneal Cancer Collapse << | Phase 2 | Completed | - | United States, Pennsylvania ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Philadelphia, Pennsylvania, United States Collapse << |
| NCT00508144 | Lung Cancer | Phase 2 | Completed | - | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
| NCT00508144 | - | - | Completed | - | - |
| NCT01565538 | - | - | Completed | - | - |
| NCT00864513 | - | - | Terminated(At interim analysis... more >> the study did not meet the response criteria to continue) Collapse << | - | - |
| NCT00410904 | Recurrent Non-small Cell Lung ... more >>Cancer Collapse << | Phase 2 | Completed | - | United States, Maryland ... more >> University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Michigan Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Collapse << |
| NCT00410904 | - | - | Completed | - | - |
| NCT00868192 | Ovarian Carcinoma ... more >> Primary Peritoneal Carcinoma Collapse << | Phase 2 | Completed | - | United States, Missouri ... more >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Collapse << |
| NCT00461786 | - | - | Completed | - | - |
| NCT00497315 | Non-Small Cell Lung Cancer | Phase 2 | Completed | - | Belgium ... more >> ZNA Middelheim Antwerpen, Antwerp, Belgium, 2020 University Hospital Antwerp Edegem, Antwerp, Belgium, 2650 St Augustinus Ziekenhuis Wilrijk, Antwerp, Belgium, 2610 Collapse << |
| NCT00630149 | Nasopharyngeal Neoplasms | Phase 2 | Completed | - | China, Guangdong ... more >> Cancer Center of Sun-Yat Sen University (CCSYSU) GuangZhou, Guangdong, China, 510000 Collapse << |
| NCT03374280 | Non Small Cell Lung Cancer | Phase 2 | Recruiting | December 30, 2021 | China, Guangdong ... more >> The first affiliated hospital of Guangzhou MC Recruiting Guangzhou, Guangdong, China, 510120 Contact: Haihong Yang, MD 0862083062825 bjrf2009@yahoo.com Principal Investigator: Haihong Yang, Dr. Collapse << |
| NCT01282151 | Carcinoma, Non Small Cell Lung | Phase 3 | Terminated(Difficulty in recru... more >>itment due to approval of maintenance pemetrexed treatment) Collapse << | - | Korea, Republic of ... more >> Chonnam National University Hwasun Hospital Hwasun, Jeonnam, Korea, Republic of, 519-709 Kyungpook National University Medical Center Daegu, Kyungpook, Korea, Republic of Hallym University Medical Center Anyang, Korea, Republic of Dankook University Hospital Cheonan, Korea, Republic of, 330-715 Keimyung University Dongsan Center Daegu, Korea, Republic of, 700-712 Yeungnam Univeristy Hospital Daegu, Korea, Republic of Chosun University Hospital Gwangju, Korea, Republic of Wonkwang University Hospital Iksan, Korea, Republic of Inha University Hospital Incheon, Korea, Republic of Pusan National University Hospital Pusan, Korea, Republic of, 602-739 Kosin University Gospel Hospital Pusan, Korea, Republic of Konkuk university medical center Seoul, Korea, Republic of, 143-729 Korea Cancer Center Hospital Seoul, Korea, Republic of Korea University Medical Center Seoul, Korea, Republic of Wonju Christian Hospital Wonju, Korea, Republic of Collapse << |
| NCT00434174 | Non Small Cell Lung Cancer | Phase 1 | Completed | - | Australia, New South Wales ... more >> Novartis Investigative Site Camperdown, New South Wales, Australia, 2050 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3002 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Germany Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Koeln, Germany, 50924 Collapse << |
| NCT00868192 | - | - | Completed | - | - |
| NCT00424723 | Neuroendocrine Tumors | Phase 2 | Completed | - | United States, Massachusetts ... more >> Dana-Farber Cancer Center Boston, Massachusetts, United States, 02115 Collapse << |
| NCT00321308 | Carcinoma, Non-Small Cell Lung | Phase 2 | Terminated(See Termination Rea... more >>son in Detailed Description.) Collapse << | - | United States, Arizona ... more >> Pfizer Investigational Site Litchfield Park, Arizona, United States, 85340 Pfizer Investigational Site Sun City, Arizona, United States, 85351 United States, Arkansas Pfizer Investigational Site Bentonville, Arkansas, United States, 72712 Pfizer Investigational Site Fayetteville, Arkansas, United States, 72703 United States, Florida Pfizer Investigational Site Hudson, Florida, United States, 34667 Pfizer Investigational Site New Port Richey, Florida, United States, 34655 United States, New Jersey Pfizer Investigational Site Mahwah, New Jersey, United States, 07430 Pfizer Investigational Site Midland Park, New Jersey, United States, 07432 Pfizer Investigational Site Paramus, New Jersey, United States, 07652 Pfizer Investigational Site Westwood, New Jersey, United States, 07675 United States, New York Pfizer Investigational Site Oneida, New York, United States, 13421 Pfizer Investigational Site Oswego, New York, United States, 13126 Pfizer Investigational Site Syracuse, New York, United States, 13210-2306 Pfizer Investigational Site Syracuse, New York, United States, 13210 United States, Ohio Pfizer Investigational Site Sylvania, Ohio, United States, 43560 United States, Washington Pfizer Investigational Site Seattle, Washington, United States, 89109 Pfizer Investigational Site Seattle, Washington, United States, 98195 Germany Pfizer Investigational Site Grosshansdorf, Germany, 22927 Pfizer Investigational Site Mannheim, Germany, 68167 Italy Pfizer Investigational Site Torino, Italy, 10126 Collapse << |
| NCT01336842 | Solid Tumors ... more >>Non-Small Cell Lung Cancer (NSCLC) Collapse << | Phase 1 | Completed | - | United States, California ... more >> University of California Davis Cancer Center Sacramento, California, United States, 95817 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 Collapse << |
| NCT00684099 | Non Small Cell Lung Cancer | Phase 1 Phase 2 | Completed | - | Greece ... more >> University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupolis, Greece "IASO" General Hospital of Athnes, Dep of Medical Oncology Athens, Greece "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece Sismanogleio General Hospital, 1st, 2nd Dep of Pulmonary Diseases Athens, Greece Sotiria" General Hospital, 1st Dep of Pulmonary Diseases Athens, Greece "Diabalkaniko" Hospital of Thessaloniki Thessaloniki, Greece "Theagenion" Anticancer Hospital of Thessaloniki Thessaloniki, Greece Collapse << |
| NCT01723800 | Recurrent Non-small Cell Lung ... more >>Cancer Stage IV Non-small Cell Lung Cancer Collapse << | Phase 1 | Completed | - | United States, California ... more >> City of Hope Medical Center Duarte, California, United States, 91010 Collapse << |
| NCT00786331 | Advanced Non-Small Cell Lung C... more >>ancer Collapse << | Phase 2 | Unknown | December 2009 | Italy ... more >> Azienda Ospedaliero-Universitaria Umberto I, Clinica di Oncologia Medica Active, not recruiting Ancona, Italy, 60020 Azienda Ospedaliera Ospedali Riuniti di Bergamo, UO di Oncologia Medica Recruiting Bergamo, Italy, 24128 Principal Investigator: Roberto Labianca, MD Azienda Istituti Ospitalieri di Cremona, UO di Oncologia Medica Recruiting Cremona, Italy, 26100 Principal Investigator: Rodolfo Passalacqua, MD Azienda Sanitaria Ospedaliera S. Croce e Carle, UO di Oncologia Medica Recruiting Cuneo, Italy, 12100 Principal Investigator: Marco Merlano, MD Ospedale S. Croce, U.O. di Oncologia Medica Recruiting Fano, PU, Italy, 61032 Principal Investigator: Rodolfo Mattioli, MD Azienda Ospedaliera Careggi, UO di Oncologia Medica Recruiting Firenze, Italy, 50139 Principal Investigator: Francesco Di Costanzo, MD EO Ospedali Galliera, SC Oncologia Medica Recruiting Genova, Italy, 16128 Principal Investigator: Andrea Decensi, MD Ospedale Versilia, UO di Oncologia Medica Recruiting Lido di Camaiore, LU, Italy, 55043 Principal Investigator: Domenico Amoroso, MD USL 6, Presidio Ospedaliero di Livorno, U.O. di Oncologia MedicaAzienda Recruiting Livorno, Italy, 57122 Principal Investigator: Alfredo Falcone, MD Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-IRST, Oncologia Medica Recruiting Meldola, FC, Italy, 47014 Principal Investigator: Dino Amadori, MD Istituto Nazionale Tumori, SC di Oncologia 2 Recruiting Milano, Italy, 20133 Principal Investigator: Emilio Baietta, MD Azienda Ospedaliero-Universitaria di Modena-Policlinico, U.O. di Oncologia Medica ed Ematologia Recruiting Modena, Italy, 41100 Principal Investigator: Fausto Barbieri, MD AO S. Gerardo, Nuovo Ospedale S. Gerardo-settore A, Oncologia Medica Not yet recruiting Monza, MI, Italy, 20052 Principal Investigator: Paolo Bidoli, MD Azienda Ospedaliero-Universitaria di Parma, UOC di Oncologia Medica Recruiting Parma, Italy, 43100 Principal Investigator: Andrea Ardizzoni, MD Ospedale Silvestrini, S.C. di Oncologia Medica Recruiting Perugia, Italy, 06156 Principal Investigator: Lucio Crinò, MD Arcispedale Santa Maria Nuova, UO di Oncologia Medica Recruiting Reggio Emilia, Italy, 42100 Principal Investigator: Corrado Boni, MD Azienda Ospedaliera S. Camillo-Forlanini, U.O. di Oncologia Medica Recruiting Roma, Italy, 00151 Principal Investigator: Filippo De Marinis, MD Ospedale SS. Annunziata, UO di Oncologia Medica Recruiting Sassari, Italy, 07100 Principal Investigator: Antonio Contu, MD Azienda Sanitaria Ospedaliera Molinette, U.O. di Oncologia Medica Recruiting Torino, Italy, 10126 Principal Investigator: Libero Ciuffreda, MD P.O. Treviglio-Caravaggio, U.O. di Oncologia Medica Not yet recruiting Treviglio, BG, Italy, 24047 Principal Investigator: Barni Sandro, MD Policlinico "G. B. Rossi"-Borgo Roma, U.O. di Oncologia Medica Clinicizzata Recruiting Verona, Italy, 37126 Principal Investigator: Antonio Santo, MD Collapse << |
| NCT03744793 | Infiltrating Bladder Urothelia... more >>l Carcinoma Sarcomatoid Variant Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant Metastatic Urothelial Carcinoma MTAP Negative Collapse << | Phase 2 | Not yet recruiting | January 1, 2020 | United States, Texas ... more >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Amishi Y. Shah 713-792-2830 Principal Investigator: Amishi Y. Shah Collapse << |
| NCT00540241 | - | - | Completed | - | Germany ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bad Homburg, Germany, 61352 Collapse << |
| NCT00923637 | Non Small Cell Lung Cancer | Phase 2 | Unknown | June 2015 | China, Guangdong ... more >> The First Affiliated Hospital of Guangzhou Medical College Recruiting Guangzhou, Guangdong, China, 510120 Contact: Daoyuan Wang, MD +86-20-83337792 ghealth2008@gmail.com Contact: Wenlong Shao, MD +86-20-83337792 myfriends2003@126.com Principal Investigator: Jianxing He, MD, FACS Collapse << |
| NCT03366766 | Non-Squamous Non-Small Cell Lu... more >>ng Carcinoma Stage I Non-Small Cell Lung Cancer Stage IA Non-Small Cell Lung Carcinoma Stage IB Non-Small Cell Lung Carcinoma Stage II Non-Small Cell Lung Cancer Stage IIA Non-Small Cell Lung Carcinoma Stage IIB Non-Small Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer Collapse << | Phase 2 | Recruiting | July 2022 | United States, Pennsylvania ... more >> Abington Hospital - Jefferson Health Not yet recruiting Abington, Pennsylvania, United States, 19001 Contact: Mark Sundemeyer, MD 215-481-2400 Principal Investigator: Mark Sundemeyer, MD Sidney Kimmel Cancer Center at Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Ralph Zinner, MD 215-503-5098 ralph.zinner@jefferson.edu Lankenau Institute for Medical Research Not yet recruiting Wynnewood, Pennsylvania, United States, 19096 Contact: Paul Gilman, MD 484-476-4837 Principal Investigator: Paul Gilman, MD Collapse << |
| NCT00438204 | Lung Cancer | Phase 2 | Terminated(All data collection... more >> has completed.) Collapse << | - | United States, Michigan ... more >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0942 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Collapse << |
| NCT00438204 | - | - | Terminated(All data collection... more >> has completed.) Collapse << | - | - |
| NCT02693717 | Bladder Cancer ... more >> Urothelial Cancer Collapse << | Phase 2 | Recruiting | May 2020 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact jgao1@mdanderson.org MD Anderson Katy Regional Care Center Recruiting Houston, Texas, United States, 77094 Contact: Jennifer Wang, MD MD Anderson Sugarland Regional Care Center Recruiting Sugar Land, Texas, United States, 77478 Contact: Jennifer Wang, MD Collapse << |
| NCT02838745 | Mesothelioma | Phase 1 | Recruiting | August 2018 | United States, Texas ... more >> Baylor St Lukes Recruiting Houston, Texas, United States, 77030 Contact: Michelle G Almarez, BBA 713-798-3680 Michelle.Almarez@bcm.edu Contact: Bryan Burt, MD 713-798-8266 Bryan.Burt@bcm.edu Principal Investigator: Bryan Burt, MD Collapse << |
| NCT00434135 | Non-Small Cell Lung Cancer ... more >> Stage IIIB or IV Collapse << | Phase 2 | Completed | - | Italy ... more >> National Tumor Institute Naples, Italy, 80131 Collapse << |
| NCT00529100 | - | - | Completed | - | - |
| NCT00507858 | Head and Neck Cancer | Phase 1 | Completed | - | United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
| NCT01909830 | Colorectal Cancer Metastatic | Phase 2 | Completed | - | Italy ... more >> UO Oncologia Medica IRCCS IRST Meldola (FC), FC, Italy, 47014 Collapse << |
| NCT01836575 | Non Small Cell Lung Carcinoma | Phase 3 | Completed | - | United States, Florida ... more >> The Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States, 33140 Brazil Instituto do Câncer do Ceará - ICC Fortaleza, Ceará, Brazil Hospital Lifecenter Belo Horizonte, Minas Gerais, Brazil Hospital Caridade de Ijuí - CACON Ijuí, RS, Brazil Hospital São Lucas Porto Alegre, RS, Brazil Centro de Pesquisas Oncológicas - CEPON Florianópolis, Santa Catarina, Brazil Hospital Amaral Carvalho Jaú, São Paulo, Brazil INCA Rio de Janeiro, Brazil Instituto do Câncer Arnaldo Vieira de Carvalho São Paulo, Brazil Collapse << |
| NCT00529100 | Non-Small Cell Lung Cancer | Phase 1 Phase 2 | Completed | - | Canada, Alberta ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Edmonton, Alberta, Canada, T6G 1Z2 Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamilton, Ontario, Canada, L8V 5C2 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ottawa, Ontario, Canada, K1H 8L6 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toronto, Ontario, Canada, M5G 2M9 Collapse << |
| NCT00216216 | Small Cell Lung Cancer | Phase 2 | Terminated(The results from th... more >>e interim analysis were not favorable to continue this trial.) Collapse << | - | United States, Delaware ... more >> Helen F. Graham Cancer Center Newark, Delaware, United States, 19713 United States, Illinois Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Elkhart Clinic Elkhart, Indiana, United States, 46515 Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Center for Cancer Care at Goshen Health System Goshen, Indiana, United States, 46527 Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Community Regional Cancer Center Indianapolis, Indiana, United States, 46256 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Center for Cancer Care, Inc., P.C. New Albany, Indiana, United States, 47150 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 Northern Indiana Oncology Associates South Bend, Indiana, United States, 46617 AP&S Clinic Terre Haute, Indiana, United States, 47804 United States, Missouri Siteman Cancer Center St. Louis, Missouri, United States, 63110 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 Collapse << |
| NCT00906282 | Non Small Cell Lung Cancer | Phase 2 | Completed | - | United States, Florida ... more >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Medical Oncology Associates of Augusta Augusta, Georgia, United States, 30901 Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, Nebraska Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 Collapse << |
| NCT00906282 | - | - | Completed | - | - |
| NCT03537833 | - | - | Recruiting | September 1, 2020 | France ... more >> Chu Reims Recruiting Reims, France, 51092 Contact: Damien JOLLY 326788472 ext 33 djolly@chu-reims.fr Collapse << |
| NCT00528619 | Neoplasms | Phase 1 | Completed | - | United States, Colorado ... more >> Pfizer Investigational Site Aurora, Colorado, United States, 80045 Canada, Ontario Pfizer Investigational Site Ottawa, Ontario, Canada, K1H 8L6 Canada, Quebec Pfizer Investigational Site Montreal, Quebec, Canada, H2L 4M1 Collapse << |
| NCT00528281 | Lung Cancer, Non-Small Cell | Phase 1 | Completed | - | Germany ... more >> GSK Investigational Site Heidelberg, Baden-Wuerttemberg, Germany, 69126 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 Italy GSK Investigational Site Orbassano (TO), Piemonte, Italy, 10043 Poland GSK Investigational Site Poznan, Poland, 60-569 United Kingdom GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE7 7DN Collapse << |
| NCT00489359 | Ovarian Cancer ... more >> Primary Peritoneal Cancer Collapse << | Phase 1 Phase 2 | Completed | - | Argentina ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bahia Blanca, Argentina, B8000HXM For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Buenos Aires, Argentina, C1199ACK For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ramos Mejia, Argentina, B1704ESN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salta, Argentina, 4400 Canada, Alberta For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toronto, Ontario, Canada, M5G 2M9 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 13353 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bonn, Germany, 53127 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chemnitz, Germany, D-09116 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Duesseldorf, Germany, 40489 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Erlangen, Germany, D-91054 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Essen, Germany, DE-45145 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 22081 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jena, Germany, D-07743 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kiel, Germany, D-24105 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, 55131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tübingen, Germany, 72076 Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gdansk, Poland, 80-402 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Olsztyn, Poland, 10-228 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland, 00909 Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Göteborg, Sweden, 416 85 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lund, Sweden, 22241 Collapse << |
| NCT01783834 | Previous Treated Metastatic No... more >>n-small Cell Lung Cancer Collapse << | Phase 2 | Completed | - | Korea, Republic of ... more >> Gachon university Gil Medical Center Incheon, Korea, Republic of Collapse << |
| NCT00692159 | Neoplasm | Phase 1 | Completed | - | United States, Arizona ... more >> Scottsdale, Arizona, United States, 85260 United States, California Santa Monica, California, United States, 90404 United States, Ohio Cleveland, Ohio, United States, 44106 Collapse << |
| NCT00976456 | Non-squamous Non-small Cell Lu... more >>ng Cancer Collapse << | Phase 3 | Completed | - | Germany ... more >> Krankenhaus Martha-Maria Halle-Doelau Halle, Germany, 06120 Collapse << |
| NCT00976456 | - | - | Completed | - | - |
| NCT01442909 | Non-small-cell Lung Cancer | Phase 4 | Completed | - | Taiwan ... more >> Taipei VGH Taipei City, Taiwan, 112 Collapse << |
| NCT02624700 | Breast Cancer ... more >> Metastatic Breast Cancer Recurrent Breast Cancer Collapse << | Phase 2 | Recruiting | April 1, 2025 | United States, Virginia ... more >> Virginia Commonwealth University/Massey Cancer Center Recruiting Richmond, Virginia, United States, 23298 Contact: Alison Ryan, NP 804-628-1936 masseysiit@vcu.edu Contact: Andrew S Poklepovic, MD 804-628-2321 andrew.poklepovic@vcuhealth.org Principal Investigator: Andrew S Poklepovic, MD Collapse << |
| NCT01105390 | Advanced Malignant Mesotheliom... more >>a Epithelial Mesothelioma Recurrent Malignant Mesothelioma Sarcomatous Mesothelioma Collapse << | Phase 2 | Withdrawn(withdrawn) | - | - |
| NCT00489359 | - | - | Completed | - | - |
| NCT03607149 | Non-small Cell Lung Cancer | Phase 4 | Recruiting | January 6, 2021 | France ... more >> CH William Morey Not yet recruiting Chalon-sur-Saône, France, 71100 Contact: Marie-Fleur QUILLOT Fleur-marie.quilot@ch-chalon71.fr Contact: Jerome POIROT jerome.poirot@ch-chalon71.fr Centre Georges Francois Leclerc Recruiting Dijon, France, 21079 Contact: Bruno COUDERT 03 80 73 75 28 bcoudert@cgfl.fr Contact: Emilie REDERSTORFF 03.45.34.81.16 erederstorff@cgfl.fr Principal Investigator: Bruno COUDERT Sub-Investigator: Aurélie LAGRANGE Sub-Investigator: Laure FAVIER Centre Universitaire Hospitalier de Dijon Not yet recruiting Dijon, France, 21079 Contact: Pascal FOUCHER 03 80 29 37 72 pascal.foucher@chu-dijon.fr Collapse << |
| NCT00470548 | Breast Cancer ... more >> Lung Cancer Unspecified Adult Solid Tumor, Protocol Specific Collapse << | Phase 1 Phase 2 | Terminated(Practice patterns w... more >>ith pemetrexed have evolved.) Collapse << | - | United States, California ... more >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Collapse << |
| NCT00470548 | - | - | Terminated(Practice patterns w... more >>ith pemetrexed have evolved.) Collapse << | - | - |
| NCT00268489 | Lung Cancer | Phase 2 | Completed | - | - |
| NCT00387322 | Lung Cancer U... more >>nspecified Adult Solid Tumor, Protocol Specific Collapse << | Phase 1 Phase 2 | Completed | - | United States, California ... more >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Collapse << |
| NCT00701857 | Esophageal Cancer | Phase 1 | Completed | - | United States, Arizona ... more >> University of Arizona Cancer Center Tucson, Arizona, United States, 85724 Collapse << |
| NCT03768037 | Advanced Non-squamous NSCLC | Phase 4 | Recruiting | November 26, 2020 | China, Beijing ... more >> Beijing Chest Hospital Recruiting Beijing, Beijing, China, 101149 Contact: Shucai Zhang 86-010-89509324 sczhang6304@163.com Contact: Zhe Liu 86-010-89509323 liuzhe1968@aliyun.com Collapse << |
| NCT01664754 | Stage IV Non-small Cell Lung C... more >>ancer Collapse << | Phase 1 | Active, not recruiting | September 30, 2019 | United States, California ... more >> Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 Collapse << |
| NCT00310050 | Pancreatic Cancer | Phase 1 | Terminated(slow accrual) | - | United States, North Carolina ... more >> Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Collapse << |
| NCT02829008 | Metastatic Breast Cancer | Phase 2 | Active, not recruiting | April 2020 | China, Beijing ... more >> Cancer Hospital, ChineseAMS Beijing, Beijing, China, 100021 Collapse << |
| NCT02093962 | - | - | Terminated(At the interim anal... more >>ysis, the futility boundary was not met and the study was stopped due to insufficient efficacy.) Collapse << | - | - |
| NCT02093962 | Non-small Cell Lung Cancer | Phase 2 | Terminated(At the interim anal... more >>ysis, the futility boundary was not met and the study was stopped due to insufficient efficacy.) Collapse << | - | - |
| NCT00310050 | - | - | Terminated(slow accrual) | - | - |
| NCT00053209 | Bladder Cancer ... more >> Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer Collapse << | Phase 2 | Completed | - | - |
| NCT02535312 | Advanced Malignant Solid Neopl... more >>asm Advanced Peritoneal Malignant Mesothelioma Advanced Pleural Malignant Mesothelioma Recurrent Peritoneal Malignant Mesothelioma Recurrent Pleural Malignant Mesothelioma Stage III Non-Small Cell Lung Cancer AJCC v7 Stage III Ovarian Cancer AJCC v6 and v7 Stage III Pleural Malignant Mesothelioma AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIA Ovarian Cancer AJCC v6 and v7 Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Stage IIIB Ovarian Cancer AJCC v6 and v7 Stage IIIC Ovarian Cancer AJCC v6 and v7 Stage IV Non-Small Cell Lung Cancer AJCC v7 Stage IV Ovarian Cancer AJCC v6 and v7 Stage IV Pleural Malignant Mesothelioma AJCC v7 Thymoma Unresectable Solid Neoplasm Collapse << | Phase 1 Phase 2 | Recruiting | - | United States, California ... more >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Site Public Contact 800-826-4673 becomingapatient@coh.org Principal Investigator: Marianna Koczywas Los Angeles County-USC Medical Center Recruiting Los Angeles, California, United States, 90033 Contact: Site Public Contact 323-865-0451 Principal Investigator: Anthony El-Khoueiry USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Site Public Contact 323-865-0451 Principal Investigator: Anthony El-Khoueiry Keck Medical Center of USC Pasadena Recruiting Pasadena, California, United States, 91105 Contact: Site Public Contact 323-865-0451 Principal Investigator: Anthony El-Khoueiry University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Site Public Contact 916-734-3089 Principal Investigator: Karen L. Kelly United States, Colorado University of Colorado Hospital Recruiting Aurora, Colorado, United States, 80045 Contact: Site Public Contact 720-848-0650 Principal Investigator: Stephen Leong United States, Maryland University of Maryland/Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Site Public Contact 800-888-8823 Principal Investigator: Edward A. Sausville United States, Michigan University of Michigan Comprehensive Cancer Center Suspended Ann Arbor, Michigan, United States, 48109 United States, Minnesota Mayo Clinic Active, not recruiting Rochester, Minnesota, United States, 55905 United States, Ohio Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Site Public Contact 800-293-5066 Jamesline@osumc.edu Principal Investigator: Gregory A. Otterson United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Site Public Contact 412-647-8073 Principal Investigator: Liza C. Villaruz United States, Tennessee Vanderbilt University/Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Site Public Contact 800-811-8480 Principal Investigator: Leora Horn United States, Wisconsin University of Wisconsin Hospital and Clinics Active, not recruiting Madison, Wisconsin, United States, 53792 Collapse << |
| NCT00316225 | Non-small Cell Lung Cancer ... more >> Mesothelioma Lung Neoplasms Collapse << | Phase 2 | Completed | - | Denmark ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kobenhavn, Denmark, 2100 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30625 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28041 Collapse << |
| NCT00316225 | - | - | Completed | - | - |
| NCT01784640 | Recurrent Non-small Cell Lung ... more >>Cancer Squamous Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Collapse << | Phase 1 | Active, not recruiting | January 31, 2020 | United States, California ... more >> Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 Collapse << |
| NCT00589667 | Head and Neck Cancer | Phase 2 | Completed | - | United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Collapse << |
| NCT01397305 | Rectal Cancer | Phase 1 Phase 2 | Completed | - | Sweden ... more >> Sahlgrenska University Hospital Göteborg, Sweden, 416 85 Collapse << |
| NCT01001910 | Recurrent Fallopian Tube Carci... more >>noma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Collapse << | Phase 2 | Completed | - | United States, New York ... more >> Albert Einstein College of Medicine Bronx, New York, United States, 10461 Columbia University Medical Center New York, New York, United States, 10032 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Collapse << |
| NCT00293579 | - | - | Completed | - | - |
| NCT00276783 | Brain and Central Nervous Syst... more >>em Tumors Lymphoma Metastatic Cancer Collapse << | Phase 2 | Active, not recruiting | December 2019 | United States, Illinois ... more >> Hematology-Oncology Associates of Illinois Chicago, Illinois, United States, 60611-2998 Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Collapse << |
| NCT01088906 | Carcinoma, Non Small Cell Lung | Phase 2 | Terminated(No safety reasons. ... more >>Low recruitment.) Collapse << | - | Spain ... more >> H. Clínica Benidorm Benidorm, Alicante, Spain, 03501 H. General de Elche Elche, Alicante, Spain, 03202 H. Germans Trias i Pujol Badalona, Barcelona, Spain, 088916 H. Insular de Gran Canarias Las Palmas de Gran Canarias, Gran Canarias, Spain, 35016 H. Universitario de Canarias La Laguna, Tenerife, Spain, 38320 MD Anderson Madrid, Spain, 28033 Hospital 12 de Octubre Madrid, Spain, 28041 H. Morales Messeguer Murcia, Spain, 30008 Collapse << |
| NCT00589667 | - | - | Completed | - | - |
| NCT01473563 | Nonsquamous Non-Small Cell Neo... more >>plasm of Lung Non-Small Cell Lung Cancer Metastatic Non-Small Cell Lung Cancer Stage IIIB Collapse << | Phase 2 | Completed | - | Sweden ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Linkoping, Sweden, 58185 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Solna, Sweden, 17176 United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, Greater London, United Kingdom, SE1 9RT For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Maidstone, Kent, United Kingdom, ME16 9QQ For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nottingham, Nottinghamshire, United Kingdom, NG5 1PD For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aberdeen, Scotland, United Kingdom, AB25 2ZN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Huddersfield, West Yorkshire, United Kingdom, HD3 3EA For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, United Kingdom, B95SS For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Manchester, United Kingdom, M20 4BX Collapse << |
| NCT01473563 | - | - | Completed | - | - |
| NCT03023319 | Carcinoma, Non-Small-Cell Lung... more >> Mesothelioma Bladder Cancer Ovarian Cancer Peritoneal Cancer Thymoma Thymus Cancer Uterine Cervical Cancer Collapse << | Phase 1 | Recruiting | July 2020 | United States, Ohio ... more >> UC Health Recruiting Cincinnati, Ohio, United States, 45219 Contact: UCCI Clinical Trials Office 513-584-7698 kastla@ucmail.uc.edu Collapse << |
| NCT00293579 | Head and Neck Cancer | Phase 2 | Completed | - | United States, Ohio ... more >> Ohio State University Columbus, Ohio, United States, 43210 Collapse << |
| NCT00921310 | Carcinoma, Non-Small-Cell Lung | Phase 1 Phase 2 | Terminated(Withdrawal of fundi... more >>ng from sponsor) Collapse << | - | United States, Missouri ... more >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Collapse << |
| NCT00487669 | Advanced Non-small Cell Lung C... more >>ancer Collapse << | Phase 2 | Completed | - | United States, New Hampshire ... more >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Collapse << |
| NCT00700336 | Malignant Pleural Mesothelioma... more >> Solid Tumors Collapse << | Phase 1 Phase 2 | Completed | - | United States, Arizona ... more >> Mayo Clinic Scottsdale, Arizona, United States Arizona Cancer Center Tucson, Arizona, United States United States, California City of Hope Duarte, California, United States United States, Illinois University of Chicago Chicago, Illinois, United States United States, Michigan Karmanos Cancer Institute/Wayne State University Detroit, Michigan, United States United States, Nevada Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 United States, New Mexico University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87131 United States, New York Memorial-Sloan Kettering Cancer Center New York, New York, United States, 10022 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States United States, Pennsylvania Penn State Milton S. Hershey Medical Ctr. Hershey, Pennsylvania, United States, 17033 United States, Texas Cancer Therapy & Research Center San Antonio, Texas, United States, 78229 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States Collapse << |
| NCT00907179 | Non-Small Cell Lung Cancer | Phase 1 | Terminated(Widespread use firs... more >>tline Pemetrexed; slow recruitment; funding withdrawn..) Collapse << | - | United States, Pennsylvania ... more >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Collapse << |
| NCT00487669 | - | - | Completed | - | - |
| NCT00107419 | Sarcoma | Phase 2 | Completed | - | - |
| NCT00921310 | - | - | Terminated(Withdrawal of fundi... more >>ng from sponsor) Collapse << | - | - |
| NCT03460678 | Carcinoma, Non-Small-Cell Lung | Phase 4 | Recruiting | December 2019 | Jordan ... more >> King Hussein Cancer Center (KHCC) Recruiting Amman, Jordan, 11118 Principal Investigator: Taher Abu Hijleh, MD Sub-Investigator: Samir Yaser, MD Sub-Investigator: Kamal Al Rabi, MD Lebanon American University of Beirut Medical Center Not yet recruiting Beirut, Lebanon, 1107 2020 Principal Investigator: Arafat Tfayli, MD Collapse << |
| NCT01450384 | Unspecified Adult Solid Tumor | Phase 1 | Completed | - | United States, Virginia ... more >> Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Collapse << |
| NCT00738881 | Recurrent Non-Small Cell Lung ... more >>Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer Collapse << | Phase 3 | Terminated(Slow accrual) | - | - |
| NCT00738881 | - | - | Terminated(Slow accrual) | - | - |
| NCT02426658 | Stage IV Non-Small Cell Lung C... more >>ancer Collapse << | Phase 2 | Recruiting | November 2019 | United States, North Carolina ... more >> Comprehensive Cancer Center of Wake Forest University Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Stefan C. Grant 336-713-5172 scgrant@wakehealth.edu Principal Investigator: Stefan C. Grant Collapse << |
| NCT00265785 | Lung Cancer | Phase 2 | Terminated(Closed due to poor ... more >>accrual) Collapse << | - | - |
| NCT00712062 | Primary Central Nervous System... more >> Lymphoma Collapse << | Phase 2 | Withdrawn(Lack of accrual) | - | - |
| NCT01953419 | Gastric Cancer | Phase 2 | Completed | - | China, Guangdong ... more >> Sun Yat-sen UniversityCancer center Guangzhou, Guangdong, China, 510060 Collapse << |
| NCT00424242 | Brain and Central Nervous Syst... more >>em Tumors Chronic Myeloproliferative Disorders Leukemia Lymphoma Lymphoproliferative Disorder Metastatic Cancer Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Precancerous Condition Secondary Myelofibrosis Unspecified Adult Solid Tumor, Protocol Specific Collapse << | Early Phase 1 | Active, not recruiting | March 2020 | United States, Illinois ... more >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Collapse << |
| NCT02004184 | Carcinoma, Non-small-cell Lung | Phase 3 | Terminated(Poor enrollment due... more >> to the introduction of immunotherapy) Collapse << | - | Norway ... more >> St Olavs Hospital Trondheim, Norway Collapse << |
| NCT02518802 | Lung Neoplasms | Phase 3 | Recruiting | January 2020 | China, Shaanxi ... more >> Tangdu Hospital of the Fourth Millitary Medical University Recruiting Xi'an, Shaanxi, China, 710038 Contact: Li Xiaofei, MD +8629,84777436 lxfchest@fmmu.edu.cn Contact: Yan Xiaolong, MD +862984717558 yanxiaolong@fmmu.edu.cn Collapse << |
| NCT02588781 | Colorectal Cancer | Phase 2 | Recruiting | July 2018 | Korea, Republic of ... more >> Samsung Medical Center Recruiting Seoul, seoul, korea, Republic of, Korea, Republic of, 135-710 Contact: yoonJeong Ahn 221487395 ext 82 Principal Investigator: SeungTae Kim, M.D., Ph.D. Collapse << |
| NCT01172028 | Breast Cancer ... more >> Esophageal Cancer Gastric Cancer Head and Neck Cancer Lung Cancer Ovarian Cancer Prostate Cancer Collapse << | Phase 1 | Completed | - | United States, Arizona ... more >> Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724-5024 Collapse << |
| NCT00265785 | - | - | Terminated(Closed due to poor ... more >>accrual) Collapse << | - | - |
| NCT01333696 | Squamous Cell Carcinoma of Hea... more >>d and Neck Collapse << | Phase 2 | Unknown | June 2013 | China ... more >> Fudan University Shanghai Cancer Center Recruiting Shanghai, China, 200032 Contact: Ye Guo, MD 86 21 64175590 ext 8906 pattrick_guo@msn.com Principal Investigator: Ye Guo, MD Collapse << |
| NCT02134912 | Adenocarcinoma of the Lung ... more >> Large Cell Lung Cancer Recurrent Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Collapse << | Phase 2 | Terminated(science has moved f... more >>orward and there is no intent to complete the study) Collapse << | - | - |
| NCT01918761 | Non Small Cell Lung Cancer | Phase 1 | Suspended(poor accrual) | September 15, 2018 | Austria ... more >> Medizinische Universität Graz Klinische Abteilung für Onkologie Graz, Austria Universitätsklinik für Innere Medizin I Innsbruck, Austria Collapse << |
| NCT02284490 | Brain Metastases | Phase 2 | Unknown | November 2017 | China, Shandong ... more >> Neurosurgery, Shandong Cancer Hospital and Institute Jinan, Shandong, China, 250117 Collapse << |
| NCT02868892 | - | - | Terminated(departure of PI fro... more >>m institution and poor population for study participation) Collapse << | - | - |
| NCT00230542 | Ovarian Cancer ... more >> Peritoneal Cancer Fallopian Tube Cancer Collapse << | Phase 2 | Completed | - | United States, Massachusetts ... more >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Collapse << |
| NCT02868892 | Adenocarcinoma of the Cervix ... more >> Adenosquamous Cell Carcinoma of the Cervix Collapse << | Phase 2 | Terminated(departure of PI fro... more >>m institution and poor population for study participation) Collapse << | - | United States, Arizona ... more >> Western Regional Medical Center, Inc. Goodyear, Arizona, United States, 85338 Collapse << |
| NCT01287520 | Advanced Cancer | Phase 1 | Completed | - | United States, Florida ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampa, Florida, United States United States, Tennessee For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nashville, Tennessee, United States Collapse << |
| NCT02980991 | Lung Adenocarcinoma | Phase 2 | Unknown | April 2018 | China ... more >> Fudan University Shanghai Cancer Center Recruiting Shanghai, China, 200032 Contact: Haiquan Chen, MD +86-21 64175590 ext 1707 hqchen1@yahoo.com Contact: Xinghua Cheng, MD,PhD +8618017317567 chengxinghua_001@163.com Principal Investigator: Haiquan Chen, MD Collapse << |
| NCT00490373 | Pancreatic Cancer | Phase 2 | Completed | - | Germany ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany Collapse << |
| NCT00065533 | Breast Cancer | Phase 2 | Completed | - | Argentina ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Buenos Aires, Argentina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Capitol Federal, Argentina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. S.M. De Tucuman, Argentina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Tucuman, Argentina Belgium For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Brussels, Belgium For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Leuven, Belgium For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Namur, Belgium Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Munich, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Wiesbaden, Germany Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Bucuresti, Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Cluj, Romania Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Badalona, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Barcelona, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Madrid, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Malaga, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Santander, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Valencia, Spain United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Newcastle Upon Tyne, Tyne and Wear, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Birmingham, West Midlands, United Kingdom Collapse << |
| NCT00786552 | Thyroid Cancer | Phase 2 | Unknown | November 2013 | Germany ... more >> Medical Center II, University of Kiel Recruiting Kiel, Germany, 24105 Contact: Joerg T Hartmann, MD +49 431 597 2484 joerg.hartmann@uk-sh.de Collapse << |
| NCT00227019 | Non-small Cell Lung Cancer (NS... more >>CLC) Lung Cancer Neoplasm Metastasis Collapse << | Phase 2 | Completed | - | United States, California ... more >> Stanford University School of Medicine Stanford, California, United States, 94305 United States, New Hampshire Norris Cotton Cancer Center Lebanon, New Hampshire, United States, 03756 United States, New Jersey Cooper Cancer Institute Voorhees, New Jersey, United States, 08043 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 Collapse << |
| NCT00227019 | - | - | Completed | - | - |
| NCT00614965 | Non Small Cell Lung Cancer | Phase 2 | Completed | - | Greece ... more >> Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece Collapse << |
| NCT00606021 | Non Small Cell Lung Cancer | Phase 2 | Completed | - | Egypt ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Assiut, Egypt, 0000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cairo, Egypt, 11372 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mounofia, Egypt, 32514 Lebanon For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beirut, Lebanon Saudi Arabia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Riyadh, Saudi Arabia, 11211 Collapse << |
| NCT00380718 | Non-small Cell Lung Cancer | Phase 4 | Completed | - | Taiwan ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 407 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 112 Collapse << |
| NCT00606021 | - | - | Completed | - | - |
| NCT00923273 | Carcinoma, Non-Small-Cell Lung | Phase 1 Phase 2 | Completed | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
| NCT00380718 | - | - | Completed | - | - |
| NCT00923273 | - | - | Completed | - | - |
| NCT00191308 | - | - | Completed | - | - |
| NCT00886678 | Non-Small Cell Lung Cancer | Phase 2 | Unknown | July 2010 | China, Zhejiang ... more >> Zhejiang Cancer Hospital Hangzhou, Zhejiang, China, 310022 Collapse << |
| NCT00061464 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Completed | - | United States, Florida ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Miami, Florida, United States United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Chicago, Illinois, United States United States, Louisiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Shreveport, Louisiana, United States United States, South Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Columbia, South Carolina, United States Collapse << |
| NCT00191308 | Non-Small Cell Lung Cancer ... more >> Carcinoma Collapse << | Phase 2 | Completed | - | Poland ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bystra Slaska, Poland, 43-360 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland, 60-569 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland, 02-781 Collapse << |
| NCT00754364 | NSCLC | Phase 2 | Terminated(low enrollment rate... more >>) Collapse << | December 2015 | Italy ... more >> Istituto Clinco Humanitas Rozzano, Milan, Italy, 20089 Collapse << |
| NCT00061451 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Completed | - | United States, California ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palo Alto, California, United States United States, Missouri For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Columbia, Missouri, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kansas City, Missouri, United States United States, Montana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Great Falls, Montana, United States United States, Washington For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seattle, Washington, United States Collapse << |
| NCT02488694 | Non-small-cell Lung Cancer Wit... more >>h Somatic EGFR Mutations Collapse << | Phase 2 | Terminated(unsufficient recrui... more >>tment) Collapse << | - | Germany ... more >> Universitätsklinikum Essen Essen, Germany Collapse << |
| NCT02879669 | To Determine Safety, Tolerabil... more >>ity and Efficacy of ONCOS-102 in Combination With Chemotherapy Collapse << | Phase 1 Phase 2 | Recruiting | - | France ... more >> Centre Georges-François Leclerc Recruiting Dijon, France Contact: Nicolas Isambert, MD CHU de Rennes - Pontchaillou Recruiting Rennes, France Contact: Hervé Lena, MD Spain Hospital Universitario Quirón Recruiting Barcelona, Spain Contact: Santiago Viteri Vall d'Hebron Univerity Hospital Recruiting Barcelona, Spain Contact: Susanna Cedres, MD Hospital Universitari de Girona Doctor Josep Trueta - Institut Català d'Oncologia Recruiting Girona, Spain Contact: Joaquim Bosch Hospital 12 de octubre Recruiting Madrid, Spain Contact: Luis Paz-Ares, MD Hospital Universitario HM Sanchinarro Recruiting Madrid, Spain Contact: Javier de Castro, MD Collapse << |
| NCT01837329 | Non-Small Cell Lung Cancer | Phase 1 | Recruiting | October 2018 | United States, New York ... more >> University of Rochester Recruiting Rochester, New York, United States, 14642 Contact: Amy Jasek 585-273-1912 Amy_Jasek@urmc.rochester.edu Principal Investigator: David Dougherty, MD Collapse << |
| NCT00573989 | Head and Neck Cancer | Phase 1 Phase 2 | Terminated(Drug Supply Issue) | - | United States, North Carolina ... more >> UNC Linberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Collapse << |
| NCT00409006 | Non-small Cell Lung Cancer | Phase 2 | Completed | - | China ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fujian, China, 350014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Qingdao, China, 266003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 201900 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 137-701 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changhua, Taiwan, 500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 Collapse << |
| NCT00573989 | - | - | Terminated(Drug Supply Issue) | - | - |
| NCT00651456 | Mesothelioma | Phase 2 Phase 3 | Completed | - | - |
| NCT00867009 | - | - | Completed | - | - |
| NCT00409006 | - | - | Completed | - | - |
| NCT00533429 | Non-small Cell Lung Cancer | Phase 2 | Completed | - | United States, Arkansas ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bentonville, Arkansas, United States, 72712 United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States, 60611 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Galesburg, Illinois, United States, 61401 United States, Indiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bloomington, Indiana, United States, 47403 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Evansville, Indiana, United States, 47714 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fort Wayne, Indiana, United States, 46815 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States, 46202 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lafayette, Indiana, United States, 47904 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Muncie, Indiana, United States, 47303 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. South Bend, Indiana, United States, 46601 United States, Michigan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jackson, Michigan, United States, 49201 United States, Nebraska For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Omaha, Nebraska, United States, 68114 Collapse << |
| NCT00867009 | Non-Small-Cell Lung Cancer | Phase 2 | Completed | - | Austria ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Graz, Austria, 8036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salzburg, Austria, 5020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wels, Austria, 4600 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 13125 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Halle, Germany, D-06120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Homburg, Germany, 66421 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mannheim, Germany, 68167 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tuebingen, Germany, 72076 Greece For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Athens, Greece, 11527 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Patras, Greece, 26500 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bari, Italy, 70126 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bergamo, Italy, 24128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palermo, Italy, 90146 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Potenza, Italy, 85028 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Torino, Italy, 10100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Treviso, Italy, 31100 Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Amsterdam, Netherlands, 1081 HV For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Groningen, Netherlands, 9713 GZ For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Maastricht, Netherlands, 6229 HX For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. S-Hertogenbosch, Netherlands, 5211 NL Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lleida, Spain, 25198 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Reus, Spain, 43201 Collapse << |
| NCT00806819 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Completed | - | - |
| NCT00051493 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Completed | - | United States, Texas ... more >> Houston, Texas, United States Collapse << |
| NCT02578680 | - | - | Active, not recruiting | - | - |
| NCT02578680 | Non-Small-Cell Lung Carcinoma | Phase 3 | Active, not recruiting | April 15, 2019 | - |
| NCT00072865 | Breast Cancer ... more >> Neoplasm Metastasis Collapse << | Phase 2 | Completed | - | Russian Federation ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Moscow, Russia, Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Saint Petersburg, Russia, Russian Federation Collapse << |
| NCT00290017 | Carcinoma, Non-Small-Cell Lung... more >> Lung Cancer Neoplasms, Lung Neoplasms, Pulmonary Collapse << | Phase 3 | Terminated(FDA Hold May 2007) | - | - |
| NCT00806819 | - | - | Completed | - | - |
| NCT01041781 | - | - | Terminated(DSMB recommendation... more >>) Collapse << | - | - |
| NCT01041781 | Lung Cancer | Phase 3 | Terminated(DSMB recommendation... more >>) Collapse << | - | - |
| NCT00035035 | Pancreatic Neoplasms ... more >> Metastases, Neoplasm Collapse << | Phase 3 | Completed | - | - |
| NCT02679443 | Lung Adenocarcinoma ... more >> Neutropenia Anemia Thrombocytopenia Nonsquamous Nonsmall Cell Neoplasm of Lung Collapse << | Not Applicable | Completed | - | India ... more >> PGIMER Chandigarh, India, 160012 Collapse << |
| NCT01323062 | Non Small Cell Lung Cancer (NS... more >>CLC) Collapse << | Phase 1 | Completed | - | United States, North Carolina ... more >> Lineberger Comprehensive Cancer Center, UNC Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15232 Collapse << |
| NCT03151161 | Lung, Carcinoma | Phase 2 | Not yet recruiting | May 2019 | China, Guangdong ... more >> Recruiting Guanzhou, Guangdong, China, 510000 Contact: Long Hao, Prof +86 2087343261 longhao@sysucc.org.cn Contact: Ruping Xing +86 2087343736 xingrp@sysucc.org.cn Collapse << |
| NCT02709512 | Mesothelioma | Phase 2 Phase 3 | Recruiting | June 2021 | - |
| NCT02919462 | Carcinoma, Non-Small-Cell Lung... more >> Secondary Advanced Stage IIIB High Thymidylate Synthase Expression Collapse << | Phase 2 | Terminated(low recruitement ra... more >>te) Collapse << | - | Italy ... more >> Ircc Irst Meldola, FC, Italy, 47014 U.O. Oncologia Medica Faenza, RA, Italy, 48018 Claudio Dazzi Ravenna, RA, Italy, 48121 Ospedale di Piacenza, ASL Piacenza Piacenza, Italy U.O. Oncologia Ospedale degli Infermi Rimini, Italy Collapse << |
| NCT00349089 | Non-small Cell Lung Cancer | Phase 2 | Unknown | December 2013 | Belgium ... more >> Ziekenhuis Oost Limburg Genk, Belgium, 3600 Department of Pulmonology (Respiratory Tumor Unit), University Hospital Gasthuisberg, Catholic University Leuven, Belgium. Leuven, Belgium, 3000 Germany Helios-Klinikum Emil von Behring Berlin, Germany, 14109 Klinikum Bremen-Ost Bremen, Germany, 28325 Westdeutsches Tumorzentrum Essen, Germany, 45122 Department of Hematology and Oncology, University of Goettingen Goettingen, Germany, 37075 Lungenzentrum Großhansdorf Großhansdorf, Germany, 22927 Clinic for thoracic diseases at the University of Heidelberg Heidelberg, Germany, 69120 Lungenklinik Hemer Hemer, Germany, 58675 Klinik Löwenstein Loewenstein, Germany, 74245 University of München Muenchen, Germany Oldenburg Hospital Oldenburg, Germany Dr. Horst Schmidt Klinik Wiesbaden, Germany, 65199 Luxembourg Centre Hospitalier du Luxembourg Luxembourg, Luxembourg, L-1210 Collapse << |
| NCT01630174 | - | - | Unknown | - | China, Shandong ... more >> Shandong Cancer hospital and institute Recruiting Jinan, Shandong, China, 250017 Principal Investigator: Baosheng Li, Ph.D. Sub-Investigator: Zhongtang Wang, M.D. Collapse << |
| NCT00063570 | Breast Cancer ... more >> Breast Neoplasms Collapse << | Phase 2 | Completed | - | United States, Colorado ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Aurora, Colorado, United States United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Plantation, Florida, United States United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Morrisville, North Carolina, United States United States, Pennsylvania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Philadelphia, Pennsylvania, United States United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Dallas, Texas, United States United States, Washington For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Seattle, Washington, United States Puerto Rico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. San Juan, Puerto Rico Collapse << |
| NCT00762034 | Non-small Cell Lung Cancer | Phase 3 | Completed | - | - |
| NCT00129974 | - | - | Terminated(failure to accrue) | - | - |
| NCT00063570 | - | - | Completed | - | - |
| NCT01109615 | Metastatic Colorectal Cancer | Phase 2 | Terminated(Lacking effect of t... more >>reatment) Collapse << | - | Denmark ... more >> Vejle Hospital Vejle, Denmark, DK-7100 Collapse << |
| NCT02087241 | Previously Untreated Stage IV ... more >>Non-Squamous Non Small Cell Lung Cancer Collapse << | Phase 2 | Terminated(The sponsor decided... more >> to terminate the study.) Collapse << | - | United States, Colorado ... more >> Research Site Englewood, Colorado, United States United States, Florida Research Site Fort Myers, Florida, United States Research Site Orlando, Florida, United States United States, Illinois Research Site Peoria, Illinois, United States United States, Indiana Research Site Fort Wayne, Indiana, United States United States, Kansas Research Site Wichita, Kansas, United States United States, Ohio Research Site Cincinnati, Ohio, United States United States, Tennessee Research Site Nashville, Tennessee, United States Collapse << |
| NCT00762034 | - | - | Completed | - | - |
| NCT00129974 | Carcinoma, Small Cell | Phase 2 | Terminated(failure to accrue) | - | United States, Massachusetts ... more >> Tufts-New England Medical Center Boston, Massachusetts, United States, 02111 Commonwealth Hematology/Oncology Quincy, Massachusetts, United States, 02169 Baystate Medical Center Springfield, Massachusetts, United States, 01199 Collapse << |
| NCT00005636 | Malignant Mesothelioma | Phase 3 | Completed | - | United States, New Jersey ... more >> Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 Collapse << |
| NCT00166465 | Locally Advanced Unresectable ... more >>or Stage IV Colorectal Cancer Collapse << | Phase 1 Phase 2 | Completed | - | United States, Minnesota ... more >> Mayo Clinic Rochester, Minnesota, United States, 55905 Collapse << |
| NCT00408226 | Advanced Cancer ... more >> Non-Small Cell Lung Cancer Collapse << | Phase 1 Phase 2 | Completed | - | United States, Indiana ... more >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Washington Swedish Cancer Institute Seattle, Washington, United States, 98122 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Collapse << |
| NCT00343720 | Non-Small Cell Lung Cancer | Phase 2 | Completed | - | Belgium ... more >> Hopital de Jolimont Haine-Saint-Paul, Belgium, 7100 Collapse << |
| NCT01281800 | Mesothelioma | Phase 2 | Unknown | - | Slovenia ... more >> Institute of Oncology Ljubljana Recruiting Ljubljana, Slovenia, 1000 Contact: Viljem Kovac, MD +386 1 5879 504 vkovac@onko-i.si Sub-Investigator: Matjaz Zwitter, MD, PhD Principal Investigator: Viljem Kovac, MD Collapse << |
| NCT02087241 | - | - | Terminated(The sponsor decided... more >> to terminate the study.) Collapse << | - | - |
| NCT00771953 | Lung Cancer N... more >>on Small Cell Lung Cancer Collapse << | Phase 2 | Completed | - | United States, California ... more >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Florida Mercy Research Institute Miami, Florida, United States, 33133 University of Miami Miami, Florida, United States, 33136 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Maryland University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New Mexico University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 United States, New York Weill Medical Cornell University New York, New York, United States, 10065 Stony Brook Cancer Center (SUNY) Stony Brook, New York, United States, 11794 United States, Oregon Providence Portland Medical Center Portland, Oregon, United States, 97213 United States, Pennsylvania Abramson Cancer Center of Uof Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, West Virginia West Virginia University Clinical Trials Research Unit Morgantown, West Virginia, United States, 26506 Collapse << |
| NCT00771953 | - | - | Completed | - | - |
| NCT00295503 | Mesothelioma | Phase 2 | Completed | - | United States, Texas ... more >> University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390-8852 Collapse << |
| NCT00494026 | Small Cell Lung Cancer | Phase 2 | Terminated(Study stopped early... more >> based on interim results of another trial, showing inferior activity of pemetrexed/carboplatin compared to etoposide/carboplatin in SCLC.) Collapse << | - | Italy ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orbassano, Italy, 10043 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Parma, Italy, 43100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Sisto, Italy, 06156 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Terni, Italy, 05100 Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland, 60-569 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland, 02-781 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palma de Mallorca, Spain, 07014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46010 United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Southampton, Hants, United Kingdom, SO16 6YD For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guilford, Surrey, United Kingdom, GU2 7XX For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wolverhampton, West Midlands, United Kingdom, WV10 0QP Collapse << |
| NCT00190801 | Gastrointestinal Neoplasms | Phase 2 | Completed | - | Korea, Republic of ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goyang-Si, Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. In Cheon, Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of Collapse << |
| NCT00295503 | - | - | Completed | - | - |
| NCT00097383 | Breast Cancer | Phase 1 Phase 2 | Completed | - | Argentina ... more >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. La Plata, Buenos Aires, Argentina For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Rosario, Santa Fe, Argentina For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Buenos Aires, Argentina For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Ciudad De Buenos Aires, Argentina Belgium For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Brussels, Belgium For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Leuven, Belgium For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Wilrijk, Belgium Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Maceio, AL, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Belo Horizonte, BH, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Curitiba, PR, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Porto Alegre, RS, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Sao Paulo, Sao Paulo/SP, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Sao Paulo, SP, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Sorocaba, SP, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Sao Paulo, Brazil Mexico For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Guadalajara, Jalisco, Mexico For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Mexico, Mexico D.F., Mexico For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Col. Campestre Churubusco, Mexico For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Mexico City, Mexico Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Arquiparque-Miraflores, Alges, Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Coimbra, Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Lisboa, Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Porto, Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Proto, Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Santa Maria Da Feira, Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Santarem, Portugal Collapse << |
| NCT00538681 | Lung Cancer | Phase 2 | Completed | - | Belgium ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leuven, Belgium, 3000 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gauting, Germany, 82131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. GroBhansdorf, Germany, D-22927 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, D 21075 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Germany, 69126 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bergamo, Italy, 24128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Catania, Italy, 95100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Padova, Italy, 35128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trento, Italy, 38100 Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Otwock, Poland, 05-400 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland, 60-569 Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bucharest, Romania, 022328 Collapse << |
| NCT03376737 | Lung Adenocarcinoma | Phase 2 | Recruiting | June 2019 | China, Henan ... more >> Henan Cancer Hospital Recruiting Zhengzhou, Henan, China, 450008 Contact: Guowei Zhang dugu4986@126.com Collapse << |
| NCT03058094 | NSCLC | Phase 3 | Not yet recruiting | January 2020 | China, Beijing ... more >> Beijing Cancer Hospital Not yet recruiting Beijing, Beijing, China, 100000 Contact: Jian Fang Chinese General PLA Hospital Not yet recruiting Beijing, Beijing, China, 100000 Contact: Yi Hu Peking Union Medical College Hospital Not yet recruiting Beijing, Beijing, China, 100000 Contact: Mengzhao Wang China, Chongqing Xinqiao Hospital Army Medical University Not yet recruiting Chongqing, Chongqing, China, 400000 Contact: Dong Wang China, Fujian Fujian Cancer Hospital Not yet recruiting Fuzhou, Fujian, China, 350000 Contact: Cheng Huang Fuzhou General Hospital of Nanjing Military Command Not yet recruiting Fuzhou, Fujian, China, 350000 Contact: Xuenong Ouyang China, Hebei Tumor Hospital of Hebei Province Not yet recruiting Shijiazhuang, Hebei, China, 050000 Contact: Cuimin Ding China, Heilongjiang Harbin Medical University Cancer Hospital Not yet recruiting Harbin, Heilongjiang, China, 150000 Contact: Gongyan Chen China, Henan Henan Cancer Hospital Not yet recruiting Zhengzhou, Henan, China, 450000 Contact: Zhiyong Ma China, Jiangsu Jiangsu Province Hospital Not yet recruiting Nanjing, Jiangsu, China, 210000 Contact: Yongqian Shu Nanjing General Hospital Not yet recruiting Nanjing, Jiangsu, China, 210000 Contact: Yong Song China, Liaoning The First Affiliated Hospital of Dalian Medical University Not yet recruiting Dalian, Liaoning, China, 116000 Contact: Jiwei Liu The second Hospital of Dalian Medical University Not yet recruiting Dalian, Liaoning, China, 116000 Contact: Yang Zhang The First Affiliated Hospital of China Medical University Not yet recruiting Shenyang, Liaoning, China, 110000 Contact: Yunpeng Liu China, Shanghai Fudan University Shanghai Cancer Center Not yet recruiting Shanghai, Shanghai, China, 200000 Contact: Jianhua Chang China, Sichuan Sichuan Cancer Hospital & Institute Not yet recruiting Chengdu, Sichuan, China, 610000 Contact: Ping Yu West China Hospital,Sichuan University Not yet recruiting Chengdu, Sichuan, China, 610000 Contact: You Lu China, Tianjin Tianjin Medical University Cancer Institute & Hospital Not yet recruiting Tianjin, Tianjin, China, 300000 Contact: Kai Li China, Zhejiang The First Affiliated Hospital,Zhejiang University Not yet recruiting Hangzhou, Zhejiang, China, 310000 Contact: Qiong Zhao Zhejiang Cancer Hospital Not yet recruiting Hangzhou, Zhejiang, China, 310000 Contact: Yiping Zhang China Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting Beijing, China, 100021 Principal Investigator: Yuankai Shi, Professor Collapse << |
| NCT00494026 | - | - | Terminated(Study stopped early... more >> based on interim results of another trial, showing inferior activity of pemetrexed/carboplatin compared to etoposide/carboplatin in SCLC.) Collapse << | - | - |
| NCT00948675 | Advanced Non-Small Cell Lung C... more >>ancer Collapse << | Phase 3 | Active, not recruiting | December 2018 | - |
| NCT00520845 | Lung Cancer | Phase 2 | Terminated(slow accrual) | - | United States, Tennessee ... more >> Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Collapse << |
| NCT00520845 | - | - | Terminated(slow accrual) | - | - |
| NCT03623776 | Efficacy and Safety | Phase 2 | Active, not recruiting | July 1, 2023 | China, Guangdong ... more >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Collapse << |
| NCT00948675 | - | - | Active, not recruiting | - | - |
| NCT00087711 | Non Small Cell Lung Carcinoma | Phase 3 | Completed | - | - |
| NCT02409342 | Non-Squamous Non-Small Cell Lu... more >>ng Cancer, Squamous Non-Small Cell Lung Cancer Collapse << | Phase 3 | Active, not recruiting | April 23, 2020 | - |
| NCT00520676 | - | - | Completed | - | - |
| NCT01139775 | Non Small Cell Lung Cancer | Phase 1 Phase 2 | Completed | - | Germany ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mannheim, Baden-Wurttemberg, Germany, 68167 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munster, Nordhein-Westfalen, Germany, 48149 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Coswig, Sachsen, Germany, 01640 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 14165 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, 60596 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Germany, 69126 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Homburg, Germany, 66421 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Immenhausen, Germany, 34376 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lübeck, Germany, 23538 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, D-55131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rheine, Germany, 48431 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ulm, Germany, 89081 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oviedo, Asturias, Spain, 33006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mataro, Barcelona, Spain, 08304 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pozuelo de Alarcon, Madrid, Spain, 28223 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08908 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Girona, Spain, 17007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28046 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28050 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sevilla, Spain, 41013 Collapse << |
| NCT00520676 | Non-Small Cell Lung Cancer | Phase 3 | Completed | - | Australia, Victoria ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ballarat, Victoria, Australia, 3350 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankston, Victoria, Australia, 3199 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wendouree, Victoria, Australia, 3355 Australia, Western Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bunbury, Western Australia, Australia, 6230 Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barretos, Brazil, 14784700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goiania, Brazil, 74075040 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santo André, Brazil, 09060-020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. São Paulo, Brazil, 01224 010 China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200032 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 120-752 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Suwon-City, Korea, Republic of, 442-723 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ulsan, Korea, Republic of, 682-714 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ciudad Obregon, Mexico, 85100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Durango, Mexico, 34208 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mexicali, Mexico, 21000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mexico City, Mexico, 11640 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 404 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 Collapse << |
| NCT00391274 | Non-Small Cell Lung Cancer | Phase 3 | Completed | - | China ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 101149 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510080 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hang Zhou, China, 310022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nan Jing, China, 210002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200433 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tianjin, China, 300060 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wu Han, China, 430030 Collapse << |
| NCT03647956 | NSCLC Stage IIIB ... more >> NSCLC Stage IV EGFR Activating Mutation Collapse << | Phase 2 | Recruiting | April 3, 2020 | Hong Kong ... more >> Department of Clinical Oncology Recruiting Hong Kong, Hong Kong Principal Investigator: Tai-Chung Lam, FRCR Sub-Investigator: Chi-Leung Chiang, FRCR Sub-Investigator: Victor Ho-Fun Lee, MD Sub-Investigator: Tsz-Him So, MBBS Collapse << |
| NCT00391274 | - | - | Completed | - | - |
| NCT03777124 | NSCLC Stage IV ... more >> KRAS Gene Mutation PD-1 Antibody Chemotherapy Effect Collapse << | Phase 2 | Not yet recruiting | April 2022 | - |
| NCT00259285 | - | - | Terminated(Trial was stopped e... more >>arly due to low enrollment.) Collapse << | - | - |
| NCT01588704 | Lung Cancer | Phase 2 | Completed | - | China, Guangdong ... more >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Collapse << |
| NCT00386815 | Malignant Pleural Mesothelioma | Phase 2 | Completed | - | Japan ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 464-8681 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 811-1395 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 060-8648 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 663-8501 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okayama, Japan, 702-8055 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 589-8511 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 104-0045 Collapse << |
| NCT01139775 | - | - | Completed | - | - |
| NCT02743923 | Carcinoma, Non-Small Cell Lung | Phase 3 | Recruiting | April 2020 | Netherlands ... more >> VUmc Medical Center Recruiting Amsterdam, Noord-Holland, Netherlands, 1081HV Contact: Idris Bahce, MD i.bahce@vumc.nl Principal Investigator: Idris Bahce, MD Medical spectrum Twente Recruiting Enschede, Overijssel, Netherlands, 7500 KA Contact: Hugo Schouwink, MD J.Schouwink@mst.nl Principal Investigator: Hugo Schouwink, MD Meander Medical Center Recruiting Amersfoort, Utrecht, Netherlands, 3818 ES Contact: Joop van den Brand, MD JJG.vanden.Brand@meandermc.nl Principal Investigator: Joop van den Brand, MD ZGT Recruiting Almelo, Netherlands, 7609 PP Contact: Jeske Staal, MD j.staal@zgt.nl Principal Investigator: Jeske Staal, MD Antoni van Leeuwenhoek Recruiting Amsterdam, Netherlands, 1066CX Contact: Egbert Smit e.smit@nki.nl Principal Investigator: Egbert Smit, MD OLVG Not yet recruiting Amsterdam, Netherlands, 1090 HM Contact: A Moons, MD A.Moons-Pasic@olvg.nl Principal Investigator: A Moons, MD Gelre Ziekenhuis Recruiting Apeldoorn, Netherlands Contact: Niels Pronk, MD n.pronk@gelre.nl Principal Investigator: Niels Pronk, MD Amphia Hospital Recruiting Breda, Netherlands Contact: Nicolaas van Walree, MD nwalree@amphia.nl Principal Investigator: Nicolaas van Walree, MD Jeroen Bosch Hospital Recruiting Den Bosch, Netherlands Contact: Bonne Biesma, MD b.biesma@jbz.nl Principal Investigator: Bonne Biesma, MD Haga Recruiting Den Haag, Netherlands, 2545 CH Contact: Pepijn Brocken, MD p.brocken@hagaziekenhuis.nl Principal Investigator: Pepijn Brocken, MD Deventer Ziekenhuis Recruiting Deventer, Netherlands Contact: Suzy Samii, MD s.samii@dz.nl Principal Investigator: Suzy Samii, MD Albert Schweitzer ziekenhuis Recruiting Dordrecht, Netherlands Contact: Eric van Thiel, MD EricvanThiel@asz.nl Principal Investigator: Eric van Thiel, MD Ziekenhuis Gelderse Vallei Recruiting Ede, Netherlands Contact: Wouter de Jong, MD jongw@zgv.nl Principal Investigator: Wouter de Jong, MD Maxima Medisch Centrum Recruiting Eindhoven, Netherlands, 5631 BM Contact: Arjen van Henten, MD a.vanhenten@mmc.nl Principal Investigator: Arjen van Henten, MD Groene Hart Recruiting Gouda, Netherlands Contact: ten Heuvel, MD alexandra.ten.heuvel@ghz.nl Principal Investigator: ten Heuvel, MD UMCG Recruiting Groningen, Netherlands, 9713 GZ Contact: Harry Groen, MD h.j.m.groen@umcg.nl Principal Investigator: Harry Groen, MD Martini Ziekenhuis Recruiting Groningen, Netherlands Contact: John van Putten, MD jwg.van.putten@mzh.nl Principal Investigator: John van Putten, MD Tergooi ziekenhuizen Recruiting Hilversum, Netherlands Contact: Jan Maarten van Haarst, MD jvanhaarst@tergooi.nl Principal Investigator: Jan Maarten van Haarst, MD Spaarne Gasthuis Recruiting Hoofddorp, Netherlands, 2130 AT Contact: Frans Krouwels, MD fkrouwels@spaarnegasthuis.nl Principal Investigator: Frans Krouwels, MD Medisch Centrum Leeuwarden Recruiting Leeuwarden, Netherlands Contact: Venmans, MD Principal Investigator: Venmans, MD Maastricht University Medical Center Recruiting Maastricht, Netherlands Contact: Anne-Marie Dingemans, MD a.dingemans@mumc.nl Principal Investigator: Anne-Marie Dingemans, MD Maasstad ziekenhuis Recruiting Rotterdam, Netherlands, 3007 AC Contact: Susan van 't Westeinde, MD westeindes@maasstadziekenhuis.nl Contact: , MD Principal Investigator: Susan van 't Westeinde, MD St. Fransicus Gasthuis Recruiting Rotterdam, Netherlands, 3045 PM Contact: Wessel Hanselaar, MD w.hanselaar@franciscus.nl Principal Investigator: Wessel Hanselaar, MD Medical Center Haaglanden Recruiting the Hague, Netherlands Contact: Klaar Maas, MD k.maas@mchaaglanden.nl Principal Investigator: Klaar Maas, MD Diakonessenhuis Utrecht Recruiting Utrecht, Netherlands, 3582 KE Contact: Leontine van Elden, MD lvelden@diakhuis.nl Principal Investigator: Leontine van Elden, MD St. Antonius ziekenhuis Recruiting Utrecht, Netherlands Contact: Franz Schramel, MD f.schramel@antoniusziekenhuis.nl Principal Investigator: Franz Schramel, MD VieCuri Medisch Centrum voor Noord-Limburg Recruiting Venlo, Netherlands Contact: Vivian van Kampen, MD vvankampen@viecuri.nl Principal Investigator: Vivian van Kampen, MD Isala Klinieken Recruiting Zwolle, Netherlands, 8000 GK Contact: Jos Stigt j.a.stigt@isala.nl Principal Investigator: Jos Stigt, MD Collapse << |
| NCT00259285 | Non-Small-Cell Lung Cancer | Phase 2 | Terminated(Trial was stopped e... more >>arly due to low enrollment.) Collapse << | - | Spain ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barakaldo, Spain, 48903 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Coruña, Spain, 15006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pamplona, Spain, 31008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46014 Collapse << |
| NCT00191412 | Liver Cancer | Phase 2 | Completed | - | United States, Colorado ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Denver, Colorado, United States Collapse << |
| NCT03242616 | Breast Neoplasms | Phase 2 | Recruiting | December 31, 2019 | Korea, Republic of ... more >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Seock-Ah Im 82-2-2072-0850 moisa@snu.ac.kr Collapse << |
| NCT00745875 | - | - | Completed | - | - |
| NCT00745875 | Non Small Cell Lung Cancer ... more >> Lung Cancer Collapse << | Phase 2 | Completed | - | Bulgaria ... more >> research Site Pleven, Bulgaria Research Site Sofia, Bulgaria Research Site Varna, Bulgaria Czech Republic Research Site Jicin, Czech Republic Research Site Prague, Czech Republic France Research Site Cedex, France Research Site Strasbourg, France Romania Research Site Bucharest, Romania Research Site Cluj-Napoca, Romania Ukraine Research Site Chernivtsi, Ukraine Research Site Kiev, Ukraine Research Site Sumy, Ukraine Research Site Uzngorod, Ukraine Collapse << |
| NCT00415194 | Head and Neck Neoplasms | Phase 3 | Completed | - | - |
| NCT00078260 | Non-Small Cell Lung Cancer | Phase 3 | Completed | - | Turkey ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ankara, Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gaziantep, Turkey Collapse << |
| NCT01860508 | Non-small Cell Lung Cancer | Not Applicable | Unknown | - | China, Shanghai ... more >> Cancer hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Jia lei Wang, Master 02164175590 ext 8907 luwangjialei@hotmail.com Collapse << |
| NCT00415194 | - | - | Completed | - | - |
| NCT01172470 | Head and Neck Cancer | Phase 2 | Completed | - | United States, Illinois ... more >> The University of Chicago Medical Center Chicago, Illinois, United States, 60653 Collapse << |
| NCT00315861 | Ovarian Cancer ... more >> Endometrial Cancer Cervical Cancer Lung Cancer Collapse << | Phase 1 | Completed | - | United States, Tennessee ... more >> Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Collapse << |
| NCT00389688 | Lung Cancer | Phase 2 | Terminated(low accrual) | - | Belgium ... more >> Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 Collapse << |
| NCT00846443 | Local Advanced Non-Small Cell ... more >>Lung Cancer Collapse << | Phase 1 | Unknown | - | China, Shanghai ... more >> Department of Radiation Oncolory, Cancer Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Liang Xiahou, MB 862164175590 ext 1404 xiahouliang@hotmail.com Principal Investigator: Xiaolong Fu, MD Collapse << |
| NCT00887549 | - | - | Completed | - | - |
| NCT00789373 | Non-Small Cell Lung Cancer | Phase 3 | Completed | - | - |
| NCT00668499 | Mesothelioma | Phase 1 Phase 2 | Withdrawn(Sponsor withdrew sup... more >>port) Collapse << | April 2011 | United States, California ... more >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Collapse << |
| NCT00516100 | Non-small Cell Lung Cancer | Phase 1 Phase 2 | Unknown | August 2012 | United States, California ... more >> Cedars-Sinai Outpatient Cancer Center Los Angeles, California, United States, 90048 Comprehensive Cancer Center at Desert Regional Medical Center Palm Springs, California, United States, 92262 California Pacific Medical Center San Francisco, California, United States, 94115 United States, New Jersey Trinitas Comprehensive Cancer Center Elizabeth, New Jersey, United States, 07207 Collapse << |
| NCT00190983 | Cervical Intraepithelial Neopl... more >>asia Uterine Neoplasms Genital Neoplasms, Female Collapse << | Phase 2 | Completed | - | United States, Pennsylvania ... more >> Gynecologic Oncology Group 215-854-0770 Philadelphia, Pennsylvania, United States Collapse << |
| NCT00427466 | Sarcoma | Phase 2 | Completed | - | Germany ... more >> Medical Center II, University of Tuebingen Tuebingen, Germany, 72076 Collapse << |
| NCT00887549 | Non-Small Cell Lung Cancer | Phase 2 | Completed | - | Ireland ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dublin, Ireland United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Derby, Derbyshire, United Kingdom, DE22 3NE For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Exeter, Devon, United Kingdom, EX2 5DW For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Maidstone, Kent, United Kingdom, ME16 9QQ For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Preston, Lancashire, United Kingdom, PR2 9HT For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Liverpool, Merseyside, United Kingdom, L14 3PE For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Northwood, Middlesex, United Kingdom, HA6 2RN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Scunthorpe, North Lincolnshire, United Kingdom, DN15 7BH For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Belfast, Northern Ireland, United Kingdom, BT9 7BL For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nottingham, Nottinghamshire, United Kingdom, NG5 1PD For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aberdeen, Scotland, United Kingdom, AB25 2ZN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wolverhampton, West Midlands, United Kingdom, WV10 0QP For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Grimsby, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Manchester, United Kingdom, M23 9LT Collapse << |
| NCT03515837 | Non-small Cell Lung Cancer | Phase 3 | Recruiting | June 15, 2023 | - |
| NCT00190983 | - | - | Completed | - | - |
| NCT01656551 | Non-small Cell Lung Cancer Met... more >>astatic Non-small Cell Lung Cancer Stage IIIB Collapse << | Phase 3 | Active, not recruiting | September 2018 | - |
| NCT02357147 | Mesothelioma, Malignant | Phase 2 | Terminated(Due to business rea... more >>sons) Collapse << | - | - |
| NCT00789373 | - | - | Completed | - | - |
| NCT01004601 | Non Small Cell Lung Cancer | Not Applicable | Completed | - | Taiwan ... more >> Chang Gung Memorial Hospital Taipei, Taiwan, 10507 Collapse << |
| NCT01169675 | Neoplasms | Phase 1 | Completed | - | Canada, Alberta ... more >> 1200.92.1001 Boehringer Ingelheim Investigational Site Edmonton, Alberta, Canada Canada, Ontario 1200.92.1002 Boehringer Ingelheim Investigational Site Hamilton, Ontario, Canada Collapse << |
| NCT00330044 | Inoperable Non Small Cell Lung... more >> Cancer Collapse << | Phase 1 | Completed | - | United States, Pennsylvania ... more >> Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States, 19107 Collapse << |
| NCT01169675 | - | - | Completed | - | - |
| NCT00768755 | Carcinoma, Non-Small Cell Lung | Phase 1 Phase 2 | Completed | - | - |
| NCT00363415 | - | - | Completed | - | - |
| NCT02964689 | Advanced Non-small Cell Lung C... more >>ancer KRAS Gene Mutation Lung Cancer Collapse << | Phase 1 | Recruiting | September 2020 | Switzerland ... more >> Universitaetsspital Basel Recruiting Basel, Switzerland, 4031 Contact: Sacha Rothschild, MD +41 (0)61 265 25 25 sacha.rothschild@usb.ch Principal Investigator: Sacha Rothschild, MD IOSI Ospedale Regionale di Bellinzona e Valli Recruiting Bellinzona, Switzerland, 6500 Contact: Patrizia Froesch, MD +41 (0)91 811 48 40 patrizia.froesch@eoc.ch Principal Investigator: Patrizia Froesch, MD Kantonsspital Graubuenden Recruiting Chur, Switzerland, CH-7000 Contact: Michael Mark, MD +41 (0)81 256 61 11 michael.mark@ksgr.ch Principal Investigator: Michael Mark, MD Kantonsspital St. Gallen Recruiting St. Gallen, Switzerland, 9007 Contact: Martin Früh, MD +41 (0)71 494 11 11 martin.frueh@kssg.ch Principal Investigator: Martin Früh, MD Collapse << |
| NCT00363415 | Small Cell Lung Cancer | Phase 3 | Completed | - | - |
| NCT01401192 | Non-small Cell Lung Cancer | Phase 2 | Unknown | - | Korea, Republic of ... more >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Myung-Ju Ahn, M.D., Ph.D. Sub-Investigator: Jong-Mu Sun, M.D., Ph.D. Collapse << |
| NCT01531790 | Non-Small Cell Lung Cancer | Phase 1 | Completed | - | China, Guangdong ... more >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China Collapse << |
| NCT02259582 | Nonsquamous Nonsmall Cell Neop... more >>lasm of Lung Collapse << | Phase 2 | Completed | - | - |
| NCT01004250 | Non-Small Cell Lung Cancer | Phase 2 | Completed | - | Denmark ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Copenhagen, Denmark, 2200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Herlev, Denmark, 2730 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Coswig, Germany, 01640 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, 60431 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 22087 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamm, Germany, 59071 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Magdeburg, Germany, D-39120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mannheim, Germany, 68167 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lecce, Italy, 73100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Padova, Italy, 35128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rome, Italy, 00144 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rozzano, Italy, 20089 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trento, Italy, 38100 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jaen, Spain, 23007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28046 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pozuelo De Alarcon, Spain, 28223 Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Malmo, Sweden, 205 02 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Solna, Sweden, 17176 Collapse << |
| NCT02259582 | - | - | Completed | - | - |
| NCT00190840 | Carcinoma, Non-Small Cell Lung | Phase 2 | Completed | - | Australia, New South Wales ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wollongong, New South Wales, Australia, 2500 Australia, Queensland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chermside, Queensland, Australia, 4032 Australia, South Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ashford, South Australia, Australia, 5035 Australia, Victoria For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fitzroy, Victoria, Australia, 3065 China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hong Kong, China Egypt For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alexandria, Egypt For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cairo, Egypt, 11796 India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyderabad, Andhra Pradesh, India, 500004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ludhiana, Punjab, India, 141001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chandigarh, India, 160012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chennai, India, 600035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Delhi, India, 110085 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goyang-Si, Gyeonggi-Do, Korea, Republic of, 411764 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oradea, Bihor, Romania, 3700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Craiova, Dolj, Romania, 1100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bucuresti, Romania, 72435 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Iasi, Romania, 6600 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Eskisehir, Turkey Collapse << |
| NCT00071136 | Lung Neoplasms | Phase 1 Phase 2 | Completed | - | United States, Florida ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC-GMT - 5 hours, EST), or speak with your personal physician. Ft. Myers, Florida, United States United States, Minnesota For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC-GMT - 5 hours, EST), or speak with your personal physician. Marshfield, Minnesota, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC-GMT - 5 hours, EST), or speak with your personal physician. Minneapolis, Minnesota, United States United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC-GMT - 5 hours, EST), or speak with your personal physician. Rochester, New York, United States United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC-GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States Collapse << |
| NCT00768755 | - | - | Completed | - | - |
| NCT01836341 | Non-small Cell Lung Cancer | Phase 1 | Withdrawn | April 2015 | - |
| NCT01004250 | - | - | Completed | - | - |
| NCT00190918 | Trophoblastic Neoplasms ... more >> Uterine Neoplasms Hydatidiform Mole Choriocarcinoma Collapse << | Phase 2 | Completed | - | United States, Pennsylvania ... more >> Gynecologic Oncology Group 215-854-0770 Philadelphia, Pennsylvania, United States Collapse << |
| NCT00389805 | Lung Cancer U... more >>nspecified Adult Solid Tumor, Protocol Specific Collapse << | Phase 1 Phase 2 | Completed | - | United States, California ... more >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Collapse << |
| NCT00389805 | - | - | Completed | - | - |
| NCT01232452 | Non-Small-Cell Lung Carcinoma | Phase 2 | Completed | - | - |
| NCT00447421 | Small Cell Lung Cancer ... more >> Carcinoma, Small Cell SCLC Collapse << | Phase 1 Phase 2 | Terminated(Interim results of ... more >>another trial showed inferior activity of treatment) Collapse << | - | Belgium ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leuven, Belgium, 3000 Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Amsterdam, Netherlands, 1081 HV For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Den Bosch, Netherlands, 5211 NL For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rotterdam, Netherlands, 3075 EA Collapse << |
| NCT00383331 | Non-Small-Cell Lung Cancer | Phase 2 | Terminated(Trial was stopped e... more >>arly due to low enrollment) Collapse << | - | United States, Minnesota ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rochester, Minnesota, United States, 55905 Collapse << |
| NCT01232452 | - | - | Completed | - | - |
| NCT00743379 | Non-Small Cell Lung Cancer ... more >> Prostate Cancer Pancreatic Cancer Collapse << | Phase 1 Phase 2 | Completed | - | United States, Arizona ... more >> Mayo Clinic Cancer Center Scottsdale, Arizona, United States, 85259 Premiere Oncology of Arizona Scottsdale, Arizona, United States, 85260 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Louisiana LSU Health Sciences Center Shreveport, Louisiana, United States, 71130 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas UT Health Science Center San Antonio, Texas, United States, 78229 United States, Washington Northwest Medical Specialties Tacoma, Washington, United States, 98405 United States, Wisconsin University of Wisconsin Madison, Wisconsin, United States, 53792 Collapse << |
| NCT00447421 | - | - | Terminated(Interim results of ... more >>another trial showed inferior activity of treatment) Collapse << | - | - |
| NCT00191503 | Adenocarcinoma | Phase 2 | Completed | - | Canada, Alberta ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Calgary, Alberta, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Edmonton, Alberta, Canada Collapse << |
| NCT02309892 | Non-Small Cell Lung Cancer | Phase 1 | Recruiting | December 2018 | United States, Ohio ... more >> University Hospitals Case Medical Center Recruiting Cleveland, Ohio, United States United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States Collapse << |
| NCT00102219 | Breast Cancer | Phase 2 | Completed | - | Brazil ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Belo Horizonte, BH, Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Rio de Janeiro, Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Sao Paulo, Brazil Greece For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Athens, Greece Hungary For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Budapest, Hungary For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Szekesfehervar, Hungary Peru For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Lima, Peru Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Krakow, Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Lodz, Poland Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Madrid, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Valencia, Spain Venezuela For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Caracas, Venezuela Collapse << |
| NCT00550173 | Non-Small-Cell Lung Cancer | Phase 2 | Completed | - | Brazil ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barretos, Brazil, 14784700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ijui, Brazil, 98700 000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. São Paulo, Brazil, 01277-900 China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100730 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanning, China, 530000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200030 Hong Kong For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sha Tin, Hong Kong India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ahmedabad, India, 380016 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bhopal, India, 462001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyderabaad, India, 500082 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jaipur, India, 302013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kochin, India, 682304 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kolkata, India, 700 026 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madurai, India, 625020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mohali, India, 160062 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mumbai, India, 400 026 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Delhi, India, 110017 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vishakhapatnam, India, 530002 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jin-Ju-Si, Korea, Republic of, 660-702 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 138-736 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Suwon-City, Korea, Republic of, 442-723 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changhua, Taiwan, 500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 407 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poole, Dorset, United Kingdom, BH15 2JB For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chelmsford, Essex, United Kingdom, CM1 7ET For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aberdeen, Scotland, United Kingdom, AB25 2ZN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guildford, Surrey, United Kingdom, GU2 7XX For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Manchester, United Kingdom, M20 4BX Collapse << |
| NCT00550173 | - | - | Completed | - | - |
| NCT01353482 | Malignant Pleural Mesothelioma | Phase 1 Phase 2 | Withdrawn(UCL CTC were informe... more >>d by Merck Sharp & Dohme on 22.08.11 that support for the trial had been withdrawn in light of results from another trial with trial drug.) Collapse << | - | - |
| NCT00087698 | - | - | Completed | - | - |
| NCT00191347 | Breast Cancer | Phase 2 | Completed | - | Canada, Ontario ... more >> For additional information regarding investigative sites for thsi trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ottawa, Ontario, Canada Collapse << |
| NCT00087698 | Pleural Neoplasms | Phase 2 | Completed | - | United States, California ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Francisco, California, United States United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States United States, Maryland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baltimore, Maryland, United States United States, Massachusetts For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Boston, Massachusetts, United States United States, Michigan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Detroit, Michigan, United States United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New York, New York, United States United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States Collapse << |
| NCT02604342 | Non-small Cell Lung Cancer | Phase 3 | Completed | - | - |
| NCT00988858 | Non Small Cell Lung Cancer | Phase 2 | Completed | - | United States, Arizona ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tucson, Arizona, United States, 85704 United States, Colorado For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Denver, Colorado, United States, 80218 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampa, Florida, United States, 33612 United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kettering, Ohio, United States, 45409 United States, Oregon For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Portland, Oregon, United States, 97213 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75201 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. The Woodlands, Texas, United States, 77380 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tyler, Texas, United States, 75702 United States, Washington For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yakima, Washington, United States, 98902 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orbassano, Italy, 10043 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 138-736 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 407 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tainan, Taiwan, 70403 Collapse << |
| NCT02604342 | - | - | Completed | - | - |
| NCT00383331 | - | - | Terminated(Trial was stopped e... more >>arly due to low enrollment) Collapse << | - | - |
| NCT01165021 | Non Small Cell Lung Cancer | Phase 2 | Completed | - | Italy ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy, 20133 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Novara, Italy, 28100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orbassano, Italy, 10043 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Padova, Italy, 35100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pisa, Italy, 56100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rome, Italy, 00144 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sondalo, Italy, 23039 Collapse << |
| NCT01165021 | - | - | Completed | - | - |
| NCT00497770 | - | - | Completed | - | - |
| NCT03050437 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Recruiting | March 2017 | Korea, Republic of ... more >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Myung-Ju Ahn, Ph.D. 822-3410-1795 silkahn@skku.edu Collapse << |
| NCT00497770 | - | - | Completed | - | - |
| NCT00447057 | Histological or Cytological Di... more >>agnosis of Locally Advanced or Metastatic NSCLC of Nonsquamous Histology and Not Amenable to Curative Therapy. Collapse << | Phase 2 | Completed | - | Austria ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salzburg, Austria, 5020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vienna, Austria, A-1140 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bochum, Germany, 44791 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Freiburg, Germany, 79106 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gauting, Germany, 82131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gerlingen, Germany, 70839 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, D 21075 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Immenhausen, Germany, 34376 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trier, Germany, 54219 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tübingen, Germany, 72076 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ulm, Germany, 89075 Hungary For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Deszk, Hungary, 6772 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Matrahaza, Hungary, 3233 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nyiregyhaza, Hungary, H-4400 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Szekesfehervar, Hungary, 8000 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alicante, Spain, 03010 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28050 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46010 Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Linkoping, Sweden, 58185 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lund, Sweden, 221 85 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Solna, Sweden, 17176 Collapse << |
| NCT00165503 | Pleural Mesothelioma ... more >> Malignant Pleural Mesothelioma Collapse << | Phase 2 | Terminated(lack of acurral) | - | United States, Massachusetts ... more >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Collapse << |
| NCT00165503 | - | - | Terminated(lack of acurral) | - | - |
| NCT00988858 | - | - | Completed | - | - |
| NCT00447057 | - | - | Completed | - | - |
| NCT02631460 | NSCLC | Phase 2 | Recruiting | December 2019 | China, Guangdong ... more >> Sun yat-sen University Cancer Center Recruiting Guang Zhou, Guangdong, China, 510060 Contact: Yan Huang, MD huangyan@sysucc.org.cn Principal Investigator: Yan Huang, MD Collapse << |
| NCT00226577 | Lung Cancer | Phase 2 | Completed | - | United States, Florida ... more >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Collapse << |
| NCT00325234 | Breast Cancer | Phase 2 | Completed | - | Germany ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guetersloh, Germany, 33332 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 22081 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stuttgart, Germany, 70190 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bergamo, Italy, 24128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bologna, Italy, 40139 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Livorno, Italy, 57128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Meldola, Italy, 47014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rome, Italy, 00168 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Giovanni Rotondo, Italy, 71013 South Africa For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Durban, South Africa, 4067 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Morningside, South Africa, 2199 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pretoria, South Africa, 0001 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Girona, Spain, 17007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Coruña, Spain, 15006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lleida, Spain, 25198 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28040 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46010 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Zaragoza, Spain, 50009 Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Besevler/Ankara, Turkey, 06500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bornova, Turkey, 35100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kayseri, Turkey, 38039 Collapse << |
| NCT00226577 | - | - | Completed | - | - |
| NCT00325234 | - | - | Completed | - | - |
| NCT02337530 | Non-Small Cell Lung Cancer | Phase 2 | Active, not recruiting | December 31, 2018 | Canada, Alberta ... more >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Abbotsford Centre Abbotsford, British Columbia, Canada, V2S 0C2 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, New Brunswick Regional Health Authority B, Zone 2 Saint John, New Brunswick, Canada, E2L 4L2 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada, K7L 5P9 Lakeridge Health Oshawa Oshawa, Ontario, Canada, L1G 2B9 Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Mount Sinai Hospital Toronto, Ontario, Canada, M5G 1X5 University Health Network Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 Collapse << |
| NCT01194453 | - | - | Completed | - | - |
| NCT00573690 | Unspecified Adult Solid Tumor,... more >> Protocol Specific Collapse << | Phase 1 | Completed | - | United States, North Carolina ... more >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Collapse << |
| NCT00281125 | Non-Small Cell Lung Cancer and... more >> Pleural Mesothelioma Collapse << | Phase 1 Phase 2 | Terminated(Suspended due to da... more >>ta issues revealed at DSMB meeting. Planned amendment but was never submitted. Study was then closed.) Collapse << | - | United States, Nevada ... more >> Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 Collapse << |
| NCT00051506 | Lung Neoplasms | Phase 2 | Completed | - | United States, Arkansas ... more >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Springdale, Arkansas, United States United States, California For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Los Angeles, California, United States United States, Florida For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Fort Myers, Florida, United States For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Miami, Florida, United States United States, New York For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Latham, New York, United States United States, North Carolina For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Burlington, North Carolina, United States For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Chapel Hill, North Carolina, United States United States, South Carolina For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Charleston, South Carolina, United States Collapse << |
| NCT01215916 | Solid Tumors | Phase 1 | Completed | - | United States, New Jersey ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Brunswick, New Jersey, United States, 08901 Collapse << |
| NCT03298763 | Adenocarcinoma of Lung | Phase 1 Phase 2 | Not yet recruiting | March 1, 2024 | United Kingdom ... more >> University College London Hospital Not yet recruiting London, United Kingdom Collapse << |
| NCT02951637 | Lung Adenocarcinoma | Phase 2 | Not yet recruiting | December 2019 | - |
| NCT01211275 | Malignant Pleural Mesothelioma | Phase 1 Phase 2 | Completed | - | Netherlands ... more >> Antoni van Leeuwenhoekziekenhuis (NKI-AVL) Amsterdam, Noord-Holland, Netherlands, 1066 CX Collapse << |
| NCT01296568 | Advanced Cancer | Phase 1 | Completed | - | Switzerland ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bruderholz, Switzerland, 4101 Collapse << |
| NCT00456261 | Lung Cancer | Phase 2 | Completed | - | United States, Alabama ... more >> Northeast Alabama Regional Medical Center Anniston, Alabama, United States, 36207 United States, Arkansas NEA Baptist Clinic Jonesboro, Arkansas, United States, 72401 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States, 33805 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 United States, Kentucky Graves-Gilbert Clinic Bowling Green, Kentucky, United States, 42101 Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Maine Mercy Hospital Portland, Maine, United States, 04101 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, North Carolina Cancer Care of Western North Carolina Asheville, North Carolina, United States, 28801 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Associates in Hematology Oncology Chattanooga, Tennessee, United States, 37404 Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Collapse << |
| NCT01296568 | - | - | Completed | - | - |
| NCT03242915 | Non-small Cell Lung Cancer | Phase 2 | Recruiting | August 2022 | United States, Illinois ... more >> Rush Universtiy Medical Center Recruiting Chicago, Illinois, United States, 60612 Contact: Mary Jo Fidler, MD Principal Investigator: Mary Jo Fidler, MD United States, Michigan The University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Shirish M Gadgeel, M.D. 734-647-6883 sgadgeel@med.umich.edu Principal Investigator: Shirish M Gadgeel, M.D. Barbara Ann Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Misako Nagaska, MD Principal Investigator: Misako Nagaska, MD United States, New York Montefiore Cancer Center Recruiting Bronx, New York, United States, 10467 Contact: Balazs Halmos, MD Principal Investigator: Balazs Halmos, MD United States, Tennessee Sarah Cannon Recruiting Nashville, Tennessee, United States, 37203 Contact: Melissa Johnson, MD Principal Investigator: Melissa Johnson, MD Collapse << |
| NCT02066038 | Lung, Carcinoma | Phase 2 | Unknown | March 2016 | - |
| NCT02737774 | Lung Adenocarcinoma | Phase 2 | Unknown | April 2017 | - |
| NCT01631136 | Advanced Non Small Cell Lung C... more >>ancer Collapse << | Phase 3 | Completed | - | - |
| NCT00456261 | - | - | Completed | - | - |
| NCT00996567 | Cancer | Phase 2 | Completed | - | Belgium ... more >> UZ Antwerpen Antwerpen, Belgium University Hospital Ghent Ghent, Belgium, 9000 AZ St. Maarten Mechelen, Belgium, 2800 Netherlands AMC Heerlen Heerlen, Netherlands Collapse << |
| NCT00103831 | Non-small Cell Lung Cancer | Phase 1 Phase 2 | Completed | - | United States, Colorado ... more >> Local Institution Denver, Colorado, United States United States, Minnesota Local Institution Rochester, Minnesota, United States Canada, Ontario Local Institution Toronto, Ontario, Canada Collapse << |
| NCT00006007 | Breast Cancer | Phase 2 | Completed | - | - |
| NCT00949650 | - | - | Completed | - | - |
| NCT02397239 | - | - | Recruiting | - | Taiwan ... more >> National Cheng Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Szu-Chun Yang, M.D. +886 972402279 yangszuchun@gmail.com Collapse << |
| NCT03559049 | Stage IV Non-small Cell Lung C... more >>ancer Collapse << | Phase 1 Phase 2 | Not yet recruiting | July 2027 | United States, Michigan ... more >> The University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States, 48109 Collapse << |
| NCT01675765 | Malignant Pleural Mesothelioma | Phase 1 | Active, not recruiting | December 2018 | United States, California ... more >> University of California at San Francisco San Francisco, California, United States, 94115 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Maryland National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Pennsylvania University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Collapse << |
| NCT00994097 | Non-small Cell Lung Cancer | Phase 2 | Completed | - | Italy ... more >> Istituto Nazionale per la ricerca sul cancro Genoa, Italy, 16132 Fondazione San Raffaele del Monte Tabor Milan, Italy, 20132 Istituto Nazionale dei Tumori Milan, Italy, 20133 Istituto Europeo Oncologico Milan, Italy Collapse << |
| NCT01907100 | Mesothelioma | Phase 3 | Completed | - | - |
| NCT00949650 | Carcinoma, Non-Small-Cell Lung... more >> Adenocarcinoma Collapse << | Phase 3 | Completed | - | - |
| NCT00034619 | Colorectal Cancer | Phase 2 | Completed | - | United States, Alabama ... more >> "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Huntsville, Alabama, United States United States, Massachusetts "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Pittsfield, Massachusetts, United States United States, Michigan "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Kalamazoo, Michigan, United States United States, New York "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Latham, New York, United States United States, North Carolina "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Asheville, North Carolina, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Goldsboro, North Carolina, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Hendersonville, North Carolina, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Winston-Salem, North Carolina, United States United States, Ohio "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Columbus, Ohio, United States United States, Oregon "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Bend, Oregon, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Portland, Oregon, United States United States, Pennsylvania "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Philadelphia, Pennsylvania, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Pittsburgh, Pennsylvania, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Reading, Pennsylvania, United States United States, South Carolina "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Charleston, South Carolina, United States United States, Utah "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Ivins, Utah, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Ogden, Utah, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Provo, Utah, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" St. George, Utah, United States United States, Washington "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Bellevue, Washington, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Seattle, Washington, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Spokane, Washington, United States Collapse << |
| NCT03317496 | Non-small Cell Lung Cancer ... more >> Urothelial Cancer Collapse << | Phase 2 | Recruiting | October 2, 2021 | - |
| NCT03164694 | Lung Cancer | Phase 2 | Recruiting | May 20, 2020 | China, Guangdong ... more >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Si-Yu Wang, Doctor +86 20 87343439 wsysums@163.net Collapse << |
| NCT00284778 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Completed | - | France ... more >> Service de Pneumologie, CHU Angers Angers, France, 49033 Service de pneumologie; Centre Hospitalier d'Annecy Annecy, France, 74011 Service de Pneumologie; Centre Hospitalier Beauvais, France, 60 021 Service de Pneumologie ; Centre hospitalier Charleville-Mezieres, France, 08 000 Service de Pneumologie; Centre Hospitalier Draguignan, France, 83300 Service de Pathologie Respiratoire; CHU de Limoges Limoges, France, 87000 Service de Pneumologie; Hôpital de la Croix Rousse Lyon, France, 69317 Service de Pneumologie-Neurologie ; Centre Hospitalier F. Quesnay Mantes La Jolie, France, 78200 Département des Maladies Respiratoires ; Hôpital Sainte Marguerite Marseille, France, 13274 Service de Pneumologie et Réanimation ; Hôpital Hôtel Dieu - Paris Paris, France, 75181 Service de Pneumologie - Hôpital St Antoine, Paris Paris, France, 75571 Service de Pneumologie ; Hôpital saint Antoine, Paris Paris, France Service de Pneumologie-Allergologie; Centre Hospitalier Général Perigueux, France, 24019 Service de Pneumologie; CHG de Roanne Roanne, France, 42300 Clinique Pneumologique; Hôpital Charles Nicolle Rouen, France, 76031 Service de Pneumologie; Hôpital Bois Guillaume Rouen, France, 76233 Service de Pathologie Respiratoire; Hôpital d'Instruction des Armées Sainte-Anne Toulon Naval, France, 83800 Service d'Oncologie Médicale; Clinique Sainte Marguerite Toulon, France, 83000 Collapse << |
| NCT01184287 | Non-Small Cell Lung Cancer | Phase 2 | Withdrawn(Program discontinued... more >>) Collapse << | - | United States, California ... more >> Tower Cancer Research Foundation Beverly Hills, California, United States, 90211 United States, Michigan Van Andel Research Institute Grand Rapids, Michigan, United States, 49503 United States, Montana Sletten Cancer Specialists Great Falls, Montana, United States, 59405 United States, New York The Cancer Institute at NYU Langone Medical Center New York, New York, United States, 10016 United States, Ohio Tri-county Hematology-Oncology Associates, Inc Canton, Ohio, United States, 44718 United States, Utah Northern Utah Associates Ogden, Utah, United States, 84403 Collapse << |
| NCT03607539 | Lung Neoplasms | Phase 3 | Not yet recruiting | September 2020 | - |
| NCT02162537 | Non-small Cell Lung Cancer Met... more >>astatic Non-small Cell Lung Cancer Adenocarcinoma of Lung Metastatic to Brain Cerebral Metastases Collapse << | Phase 3 | Recruiting | January 2019 | France ... more >> Centre Hospitalier du Pays d'Aix Recruiting Aix En Provence, France, 13613 Contact: Jacques LE TREUT jletreut@ch-aix.fr Principal Investigator: Jacques LE TREUT Centre Hospitalier Victor Dupouy Recruiting Argenteuil, France, 95100 Contact: Christine RAYNAUD christine.raynaud@ch-argenteuil.fr Principal Investigator: Christine RAYNAUD Centre d'Oncologie et de Radiothérapie du Pays Basque Recruiting Bayonne, France, 64100 Contact: Aurélien BLOUET aurelien.blouet@oncologie-pays-basque.org Principal Investigator: Aurélien BLOUET Centre Hospitalier Recruiting Beauvais, France, 60021 Contact: Jacky CREQUIT Jacky.crequit@orange.fr Principal Investigator: Jacky CREQUIT Hôpital Avicenne Not yet recruiting Bobigny, France, 93000 Contact: Antoine CARPENTIER antoine.carpentier@avc.aphp.fr Principal Investigator: Antoine CARPENTIER HIA de Clermont-Tonnerre Not yet recruiting Brest, France, 22240 Contact: Nicolas PALEIRON nicolas.paleiron@free.fr Principal Investigator: Nicolas PALEIRON CHU Recruiting Brest, France, 29200 Contact: Gilles ROBINET gilles.robinet@chu-brest.fr Principal Investigator: Gilles ROBINET Centre François Baclesse Recruiting Caen, France, 14000 Contact: Radj GERVAIS r.gervais@baclesse.fr Principal Investigator: Radj GERVAIS Centre Hospitalier Recruiting Charleville Meziere, France, 08000 Contact: Stéphane CHOUABE Schouabe@ch-charleville-mezieres.fr Principal Investigator: Stéphane CHOUABE Centre Hospitalier Laennec Recruiting Creil, France, 60109 Contact: Sandrine LOUTSKI-VETTESE sandrine.loutski@ch-creil.fr.fr Principal Investigator: Sandrine LOUTSKI-VETTESE Centre Hospitalier Intercommunal Recruiting Creteil, France, 94010 Contact: Isabelle MONNET isabelle.monnet@chicreteil.fr Principal Investigator: Isabelle MONNET Centre Hospitalier Recruiting Draguignan, France, 83300 Contact: Hervé LE CAER herve.lecaer@ch-draguignan.fr Principal Investigator: Hervé LE CAER Centre Hospitalier Recruiting GAP, France, 05000 Contact: Pascal THOMAS pascal.thomas@chicas-gap.fr Principal Investigator: Pascal THOMAS Centre Hospitalier Robert Boulin Recruiting Libourne, France, 33500 Contact: Samir ABDICHE samir.abdiche@ch-libourne.fr Principal Investigator: Samir ABDICHE Hôpital Le Cluzeau Recruiting Limoges, France, 87042 Contact: Alain VERGNENEGRE avergne@unilim.fr Principal Investigator: Alain VERGNENEGRE Centre Hospitalier Régional Recruiting Longjumeau, France, 91161 Contact: Gérard OLIVIERO gerard.oliviero@ch-longjumeau.fr Principal Investigator: Gérard OLIVIERO Centre Hospitalier de Bretagne Sud Recruiting Lorient, France, 56322 Contact: Régine LAMY r.lamy@ch-bretagne-sud.fr Principal Investigator: Régine LAMY Centre Léon Bérard Recruiting Lyon, France, 69373 Contact: Maurice PEROL maurice.perol@lyon.unicancer.fr Principal Investigator: Maurice PEROL Centre Hospitalier Les Chanaux Recruiting Macon, France, 71000 Contact: Dominique ARPIN doarpin@ch-macon.fr Principal Investigator: Dominique ARPIN Centre Hospitalier F. QUESNAY Recruiting Mantes La Jolie, France, 78200 Contact: Jean-Bernard AULIAC j-b.auliac@ch-mantes-la-jolie.rss.fr Principal Investigator: Jean-Bernard AULIAC Institut Paoli Calmette Recruiting Marseille, France, 13000 Contact: Anne MADROSZYC madroszyca@marseille.fnclcc.fr Principal Investigator: Anne MADROSZYC Hôpital Nord APHM Recruiting Marseille, France, 13915 Contact: Laurent GREILLIER laurent.greillier@mail.ap-hm.fr Principal Investigator: Laurent GREILLIER Centre Hospitalier Recruiting Meaux, France, 77108 Contact: Chrystèle LOCHER ch-locher@ch-meaux.fr Principal Investigator: Chrystèle LOCHER Centre Hospitalier Intercommunal Recruiting Meulan, France, 78250 Contact: Etienne LEROY-TERQUEM etiennelt@hotmail.fr Principal Investigator: Etienne LEROY-TERQUEM Clinique du Pont de Chaume Recruiting Montauban, France, 82000 Contact: Franck THOUVENY fthouveny@clinique-pontdechaume.fr Principal Investigator: Franck THOUVENY Centre Hospitalier Recruiting Perigueux, France, 24019 Contact: Jean-Yves DELHOUME jy.delhoume@ch-perigeux.fr Principal Investigator: Jean-Yves DELHOUME Centre Catalan d'Oncologie Recruiting Perpignan, France, 66000 Contact: Sabine VIEILLOT sabinevieillot@gmail.com Principal Investigator: Sabine VIEILLOT Centre Hospitalier René Dubos Recruiting Pontoise, France, 95303 Contact: Gislaine FRABOULET gislaine.fraboulet@ch-pontoise.fr Principal Investigator: Gislaine FRABOULET Centre Hospitalier de la Région d'Annecy (CHRA) Recruiting Pringy, France, 74374 Contact: Chantal DECROISETTE cdecroisette@ch-annecy.fr Principal Investigator: Chantal DECROISETTE Centre Hospitalier Intercommunal de Cornouaille Recruiting Quimper, France, 29107 Contact: Anne-Marie CHIAPPA am.chiappa@ch-cornouaille.fr Principal Investigator: CHIAPPA Anne-Marie Hôpital Pontchailloux Recruiting Rennes, France, 35033 Contact: Hervé LENA herve.lena@chu-rennes.fr Principal Investigator: Hervé LENA Hôpital Charles Nicolle Recruiting Rouen, France, 79031 Contact: Suzanna BOTA Suzanna.bota@chu-rouen.fr Principal Investigator: Suzanna BOTA Clinique Mutualiste de l'Estuaire Recruiting Saint Nazaire, France, 44600 Contact: Philippe DEGUIRAL philippe.deguiral@mla.fr Principal Investigator: Philippe DEGUIRAL Institut de Cancérologie de la Loire (I.C.L) Recruiting Saint Priest En Jarez, France, 42271 Contact: Pierre FOURNEL pierre.fournel@icloire.fr Principal Investigator: Pierre FOURNEL Centre Hospitalier de Salon de Provence Recruiting Salon de Provence, France, 13658 Contact: Jacques LE TREUT jletreut@ch-aix.fr Principal Investigator: Jacques LE TREUT Centre Hospitalier Recruiting Sens, France, 89108 Contact: GONZALEZ Gilles ggonzalez@ch-sens.fr Principal Investigator: GONZALEZ Gilles Centre Paul Strauss Recruiting Strasbourg, France, 67000 Contact: Roland SCHOTT rschott@strasbourg.unicancer.fr Principal Investigator: Roland SCHOTT Hopital d'Instruction des Armées Sainte Anne Recruiting Toulon, France, 83800 Contact: Henri BERARD hberard@libertysurf.fr Principal Investigator: Henri BERARD Hôpital Larrey Recruiting Toulouse, France, 31059 Contact: Laurence BIGAY-GAME bigaygame.l@chu-toulouse.fr Principal Investigator: Laurence BIGAY-GAME Clinique Pasteur Recruiting Toulouse, France, 31076 Contact: Olivier GALLOCHER o.gallocher@clinique-pasteur.com Principal Investigator: Olivier GALLOCHER Centre Hospitalier Recruiting Villefranche Sur Saone, France, 69655 Contact: Lionel FALCHERO lfalchero@ch-villefranche.fr Principal Investigator: Lionel FALCHERO Collapse << |
| NCT00034502 | Colorectal Cancer | Phase 1 Phase 2 | Completed | - | United States, Kansas ... more >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Wichita, Kansas, United States United States, New York For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. New York, New York, United States United States, Pennsylvania For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Pittsburgh, Pennsylvania, United States Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Bielefeld, Nordrhein-Westfalen, Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Halle, Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Hamburg, Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Homburg/Saar, Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Magdeburg, Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Munchen, Germany Collapse << |
| NCT00040625 | - | - | - | - | United States, New Jersey ... more >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Basking Ridge, New Jersey, United States Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician Porto Alegre, RS, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician Sao Paulo, Brazil Egypt "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Cairo, Egypt For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician Cairo, Egypt Saudi Arabia For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician Jeddah, Saudi Arabia Collapse << |
| NCT00251550 | Malignant Pleural Mesotherioma | Phase 1 Phase 2 | Completed | - | Japan ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Aichi, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Ehime, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Fukuoka, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Hokkaido, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Okayama, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Osaka, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Tokyo, Japan Collapse << |
| NCT01664533 | - | - | Completed | - | - |
| NCT00835471 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Unknown | June 2014 | Netherlands ... more >> VU medisch centrum Recruiting Amsterdam, Netherlands Contact: Smit ef.smit@vumc.nl Principal Investigator: Egbert F. Smit, MD PhD Rode Kruis Ziekenhuis Recruiting Beverwijk, Netherlands Contact: Rikers mscrk@rkz.nl Principal Investigator: C. H. Rikers, MD Amphia Ziekenhuis Recruiting Breda, Netherlands Contact: Aerts jaerts@amphia.nl Principal Investigator: Joachim G. Aerts, MD PhD Reinier de Graaf Gasthuis Recruiting Delft, Netherlands Contact: Pannekoek pkoek@rdgg.nl Principal Investigator: B. J. Pannekoek, MD Jeroen Bosch Ziekenhuis Recruiting Den Bosch, Netherlands Contact: Biesma b.biesma@jbz.nl Principal Investigator: Bonne Biesma, MD PhD Catharina-Ziekenhuis Recruiting Eindhoven, Netherlands Contact: van den Borne ben.vd.borne@cze.nl Principal Investigator: Ben E. van den Borne, MD PhD Martini Ziekenhuis Recruiting Groningen, Netherlands Contact: van Putten jwg.van.putten@mzh.nl Principal Investigator: John W. van Putten, MD PhD Kennemer Gasthuis Recruiting Haarlem, Netherlands Contact: Weenink weenink@kg.nl Principal Investigator: C. Weenink, MD PhD Academisch Ziekenhuis Maastricht Recruiting Maastricht, Netherlands Contact: Dingemans a.c.dingemans@lung.azm.nl Principal Investigator: A. C. Dingemans, MD PhD Universitair Medisch Centrum Sint Radboud Recruiting Nijmegen, Netherlands Contact: van der Drift m.vanderdrift@ulc.umcn.nl Principal Investigator: M. A. van der Drift, MD Maasstad Ziekenhuis Recruiting Rotterdam, Netherlands Contact: Slingerland slingerlandr@mcrz.nl Principal Investigator: Rob Slingerland, MD Sint Franciscus Gasthuis Recruiting Rotterdam, Netherlands Contact: in 't Veen h.intveen@sfg.nl Principal Investigator: J. C. in 't Veen, MD PhD HagaZiekenhuis Recruiting The Hague, Netherlands Contact: Codrington h.codrington@hagaziekenhuis.nl Principal Investigator: Henk E. Codrington, MD Isala Klinieken Recruiting Zwolle, Netherlands Contact: Stigt j.a.stigt@isala.nl Principal Investigator: Jos A. Stigt, MD Collapse << |
| NCT01664533 | - | - | Completed | - | Belgium ... more >> Aalst, Belgium, 9300 Antwerpen, Belgium, 2020 Boussu, Belgium, 7360 Bruxelles, Belgium, 1200 Charleroi, Belgium, 6000 Dendermonde, Belgium, 9200 Duffel, Belgium, 2570 Edegem, Belgium, 2650 Frameries, Belgium, 7080 Genk, Belgium, 3600 Gilly, Belgium, 6060 Gosselies, Belgium, 6041 Liege, Belgium, 4000 Mons, Belgium, 7000 Montegnée, Belgium, 4420 Namur, Belgium, 5000 Ottignies, Belgium, 1340 Roeselare, Belgium, 8800 Sint Niklaas, Belgium, 9100 Tournai, Belgium, 7500 Turnhout, Belgium, 2300 Collapse << |
| NCT02145078 | Recurrent Non-small Cell Lung ... more >>Cancer Stage IV Non-small Cell Lung Cancer Collapse << | Not Applicable | Terminated(Slow accrual.) | - | United States, Michigan ... more >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Collapse << |
| NCT00034606 | Carcinoma, Non-Small-Cell Lung... more >> Lung Neoplasms Neoplasms Collapse << | Phase 2 | Completed | - | United States, Minnesota ... more >> Rochester, Minnesota, United States Collapse << |
| NCT00149214 | - | - | Completed | - | - |
| NCT03663205 | Non-Small Cell Lung Cancer | Phase 3 | Recruiting | September 23, 2020 | China ... more >> Shanghai Chest Hospital Recruiting Shanghai, China Collapse << |
| NCT00149214 | Breast Cancer | Phase 2 | Completed | - | Germany ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baden-Baden, Germany, 76532 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 10967 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 20357 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Germany, D-69115 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cremona, Italy, 26100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rozzano, Italy, 20089 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation, 129128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Petersburg, Russian Federation, 197022 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jaen, Spain, 23007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sabadell, Spain, 08208 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46010 Collapse << |
| NCT00686959 | Non Small Cell Lung Cancer | Phase 3 | Completed | - | - |
| NCT00686959 | - | - | Completed | - | - |
| NCT00556322 | Non-Small Cell Lung Cancer | Phase 3 | Completed | - | - |
| NCT03544814 | Lung Adenocarcinoma ... more >> EGFR Activating Mutation Collapse << | Phase 2 | Completed | - | - |
| NCT02303899 | Mesothelioma, Malignant | Phase 2 | Active, not recruiting | December 2017 | Italy ... more >> Istituto Clinico Humanitas Rozzano, MI, Italy, 20089 Collapse << |
| NCT00055432 | Ovarian Cancer ... more >> Peritoneal Cancer Collapse << | Phase 2 | Terminated | - | United States, Georgia ... more >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Atlanta, Georgia, United States Collapse << |
| NCT01301716 | Solid Cancers | Phase 1 | Completed | - | United States, California ... more >> Los Angeles, California, United States, 90025 United States, Florida Tampa, Florida, United States, 33612 United States, Massachusetts Boston, Massachusetts, United States, 02114 Boston, Massachusetts, United States, 02215 Spain Madrid, Spain, 28050 Collapse << |
| NCT00254319 | Untreated Advanced Non-Small C... more >>ell Lung Cancer Collapse << | Phase 2 | Unknown | - | United States, New Jersey ... more >> The CINJ at Cooper University Hospital Recruiting Voorhees, New Jersey, United States, 08043 Principal Investigator: James Stevenson, MD Sub-Investigator: Generosa Grana, MD Collapse << |
| NCT01850303 | Non Small Cell Lung Cancer (Sq... more >>uamous or Non Squamous) Collapse << | Phase 3 | Active, not recruiting | December 2018 | - |
| NCT00556322 | - | - | Completed | - | - |
| NCT00733031 | Cancer, Solid... more >> Tumors Advanced Solid Malignancies Collapse << | Phase 1 | Terminated(PK results demonstr... more >>ate low and variable plasma concentrations so that achieving therapeutic concentrations is unlikely.) Collapse << | - | United States, Colorado ... more >> Research Site Aurora, Colorado, United States United States, Tennessee Research Site Nashville, Tennessee, United States Collapse << |
| NCT01005680 | Non Small Cell Lung Cancer | Phase 3 | Completed | - | China ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100730 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changchun, China, 130012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dalian, China, 116023 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510080 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanning, China, 530000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200433 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sichuan, China, 610041 Collapse << |
| NCT02120807 | Stage IV Lung Adenocarcinoma | Phase 1 | Active, not recruiting | April 2019 | United States, New Jersey ... more >> Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering West Harrison Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Collapse << |
| NCT00308750 | Non-small Cell Lung Cancer | Phase 2 | Completed | - | United States, North Carolina ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Burlington, North Carolina, United States, 27215 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chapel Hill, North Carolina, United States, 27599 United States, South Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Columbia, South Carolina, United States, 29210 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States, 77060 Collapse << |
| NCT01454102 | Non-small Cell Lung Cancer | Phase 1 | Active, not recruiting | December 29, 2018 | United States, California ... more >> Ucla Santa Monica, California, United States, 90404 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Texas Ut Southwestern Medical Center At Dallas Dallas, Texas, United States, 75390-8852 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Canada, Ontario Local Institution Hamilton, Ontario, Canada, L8V 5C2 Local Institution Ottawa, Ontario, Canada, K1H 8L6 Local Institution Toronto, Ontario, Canada, M5G 2M9 Collapse << |
| NCT01005680 | - | - | Completed | - | - |
| NCT00227539 | Lung Cancer | Phase 2 | Completed | - | United States, Washington ... more >> Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 University of Washington School of Medicine Seattle, Washington, United States, 98195 Collapse << |
| NCT00227539 | - | - | Completed | - | - |
| NCT02436733 | Malignant Pleural Mesothelioma | Phase 2 | Recruiting | April 2020 | Belgium ... more >> UZ Antwerpen Recruiting Antwerpen, Belgium Contact: Jan Van Meerbeeck, Prof UZ Gent Recruiting Gent, Belgium Contact: Veerle Surmont, Prof France Assistance Publique - Hopitaux de Marseille - Hopital Nord Recruiting Marseille, France Contact: Pascal-Alexandre Thomas, Prof Netherlands The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis Recruiting Amsterdam, Netherlands Contact: Paul Baas, Prof Erasmus MC Hospital Recruiting Rotterdam, Netherlands Contact: Joachim Aerts, Prof Collapse << |
| NCT00867711 | - | - | Completed | - | Italy ... more >> Istituto Clinico Humanitas Rozzano, Milano, Italy, 20089 Collapse << |
| NCT00509366 | Non Small Cell Lung Cancer | Phase 2 | Terminated(Study terminated du... more >>e to reproducibility issues with genomics prediction model.) Collapse << | - | United States, North Carolina ... more >> Duke University Medical Center Durham, North Carolina, United States, 27710 Maria Parham Hospital Henderson, North Carolina, United States, 27536 Scotland HealthCare System (Scotland Memorial Hospital) Laurinburg, North Carolina, United States, 28352 Southeastern Regional Medical Center, Gibson Cancer Center Lumberton, North Carolina, United States, 28358 Duke Raleigh Hospital Raleigh, North Carolina, United States, 27609 United States, South Carolina Beaufort Memorial Hospital Beaufort, South Carolina, United States, 29902 Coastal Cancer Center Myrtle Beach, South Carolina, United States, 29572 United States, Virginia Community Memorial Health Center South Hill, Virginia, United States, 23970 Collapse << |
| NCT00509366 | - | - | Terminated(Study terminated du... more >>e to reproducibility issues with genomics prediction model.) Collapse << | - | - |
| NCT03319537 | Mesothelioma | Phase 1 Phase 2 | Recruiting | October 2020 | United States, New Jersey ... more >> Memorial Sloan Kettering at Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Majorie Zauderer, MD 646-888-4656 Memoral Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Marjorie Zauderer, MD 646-888-4656 Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Marjorie Zauderer, MD 646-888-4656 United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Marjorie Zauderer, MD 646-888-4656 Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Majorie Zauderer, MD 646-888-4656 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Marjorie Zauderer, MD 646-888-4656 Contact: Andrea Cercek, MD 646-888-4189 Principal Investigator: Marjorie Zauderer, MD Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Marjorie Zauderer, MD 646-888-4656 Collapse << |
| NCT01639001 | NSCLC (Non-small Cell Lung Can... more >>cer) Collapse << | Phase 3 | Active, not recruiting | January 2019 | - |
| NCT01194453 | Non-small Cell Lung Cancer ... more >> Efficacy Collapse << | Phase 2 | Completed | - | China, Guangdong ... more >> Cancer Center of Sun Yat-Sen University (CCSU) Guangzhou, Guangdong, China Collapse << |
| NCT01193959 | - | - | Unknown | September 2011 | Italy ... more >> Istituto Clinico Humanitas Rozzano, Milano, Italy, 20089 Collapse << |
| NCT00106626 | Advanced Cancer | Phase 1 | Completed | - | - |
| NCT01639001 | - | - | Active, not recruiting | - | - |
| NCT00903292 | Non-Small Cell Lung Cancer | Not Applicable | Unknown | December 2010 | Taiwan ... more >> National Cheng-Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Hui-Shu Yang, Bachelor +886-6-2353535 ext 4289 huishuyang@gmail.com Collapse << |
| NCT01719536 | NSCLC | Phase 3 | Unknown | December 2016 | - |
| NCT00106626 | - | - | Completed | - | - |
| NCT01666977 | Non Small Cell Lung Cancer | Phase 1 Phase 2 | Completed | - | - |
| NCT02595840 | - | - | - | - | - |
| NCT01192165 | Cancer | Phase 1 | Completed | - | United States, Arizona ... more >> GSK Investigational Site Scottsdale, Arizona, United States, 85259 United States, California GSK Investigational Site Duarte, California, United States, 91010 GSK Investigational Site Sacramento, California, United States, 95817 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80218 United States, Nevada GSK Investigational Site Las Vegas, Nevada, United States, 89169 United States, New York GSK Investigational Site Albany, New York, United States, 12206 United States, South Carolina GSK Investigational Site Greenville, South Carolina, United States, 29605 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75246 GSK Investigational Site Houston, Texas, United States, 77030 GSK Investigational Site Tyler, Texas, United States, 75702 United States, Virginia GSK Investigational Site Norfolk, Virginia, United States, 23502 United States, Washington GSK Investigational Site Vancouver, Washington, United States, 98684 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M5G 2M9 France GSK Investigational Site Caen Cedex 9, France, 14033 GSK Investigational Site Marseille cedex 5, France, 13385 GSK Investigational Site Saint-Herblain cedex, France, 44805 GSK Investigational Site Toulouse cedex, France, 31052 Korea, Republic of GSK Investigational Site Seoul, Korea, Republic of, 120-752 GSK Investigational Site Seoul, Korea, Republic of, 135-710 Collapse << |
| NCT02669719 | Non Small Cell Lung Cancer | Phase 2 | Recruiting | January 2019 | China, Shanghai ... more >> Shanghai Chest Hospital Recruiting Shanghai, Shanghai, China, 200030 Contact: Baohui Han, MD 86-21-62821990 ext 61201 xkyyhan@gmail.com Principal Investigator: Baohui Han, MD Collapse << |
| NCT02407366 | Non-small Cell Lung Cancer | Phase 2 | Unknown | December 2017 | China, Guangxi ... more >> The people's Hospital of the Guangxi Zhuang Autonomous Region Recruiting Nanning, Guangxi, China, 530021 Contact: GuoSheng Feng, professor +86-771-218-6508 fengguosheng88988@163.com Collapse << |
| NCT00541073 | Malignant Mesothelioma | Phase 2 | Completed | - | France ... more >> Centre Oscar Lambret Lille, France, 59020 Collapse << |
| NCT03351842 | Chemotherapy, Adjuvant ... more >> Lung Adenocarcinoma, Stage I Treatment Histological Type of Neoplasm Collapse << | Phase 2 | Recruiting | September 1, 2024 | China ... more >> Thoracic Surgery Department of Shanghai Pulmonary Hospital Recruiting Shanghai, China, 200000 Contact: Yingran Shen 86-18117166317 elaineshen91@gmail.com Collapse << |
| NCT00227630 | Malignant Mesothelioma | Phase 2 | Completed | - | Belgium ... more >> Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 Italy Istituto Nazionale per la Ricerca sul Cancro Genoa, Italy, 16132 Azienda Ospedaliera Di Parma Parma, Italy, 43100 Universita Degli Studi di Udine Udine, Italy, 33100 Netherlands Sint Antonius Ziekenhuis Nieuwegein, Netherlands, 3435 CM Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands, 3008 AE United Kingdom Princess Royal Hospital at Hull and East Yorkshire NHS Trust Hull, England, United Kingdom, HU8 9HE Edinburgh Cancer Centre at Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Collapse << |
| NCT01502202 | Non Small Cell Lung Cancer ... more >> Adenocarcinoma Collapse << | Phase 2 | Unknown | February 2015 | Korea, Republic of ... more >> National Cancer Center Recruiting Goyang-si, Gyenggido, Korea, Republic of, 410-769 Contact: Sung Jin Yoon, RN +82-31-920-0405 jinijiniya@ncc.re.kr Contact: Jin Soo Lee, MD. Ph.D. +82-31-920-1501 jslee@ncc.re.kr Collapse << |
| NCT01063283 | Advanced Non-squamous Non-Smal... more >>l Cell Lung Cancer Collapse << | Not Applicable | Completed | - | United States, Illinois ... more >> The University of Chicago Medical Center Chicago, Illinois, United States, 60637 North Shore University Health System Evanston, Illinois, United States, 60201 Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Collapse << |
| NCT01087970 | Head and Neck Neoplasms | Phase 2 | Completed | - | - |
| NCT01087970 | - | - | Completed | - | - |
| NCT00101842 | Carcinoma, Transitional Cell | Phase 1 Phase 2 | Completed | - | United States, Texas ... more >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Dallas, Texas, United States Collapse << |
| NCT01496742 | Non-Squamous Non-Small Cell Lu... more >>ng Cancer Collapse << | Phase 2 | Completed | - | - |
| NCT02468661 | Non-Small Cell Lung Cancer | Phase 1 Phase 2 | Recruiting | March 31, 2020 | - |
| NCT02654587 | Non Small Cell Lung Cancer | Phase 3 | Recruiting | December 2021 | - |
| NCT03256136 | Lung Cancer | Phase 2 | Recruiting | October 31, 2024 | United States, Massachusetts ... more >> Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02115 Contact: Daniel B Costa, MD 617-667-9236 Principal Investigator: Daniel B Costa, MD Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Amanda J Redig, MD, PhD 617-632-6036 Principal Investigator: Amanda J Redig, MD, PhD Massachusetts general Hospital Recruiting Boston, Massachusetts, United States, 02214 Contact: Alice T Shaw, MD, PhD 617-643-0563 Principal Investigator: Alice T Shaw, MD, PhD Collapse << |
| NCT00356525 | Lung Neoplasms | Phase 2 | Terminated(Stopped early due t... more >>o low enrollment) Collapse << | - | United States, Florida ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States, 33179 United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Evanston, Illinois, United States, 60201 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wichita, Kansas, United States, 67214 United States, Minnesota For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Minneapolis, Minnesota, United States, 55455 United States, Missouri For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Louis, Missouri, United States, 63110 United States, Nebraska For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Omaha, Nebraska, United States, 68114 United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chapel Hill, North Carolina, United States, 27599 United States, Tennessee For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chattanooga, Tennessee, United States, 37404 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States, 38120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nashville, Tennessee, United States, 37203 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States, 77060 Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Caxias Do Sul, Brazil, 95070560 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Porto Alegre, Brazil, 90430-090 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santo Andre, Brazil, 09090780 India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bangalore, India, 560 029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mumbai, India, 400016 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trivandrum, India, 695011 Collapse << |
| NCT00356525 | - | - | Terminated(Stopped early due t... more >>o low enrollment) Collapse << | - | - |
| NCT03256721 | Nonsmall Cell Lung Cancer | Phase 2 | Recruiting | May 26, 2019 | China, Fujian ... more >> Fuzhou general hospital Recruiting Fuzhou, Fujian, China, 365000 Contact: Zongyang YU, PhD 13509327806 yuzy527@sina.com Contact: Xiaoyan HUANG, Master 15860818302 170889977@qq.com Collapse << |
| NCT00738582 | Malignant Pleural Mesothelioma | Phase 2 | Completed | - | - |
| NCT01445392 | Mesothelioma | Phase 1 | Terminated | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
| NCT03380468 | Lung Neoplasms | Phase 2 Phase 3 | Recruiting | December 31, 2025 | China, Shanghai ... more >> Fudan University Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Chen Haiquan, MD +86-21 64175590 ext 1707 hqchen1@yahoo.com Collapse << |
| NCT01192243 | Toxicity Non-... more >>small Cell Lung Cancer Collapse << | Phase 2 | Unknown | - | China, Shanghai ... more >> Cancer hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Jianhua Chang, MD,PhD 13916619284 changjianhua@hotmail.com Collapse << |
| NCT00034463 | Metastases Ca... more >>ncer Collapse << | Phase 1 | Completed | - | United States, Texas ... more >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. San Antonio, Texas, United States Collapse << |
| NCT01705184 | Non-small Cell Lung Cancer Met... more >>astatic Nonsquamous Nonsmall Cell Neoplasm of Lung Collapse << | Phase 2 | Completed | - | France ... more >> Avignon - Institut Sainte-Catherine Avignon, France, 84918 Caen - Centre François Baclesse Caen, France, 14000 Caen - CHU Côte de Nacre Caen, France, 14000 Centre Hospitalier Chauny, France CH du Mans Le Mans, France Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques Marseille, France Mulhouse - CH Mulhouse, France, 68000 Nantes - Centre René Gauducheau Nantes, France, 44805 Hopital Tenon - Pneumologie Paris, France, 75020 HCL - Lyon Sud (Pneumologie) Pierre Bénite, France, 69495 Rennes - CHU Rennes, France, 35033 Strasbourg - NHC Strasbourg, France, 63000 Collapse << |
| NCT00334594 | Malignant Mesothelioma | Phase 2 | Completed | - | Germany ... more >> Universitaetsklinikum Freiburg Freiburg, Germany, D-79106 Switzerland Kantonsspital Aarau Aarau, Switzerland, CH-5001 Kantonsspital Baden Baden, Switzerland, CH-5404 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Spital Tiefenau Bern 4, Switzerland, 3004 Inselspital Bern Bern, Switzerland, CH-3010 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital Olten Olten, Switzerland, CH-4600 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 SpitalSTS AG Simmental-Thun-Saanenland Thun, Switzerland, 3600 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Collapse << |
| NCT01829113 | Non Squamous Non Small Cell Lu... more >>ng Cancer Collapse << | Phase 2 | Completed | - | United States, Colorado ... more >> Rocky Mountain Cancer Center Denver, Colorado, United States, 80218 United States, Florida Florida Cancer Specialists-South Fort Myers, Florida, United States, 33916 Florida Hospital Cancer Insitute Orlando, Florida, United States, 32804 Florida Cancer Specialists-North Saint Petersburg, Florida, United States, 33705 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Missouri Research Medical Center Kansas City, Missouri, United States, 64132 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, New Jersey Hematology-Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07932 United States, Ohio Oncology Hematology Care, Inc. Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates Columbia, South Carolina, United States, 29210 United States, Tennessee Tennessee Oncology - Chattanooga Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas The Center for Cancer and Blood Disorders Fort Worth, Texas, United States, 76104 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Virginia Cancer Institute Richmond, Virginia, United States, 23230 Collapse << |
| NCT00892710 | Non Small Cell Lung Cancer | Phase 2 | Completed | - | - |
| NCT01057589 | Head and Neck Neoplasms | Phase 2 | Completed | - | Belgium ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Edegem, Belgium, 2650 France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Herblain, France, 44805 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dresden, Germany, 01307 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Essen, Germany, 45122 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leipzig, Germany, 04103 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy, 20133 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pamplona, Spain, 31008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46014 United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cardiff, South Glamorgan, United Kingdom, CF14 2TL For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, United Kingdom, SW3 6JJ Collapse << |
| NCT00961415 | Non-Squamous Non-Small Cell Lu... more >>ng Cancer Collapse << | Phase 3 | Completed | - | - |
| NCT01057589 | - | - | Completed | - | - |
| NCT01829113 | - | - | Completed | - | - |
| NCT02029690 | Pleural Mesothelioma Malignant... more >> Advanced Peritoneal Mesothelioma Malignant Advanced Non-squamous Non-small Cell Lung Carcinoma Stage IIIB/IV (NSCLC) Metastatic Uveal Melanoma Hepatocellular Carcinoma (HCC) Glioma Sarcomatoid Cancers Collapse << | Phase 1 | Active, not recruiting | February 2019 | United States, Minnesota ... more >> Mayo Clinic Rochester Rochester, Minnesota, United States, 55902 United Kingdom Centre for Experimental Cancer Medicine (CECM) London, England, United Kingdom, EC1M 6BQ Cambridge Hospital Cambridge, United Kingdom, CB2 0QQ Guys Hospital London, United Kingdom, SE1 7EH Collapse << |
| NCT00892710 | - | - | Completed | - | - |
| NCT01481259 | Non-small Cell Lung Cancer | Phase 2 Phase 3 | Unknown | July 2013 | China, Guangxi ... more >> Clinical Cancer Center, People's Hospital of Guangxi Zhuang Autonomous Region Recruiting Nanning, Guangxi, China, 530021 Collapse << |
| NCT00961415 | - | - | Completed | - | - |
| NCT00415636 | Cancer | Phase 1 | Completed | - | United States, Arizona ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Scottsdale, Arizona, United States, 85258 Collapse << |
| NCT00609518 | - | - | Completed | - | - |
| NCT00609518 | Non Small Cell Lung Cancer | Phase 2 | Completed | - | Australia, New South Wales ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bankstown, New South Wales, Australia, 2200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Concord, New South Wales, Australia, 2139 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kingswood Penrith, New South Wales, Australia, 2747 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Liverpool, New South Wales, Australia, 2170 Australia, Queensland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Redcliffe, Queensland, Australia, 4020 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bologna, Italy, 40100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy, 20132 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Napoli, Italy, 80100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pisa, Italy, 56100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rome, Italy, 00149 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mexico City, Mexico, 14000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toluca, Mexico, CP50180 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pozuelo De Alarcon, Spain, 28223 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sevilla, Spain, 41014 Collapse << |
| NCT00415636 | - | - | Completed | - | - |
| NCT01373463 | Nonsquamous Nonsmall Cell Neop... more >>lasm of Lung Nonsmall Cell Lung Cancer Stage III Collapse << | Phase 1 | Terminated(Investigator left s... more >>ite) Collapse << | - | United States, South Carolina ... more >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Collapse << |
| NCT01303926 | Non-squamous Nonsmall Cell Neo... more >>plasm of Lung Collapse << | Phase 3 | Unknown | June 2012 | Italy ... more >> "Giovanni Paolo II" Oncology Institute Bari, BA, Italy, 70124 "San Paolo Hospital" Oncology Service Bari, BA, Italy Division of Medical Oncology, "Fatebenefratelli" Hospital Benevento, BN, Italy Division of Medical Oncology, "Sen. Perrino" Hospital, Brindisi, Italy Brindisi, BR, Italy, 72100 7 Division of Medical Oncology, "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, FG, Italy Medical Oncology Division "Vito Fazzi" Hospital Lecce, Le, Italy Division of Medical Oncology, "Buccheri-La Ferla" Hospital Palermo, PA, Italy Division of Medical Oncology, "La Maddalena" Hospital Palermo, PA, Italy Division of Medical Oncology, Castellaneta Hospital Castellaneta, TA, Italy Division of Medical Oncology "San Giuseppe Moscati Hospital" Taranto, TA, Italy Clinical Trials Office, Department of Medical Sciences, Azienda ULSS 13 Mirano, VE, Italy National Cancer Institute "G. Pascale" Thoracic Dept. Napoli, Italy Collapse << |
| NCT03513666 | NSCLC | Phase 2 | Recruiting | June 2019 | China, Shanghai ... more >> Shanghai Pulmonary Hospita Recruiting Shanghai, Shanghai, China Contact: Caicun Zhou Collapse << |
| NCT01160744 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Completed | - | - |
| NCT00974584 | Non-Squamous Non-Small Cell Lu... more >>ng Cancer Collapse << | Phase 1 | Completed | - | United States, New York ... more >> Buffalo, New York, United States, 14263 France Villejuif, France, 94805 Netherlands Groningen, Netherlands, 9700 RB Collapse << |
| NCT01160744 | - | - | Completed | - | - |
| NCT02899299 | Mesothelioma | Phase 3 | Active, not recruiting | September 28, 2021 | - |
| NCT00489983 | Non-Small Cell Lung Cancer | Phase 2 | Completed | - | Germany ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, United Kingdom Collapse << |
| NCT00932893 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Completed | - | - |
| NCT00799240 | Non Small Cell Lung Cancer | Phase 2 | Completed | - | United States, Kansas ... more >> Hutchinson Clinic, PA Hutchinson, Kansas, United States, 67502 Kansas University Cancer Center Kansas City, Kansas, United States, 66160 Stormont Vail Healthcare Topeka, Kansas, United States, 66606 United States, Missouri VA Medical Center Kansas City, Missouri, United States, 64128 Collapse << |
| NCT03706287 | Lung Cancer Metastatic | Phase 1 Phase 2 | Not yet recruiting | March 10, 2021 | China, Sichuan ... more >> Sichuan Cancer Hospital Not yet recruiting Chengdu, Sichuan, China, 610041 Contact: juan li, doctor +8613880276636 dr.lijuan@gmail.com Contact: rui shi, doctor +8613880898008 shirui729@hotmail.com Principal Investigator: ping yu, doctor Principal Investigator: juan li, doctor China Chengdu fifth people's hospital Not yet recruiting Chengdu, China Contact: mei mei Principal Investigator: mei mei People's hospital of deyang city Deyang, China The affiliated hospital of southwest medical university Not yet recruiting Luzhou, China Contact: Sheng Lin Principal Investigator: Sheng Lin Nanchong central hospital Not yet recruiting Nanchong, China Contact: xin hu Principal Investigator: xin hu Suining central hospital Not yet recruiting Suining, China Contact: qiang zhou Principal Investigator: qiang zhou Collapse << |
| NCT03110484 | Biliary Tract Cancer | Phase 2 | Not yet recruiting | June 2019 | Korea, Republic of ... more >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Collapse << |
| NCT00475657 | - | - | Terminated(Terminated due to l... more >>ack of efficacy) Collapse << | - | - |
| NCT00470405 | Lymphoma Soli... more >>d Tumor Collapse << | Phase 1 | Completed | - | United States, Tennessee ... more >> Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Collapse << |
| NCT01578668 | Lung Adenocarcinoma ... more >> Brain Metastases Collapse << | Phase 2 | Completed | - | China, Guangdong ... more >> The first affiliated hospital of Guangzhou MC Guangzhou, Guangdong, China, 510120 Collapse << |
| NCT00660816 | Lung Cancer | Phase 2 | Completed | - | United States, Michigan ... more >> Wayne State University Detroit, Michigan, United States, 48202 United States, New York Columbia Presbyterian New York City, New York, United States, 10032 United States, Ohio Lake/University Ireland Cancer Center Cleveland, Ohio, United States, 44060 Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 MetroHealth Medical Center Cleveland, Ohio, United States, 44109 UHHS Chagrin Highlands Medical Center Cleveland, Ohio, United States, 44122 Southwest General Health Center Cleveland, Ohio, United States, 44130 UHHS Westlake Medical Center Cleveland, Ohio, United States, 44145 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Riverside Methodist Hospital Columbus, Ohio, United States, 43124 Ohio State University Columbus, Ohio, United States, 43210 UH-Monarch Mayfield Heights, Ohio, United States, 44124 UH-Firelands Sandusky, Ohio, United States, 44870 Collapse << |
| NCT00475657 | Small Cell Lung Cancer | Phase 2 | Terminated(Terminated due to l... more >>ack of efficacy) Collapse << | - | Spain ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ferrol, Spain, 15405 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Coruña, Spain, 15002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lugo, Spain, 27004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ourense, Spain, 15009 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santiago de Compostela, Spain, 15706 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vigo, Spain, 36211 Collapse << |
| NCT01020786 | Non Small Cell Lung Cancer | Phase 4 | Completed | - | Japan ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 460-0001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 277 8577 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ehime, Japan, 790-0007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 812-8582 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 062-0931 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 673-8558 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 236-0051 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kumamoto, Japan, 860-8556 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miyagi, Japan, 980-8574 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Niigata, Japan, 951-8520 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okayama, Japan, 700-8558 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 589-8511 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shizuoka, Japan, 411-8777 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tochigi, Japan, 320-0834 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 113-8677 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yamaguchi, Japan, 755-0241 Collapse << |
| NCT00932893 | - | - | Completed | - | - |
| NCT01020786 | - | - | Completed | - | - |
| NCT00482014 | Non-Small-Cell Lung Cancer | Phase 1 Phase 2 | Completed | - | United States, California ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States, 90095 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wichita, Kansas, United States, 67214 United States, Missouri For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St Louis, Missouri, United States, 63110 United States, Nevada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Las Vegas, Nevada, United States, 89135 United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Burlington, North Carolina, United States, 27216 United States, Tennessee For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States, 38120 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Corpus Christi, Texas, United States, 78405 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75390 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Temple, Texas, United States, 76508 India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Delhi, India, 110085 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trivandrum, India, 695 011 Collapse << |
| NCT00660816 | - | - | Completed | - | - |
| NCT00320515 | Neoplasm, Gastric | Phase 1 Phase 2 | Completed | - | Argentina ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Buenos Aires, Argentina, 1264 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tucumain, Argentina, 4000 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 136-705 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ciudad Obregon, Mexico, 85100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guadalajara, Mexico, 44280 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tainan, Taiwan, 704 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 112 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 Collapse << |
| NCT00320515 | - | - | Completed | - | - |
| NCT00517595 | Non-Small Cell Lung Cancer | Phase 2 | Completed | - | United States, Connecticut ... more >> Medical Oncology & Hematology Waterbury, Connecticut, United States, 06708 United States, Georgia Augusta Oncology Associates Augusta, Georgia, United States, 30901 Central Georgia Cancer Care Macon, Georgia, United States, 31201 Northwest Georgia Oncology Center Marietta, Georgia, United States, 30060 United States, Montana Hematology Oncology Centers of the Northern Rockies Billings, Montana, United States, 59101 United States, Ohio Tri-County Oncology Hematology Associates Canton, Ohio, United States, 44718 United States, Oregon Pacific Oncology, PC Portland, Oregon, United States, 97225 United States, Pennsylvania Pennsylvania Oncology Hematology Associates Philadelphia, Pennsylvania, United States, 19106 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 United States, Virginia Cancer Specialists of Tidewater Chesapeake, Virginia, United States, 23320 Collapse << |
| NCT00179699 | Non-Small Cell Lung Cancer | Phase 1 | Terminated | - | United States, Florida ... more >> MD Anderson - Orlando Orlando, Florida, United States, 32806 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Kentucky Norton Healthcare Louisville, Kentucky, United States, 40202 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, New York North Shore Hem/Onc Associates East Setauket, New York, United States, 11733-3456 Collapse << |
| NCT00248495 | Lung Cancer | Phase 2 | Completed | - | United States, New York ... more >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Collapse << |
| NCT00482014 | - | - | Completed | - | - |
| NCT00269152 | - | - | Completed | - | - |
| NCT00248495 | - | - | Completed | - | - |
| NCT00269152 | Non-Small Cell Lung Cancer | Phase 2 | Completed | - | France ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bordeaux, France, 33076 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris, France, 75571 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rennes, France, 35033 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St Priest En Jarez, France, 42270 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toulouse, France, 31059 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bad Berka, Germany, 99437 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bielefeld, Germany, D-33604 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Großhansdorf, Germany, D-22927 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Halle, Germany, D-06120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, D-30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kassel, Germany, 34125 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Köln, Germany, D-51109 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Loewenstein, Germany, 74245 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, D-55131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mannheim, Germany, 68167 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28046 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santiago De Compostela, Spain, 15706 Collapse << |
| NCT00407459 | Mesothelioma | Phase 2 | Completed | - | Italy ... more >> Istituto Clinico Humanitas Rozzano, Milan, Italy, 20089 Collapse << |
| NCT00102804 | Non-Small Cell Lung Cancer | Phase 3 | Completed | - | - |
| NCT00619424 | Lung Cancer, Non-Small Cell | Phase 1 | Completed | - | United States, Colorado ... more >> GSK Investigational Site Aurora, Colorado, United States, 80045 United States, New York GSK Investigational Site Buffalo, New York, United States, 14263 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 Italy GSK Investigational Site Orbassano (TO), Piemonte, Italy, 10043 Collapse << |
| NCT00517595 | - | - | Completed | - | - |
| NCT02448797 | Non-small Cell Lung Cancer | Phase 3 | Recruiting | December 2022 | China, Beijing ... more >> 307 Hospital of PLA Recruiting Beijing, Beijing, China, 100071 Principal Investigator: Xiao-qing Liu, M.D. China, Fujian Fujian Provincal Cancer Hospital Recruiting Fuzhou, Fujian, China, 350014 Contact: Huang Cheng, M.D. 0086-13905010397 Principal Investigator: Huang Cheng, M.D. China, Guangdong The First Affiliated Hospital Of Guangzhou Medical Collage Recruiting Guangzhou, Guangdong, China, 510120 Contact: He Jianxing 0086-13802777270 Principal Investigator: He Jianxing, M.D. Shenzhen People's Hospital Recruiting Shenzhen, Guangdong, China, 518020 Contact: Zheng Wang, MD 13502886638 Principal Investigator: Zheng Wang, MD China, Liaoning The First Hospital of China Medical University Recruiting Shenyang, Liaoning, China, 110001 Contact: Liu Yunpeng, M.D. 0086-13898865122 Principal Investigator: Liu Yunpeng, M.D. First Affiliated Hospital of China Medical University Active, not recruiting Shenyang, Liaoning, China, 150081 China, Shanghai Shanghai Pulmonary Hospital Recruiting Shanghai, Shanghai, China, 200433 Principal Investigator: Cai-Cun Zhou China, Zhejiang The First Affiliated Hospital of Medical School of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310000 Contact: Zhou Jianying, M.D. 0086-13750881678 drzjy@163.com Principal Investigator: Zhou Jianying, M.D. Collapse << |
| NCT00102804 | - | - | Completed | - | - |
| NCT01017874 | Non Small Cell Lung Cancer | Phase 3 | Completed | - | Hong Kong ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kowloon, Hong Kong Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Incheon, Korea, Republic of, 405-760 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 110-744 Singapore For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore, 258499 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kuei Shan Hsiang, Taiwan, 33305 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Liouying/Tainan, Taiwan, 736 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Puzih City, Taiwan, 613 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 407 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 100 Thailand For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bangkok, Thailand, 10700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiang Mai, Thailand, 50200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hat Yai, Thailand, 90110 Collapse << |
| NCT03402048 | Stage IV, NSCLC ... more >> Lung Neoplasms Bronchial Neoplasms Carcinoma, Bronchogenic Lung Diseases Neoplasms Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms Collapse << | Phase 3 | Recruiting | December 2018 | Italy ... more >> IRCSSIstituto Scientifico Romagnolo per lo studio e la cura dei tumori IRST Recruiting Meldola, Forlì, Italy Contact: Marco Angelo Burgio, MD Istituto Nazionale Tumori Recruiting Aviano, Pordenone, Italy Contact: Alessandra Bearz, MD Ospedale di Faenza Recruiting Faenza, Ravenna, Italy Contact: Alessandro Gamboni, MD Ospedale di Lugo Recruiting Lugo, Ravenna, Italy Contact: Gianni Michele Turolla, MD AUSL Rimini-Oncologia Medica Cattolica Recruiting Cattolica, Rimini, Italy Contact: Maximilian Papi, MD AOU San Luigi Gonzaga, Department of Oncology, University of Turin Recruiting Orbassano, Turin, Italy, 10043 Contact: Silvia Novello, MD, PhD +390119026978 silvia.novello@unito.it Ospedale Giovanni Paolo II Recruiting Bari, Italy Contact: Domenico Galetta, MD AO Cannizzaro Recruiting Catania, Italy Contact: Giuseppe Banna, MD AOU Santa Croce e Carle Recruiting Cuneo, Italy Contact: Ida Colantonio, MD Azienda Ospedaliera Careggi Recruiting Firenze, Italy Contact: Fabiana Cecere, MD Istituto Nazionale per la Ricerca sul Cancro Recruiting Genova, Italy Contact: Francesco Grossi, MD Ospedale Galliera Recruiting Genova, Italy Contact: Carlotta Defferrari, MD Azienda Ospedaliera Fatebenefratelli Recruiting Milano, Italy Contact: Gabriella Farina, MD Ospedale S. Raffaele Recruiting Milano, Italy Contact: Vanesa Gregorc AO San Gerardo Recruiting Monza, Italy Contact: Paolo Bidoli, MD Istituto Oncologico Veneto Recruiting Padova, Italy Contact: Adolfo Favaretto, MD Ospedale Santa MAria della Misericordia Recruiting Perugia, Italy Contact: Lucio Crinò, MD Ospedale S MAria delle Croci Recruiting Ravenna, Italy Contact: Claudio Dazzi, MD Arcispedale Santa Maria Nuova Recruiting Reggio Emilia, Italy Contact: Corrado Boni, MD AUSL Rimini-Oncologia medica Recruiting Rimini, Italy Contact: Maximilian Papi, MD Istituto Nazionale Tumori Regina Elena Recruiting Roma, Italy Contact: Francesco Cognetti, MD Ospedale S. Giovanni Addolorata Recruiting Roma, Italy Contact: oLGA Martelli, MD Policlinico Umberto I- Università la Sapienza Recruiting Roma, Italy Contact: Enrico Cortesi, MD AOU Sassari Recruiting Sassari, Italy Contact: Lorenzo Cordero, MD Azienda Ospedaliera Sondalo Recruiting Sondalo, Italy Contact: Giuseppe Valmadre, MD Ospedale Santa Chiara Recruiting Trento, Italy Contact: Orazio Caffo, MD AOU S.M. Misericordia Recruiting Udine, Italy Contact: Alessandro Follador, MD AOU Verona Recruiting Verona, Italy Contact: Gianpaolo Tortora, MD Collapse << |
| NCT03425643 | Non-small Cell Lung Cancer | Phase 3 | Recruiting | June 29, 2026 | - |
| NCT03628521 | Lung Cancer A... more >>dvanced Stage Collapse << | Phase 1 | Recruiting | December 31, 2020 | China, Shanghai ... more >> Shanghai Chest Hospital Recruiting Shanghai, Shanghai, China, 200030 Contact: Baohui Han, MD，PhD +8618930858216 18930858216@163.com Collapse << |
| NCT03002844 | Nonsmall Cell Lung Cancer ... more >> EGFR Gene Mutation Collapse << | Phase 2 | Unknown | December 2018 | - |
| NCT01774578 | Non-small Cell Lung Cancer ... more >> Progression of Non-small Cell Lung Cancer Non-small Cell Lung Cancer Recurrent Collapse << | Phase 2 Phase 3 | Active, not recruiting | - | - |
| NCT01655225 | Advanced Cancer ... more >> Metastatic Cancer Non-Hodgkin's Lymphoma Metastatic Breast Cancer Malignant Mesothelioma Non-small Cell Lung Cancer Collapse << | Phase 1 | Recruiting | March 1, 2021 | United States, California ... more >> UCLA Medical Center Recruiting Los Angeles, California, United States, 90095 Contact 3103258252 Principal Investigator: Parvin Fatheddin Peddi United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact 646-888-4226 Principal Investigator: Anna M Varghese United States, Oklahoma Peggy and Charles Stephenson Oklahoma Cancer Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact 4052718777 Principal Investigator: Raid M D Aljumaily United States, Pennsylvania Penn Presbyterian Medical Center Completed Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Sarah Cannon Cancer Center Recruiting Nashville, Tennessee, United States, 37203 Contact 615-239-7615 Principal Investigator: SMO Sarah Cannon Research Inst. Tennessee Oncology PLLC Recruiting Nashville, Tennessee, United States, 37203 Contact 6153297274 Principal Investigator: Johanna Chock Bendell Italy Azienda Ospedaliero - Universitaria S. Luigi Gonzaga Completed Orbassano, Torino, Italy, 10043 Puerto Rico Fundacion de Investigacion de Diego Recruiting San Juan, Puerto Rico, 00927 Contact 7877221248 Principal Investigator: Mirelis Acosta-Rivera Collapse << |
| NCT01714037 | Non-small Cell Lung Cancer | Phase 1 | Terminated | - | France ... more >> Centre GF Leclerc Dijon, France Centre Léon Bérard Lyon, France Institut de Cancérologie de l'Ouest- Institut René Gauduchau Nantes, France Institut Claudius Regaud Toulouse, France Spain Hospital Universitari Vall d'Hebron Barcelona, Spain Hospital Puerta de Hierro Majadahonda Madrid, Spain Hospital Universitario Virgen del Rocío Seville, Spain United Kingdom Freeman Hospital Newcastle, United Kingdom Collapse << |
| NCT03636685 | NSCLC Adenoca... more >>rcinoma Squamous Cell Carcinoma Collapse << | Phase 1 Phase 2 | Not yet recruiting | August 14, 2020 | - |
| NCT02079636 | Carcinoma, Non-small Cell Lung | Phase 1 | Active, not recruiting | July 2, 2020 | United States, Arkansas ... more >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, California UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States, 90095 University of California, Davis - Health Systems Sacramento, California, United States, 95817 United States, Indiana Indiana Cancer Pavilion Indianapolis, Indiana, United States, 46202 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New Mexico University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87102 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28204 United States, Tennessee The West Clinic Germantown, Tennessee, United States, 38138 Spain Hospital Universitario Ramon y Cajal Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Majadahonda, Spain, 28222 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sevilla, Spain, 41013 Collapse << |
| NCT02148380 | Non-Small-Cell Lung Cancer | Not Applicable | Completed | - | China ... more >> Shanghai Chest Hospital Shanghai, China, 200030 Collapse << |
| NCT03062800 | Advanced Nsclc | Phase 2 | Recruiting | October 2018 | China, Shandong ... more >> Qilu hospital of Shandong University Recruiting Jinan Shi, Shandong, China, 250012 Contact: Shuguang Li, MD. +86 18560082862 lishuguang96@163.com Principal Investigator: Xiuwen Wang, MD. Collapse << |
| NCT02710396 | Carcinoma, Non-Small-Cell Lung... more >> Cancer of the Head and Neck Urinary Bladder Neoplasms Esophageal Squamous Cell Carcinoma Carcinoma, Transitional Cell Collapse << | Phase 2 | Recruiting | March 31, 2023 | United States, Connecticut ... more >> Yale Cancer Center Not yet recruiting New Haven, Connecticut, United States, 06510 Contact: Roy Herbst, MD 203-785-6879 roy.herbst@yale.edu Principal Investigator: Roy Herbst, MD United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Not yet recruiting Baltimore, Maryland, United States, 21231 Contact: Julie Brahmer, MD 410-502-7159 brahmju@jhmi.edu Principal Investigator: Julie Brahmer, MD United States, New York Laura & Isaac Perlmutter Cancer Center at NYU Langone Not yet recruiting New York, New York, United States, 10016 Contact: Leena Gandhi, MD, PhD Leena.Gandhi@nyumc.org Principal Investigator: Leena Gandhi, Md, PhD Columbia University Recruiting New York, New York, United States, 10032 Contact: Anurita Sadhu, BA 212-342-3747 as5055@cumc.columbia.edu Contact: Sara Marcus, MPH (212) 304-5579 sm4100@columbia.edu Sub-Investigator: Catherine Shu, MD Sub-Investigator: Mark Stoopler, MD Principal Investigator: Naiyer Rizvi, MD United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Hossein Borghaei, DO 215-728-6900 Hossein.Borghaei@fccc.edu Principal Investigator: Hossein Borghaei, DO Collapse << |
| NCT03737994 | ALK Gene Rearrangement ... more >> ALK Positive Non-Squamous Non-Small Cell Lung Carcinoma Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8 Collapse << | Phase 2 | Not yet recruiting | December 13, 2025 | - |
| NCT03380871 | Carcinoma, Non-Small-Cell Lung... more >> Lung Cancer Nonsquamous Nonsmall Cell Neoplasm of Lung Collapse << | Phase 1 | Recruiting | February 2021 | United States, California ... more >> University of California - Los Angeles Recruiting Santa Monica, California, United States, 90404 Contact: Virginia Del Casal, BSN fdelcasal@mednet.ucla.edu Principal Investigator: Edward Garon, MD United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Alice Shaw, M.D., Ph.D. Principal Investigator: Alice Shaw, M.D., Ph.D. Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Jenna Scanlon 617-632-4764 jennae_scanlon@dfci.harvard.edu Principal Investigator: Mark Awad, M.D., Ph.D United States, Missouri Washington University in St. Louis Recruiting Saint Louis, Missouri, United States, 63130 Contact: Usha Rawat, MPH 314-286-2098 rawat@wustl.edu Contact: Cindy Fogal, PhD, CCRP 314-362-1518 clfogal@wustl.edu Principal Investigator: Ramaswamy Govindan, MD United States, Tennessee Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact 615-339-4214 asksarah@sarahcannon.com Principal Investigator: David Spigel, M.D. Collapse << |
| NCT03177291 | Lung Cancer N... more >>on Small Cell Lung Cancer Advanced Cancer Metastatic Lung Cancer Squamous Cell Lung Cancer Non-Squamous Non-Small Cell Neoplasm of Lung Collapse << | Phase 1 | Recruiting | April 2022 | United States, Florida ... more >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Germaine Gonzalez-Vazquez 813-745-6636 germain.gonzalezvazquez@moffitt.org Contact: Jhanelle Gray, M.D. 813-745-7282 jhanelle.gray@moffitt.org Principal Investigator: Jhanelle Gray, M.D. Sub-Investigator: Scott Antonia, M.D., Ph.D. Sub-Investigator: Alberto Chiappori, M.D. Sub-Investigator: Benjamin Creelan, M.D. Sub-Investigator: Eric Haura, M.D. Sub-Investigator: Tawee Tanvetyanon, M.D. Sub-Investigator: Charles Williams, Jr., M.D. Collapse << |
| NCT01218516 | Adenocarcinoma of the Lung | Phase 2 | Completed | - | - |
| NCT01674738 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Withdrawn(Decision of the Spon... more >>sor, as the funding of the study was no longer guaranteed.) Collapse << | - | - |
| NCT02864251 | Non-Small-Cell Lung Carcinoma | Phase 3 | Recruiting | December 31, 2023 | - |
| NCT03489616 | Carcinoma, Non-Small-Cell Lung | Not Applicable | Recruiting | December 31, 2019 | China, Shandong ... more >> Shandong Cancer Hospital and Institute Recruiting Jinan, Shandong, China, 250000 Contact: MINGHUAN LI, Doctor 13153035389 ext 0531-67626112 Sy_lmh2001@163.com Contact: JIMING YU, Doctor 13806406293 ext 0531-87984729 jn7984729@public.jn.sd.cn SHANDONG Cancer Hospital Recruiting Jinan, Shandong, China, 250000 Collapse << |
| NCT01828112 | - | - | Active, not recruiting | - | - |
| NCT02899195 | Mesothelioma ... more >>Pleural Mesothelioma Collapse << | Phase 2 | Active, not recruiting | December 2020 | - |
| NCT00859495 | Pleural Mesothelioma | Phase 2 | Unknown | December 2014 | United States, New York ... more >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Collapse << |
| NCT02322281 | Non-small Cell Lung Cancer | Phase 3 | Terminated(Sponsor discontinue... more >>d development of CO-1686 for NSCLC) Collapse << | - | - |
| NCT02507518 | Non-small Cell Lung Cancer | Phase 2 | Recruiting | March 2019 | France ... more >> CHU Rouen-Hôpital Bois-Guillaume Recruiting Bois-Guillaume, France, 76230 Contact: Dominique Paillotin, MD +33232889083 dominique.paillotin@chu-rouen.fr CH Dieppe Recruiting Dieppe, France, 76200 Contact: Julie Tillon, MD +33232888031 julie.tillon@chu-rouen.fr Centre hospitalier intercommunal Elbeuf Louviers Recruiting Elbeuf, France, 76500 Contact: Pierre-Alexandre Hauss, MD 02 32 82 21 45 pierre-alexandre.hauss@chi-elbeuf-louviers.fr Centre Henri Becquerel Recruiting Rouen, France, 76000 Contact: Stephanie Becker, MD +33232082258 stephanie.becker@chb.unicancer.fr CHU Rouen Recruiting Rouen, France, 76000 Contact: Suzanna Bota, MD +33232888287 suzanna.bota@chu-rouen.fr Collapse << |
| NCT01828112 | Non-Small Cell Lung Cancer | Phase 3 | Active, not recruiting | February 15, 2021 | - |
| NCT01935947 | Recurrent Non-Small Cell Lung ... more >>Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer Collapse << | Phase 2 | Terminated | - | United States, California ... more >> USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States, 92663 United States, Maryland Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 Collapse << |
| NCT01935947 | - | - | Terminated | - | - |
| NCT01343264 | - | - | Unknown | - | Germany ... more >> Dr. Horst Schmidt Klinik, Department of Thoracic Surgery Recruiting Wiesbaden, Germany Contact: Joachim Schirren, MD, PhD +49 611 433132 joachim.schirren@hsk-wiesbaden.de Principal Investigator: Joachim Schirren, MD, PhD Sub-Investigator: Servet Bölükbas, MD, PhD Collapse << |
| NCT00502567 | Advanced Solid Tumor | Phase 1 | Completed | - | United States, Michigan ... more >> Research Site Ann Arbor, Michigan, United States Research Site Detroit, Michigan, United States United States, Tennessee Research Site Nashville, Tennessee, United States Collapse << |
| NCT03656094 | Non-small Cell Lung Cancer Met... more >>astatic Collapse << | Phase 2 | Not yet recruiting | November 1, 2021 | Korea, Republic of ... more >> Jong-Mu Sun Not yet recruiting Seoul, Korea, Republic of, 06351 Contact: Jong-Mu Sun 82234103459 ext 82234103459 jongmu.sun@skku.edu Collapse << |
| NCT03456063 | Non-Small-Cell Lung | Phase 3 | Recruiting | November 20, 2024 | - |
| NCT02859077 | Non-Small-Cell Lung Cancer | Phase 3 | Unknown | July 2018 | - |
| NCT00095225 | Non-Small-Cell Lung Carcinoma ... more >> Neoplasm Recurrence, Local Collapse << | Phase 2 | Completed | - | - |
| NCT00577707 | - | - | Completed | - | - |
| NCT01257139 | Non Small-cell Lung Cancer | Phase 3 | Completed | - | France ... more >> CH du Pays d'Aix Aix en Provence, France CHU Amien Picardie Amiens, France Centre Hospitalier Universitaire d'Angers Angers, France Centre Hospitalier d'Annecy Annecy, France Centre Hospitalier Général de la Fontonne Antibes Antibes, France CH de Bastia Bastia, France Centre Hospitalier de Beauvais Beauvais, France CHU Bordeaux Hôpital Haut Lévêque Bordeaux Pessac, France Centre Hospitalier Universaitaire de Brest Brest, France HIA Tonnerre Brest, France Centre François Baclesse Caen, France CH René Dubos - Pontoise Cergy Pontoise, France Centre Hospitalier Charleville mézières Charleville Mézières, France CHI Créteil Créteil, France Centre hospitalier de Draguignan Draguignan, France Centre Hospitalier de Elbeuf Elbeuf, France CH Gap Gap, France CH La Roche sur Yon La Roche sur Yon, France Hôpital A Mignot Le Chesnay Le Chesnay, France Centre Omar Lambret Lille, France Hôpital du Cluzeau Limoges, France CHR Longjumeau Longjumeau, France Centre Hospitalier de Bretagne Sud Lorient, France Hôpital de la Croix Rousse Lyon, France Centre Hospitalier Mantes La Jolie, France Hôpital Sainte Marguerite Marseille, France Institut Paoli-Calmette Marseille, France Centre Hospitalier Martigues, France Hôpital Saint Farron Meaux, France Centre Hospitalier de Mulhouse Mulhouse, France CHR Orléans Orléans, France Paris Hôpital saint Antoine Paris, France Centre Catalan Perpignan, France Centre Hospitalier de Périgueux Périgueux, France Rennes Hospital University Rennes, France, 35033 CHU Rouen Hôpital Boisguillaume Rouen, France Hôpital Charles Nicolle Rouen, France Hôpital Yves Le Foll saint Brieuc, France CHU Saint Etienne - Hôpital Nord Saint Etienne, France Centre Hospitalier Général Salon de Provence Salon de Provence, France Institut de Cancérologie de la Loire St Priest en Jarez, France Hôpital d'Instruction des Armées Toulon Naval, France Hôpital Font-Pre Toulon, France CHU Touloues Toulouse, France Centre Hospitalier De Villefranche sur Saone Villefranche sur Saone, France Collapse << |
| NCT02761863 | - | - | Not yet recruiting | July 30, 2021 | - |
| NCT02900742 | Cancer | Phase 3 | Unknown | December 2016 | - |
| NCT03758677 | Non Small Cell Lung Cancer | Phase 2 | Not yet recruiting | November 20, 2021 | China, Jilin ... more >> The First Hospital of Jilin University Not yet recruiting Changchun, Jilin, China, 130021 Contact: Kewei Ma 008613756060506 makw@jlu.edu.cn Contact: Yinghui Xu 008613944826247 305682733@qq.com Collapse << |
| NCT00577707 | Non Small Cell Lung Cancer ... more >> Lung Cancer Collapse << | Phase 2 | Completed | - | United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Collapse << |
| NCT01868022 | Neoplasms | Phase 1 | Completed | - | - |
| NCT00766246 | Non-small Cell Lung Cancer Sta... more >>ge IIIB Non-small Cell Lung Cancer Stage IV Collapse << | Phase 2 | Terminated(Withdrawal of fundi... more >>ng support) Collapse << | - | - |
| NCT01395758 | - | - | Completed | - | - |
| NCT01098266 | Malignant Pleural Mesothelioma | Phase 3 | Completed | - | - |
| NCT00034489 | Breast Neoplasms | Phase 2 | Completed | - | United States, Minnesota ... more >> Rochester, Minnesota, United States Collapse << |
| NCT00863512 | Lung Cancer | Phase 3 | Terminated | - | - |
| NCT00863512 | - | - | Terminated | - | - |
| NCT02220894 | Non-small Cell Lung Cancer | Phase 3 | Active, not recruiting | January 31, 2020 | - |
| NCT02037997 | Non Small Cell Lung Cancer | Phase 2 | Unknown | December 2017 | China, Shanghai ... more >> Cancer hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Chang J hua, PD 13916619284 changjianhua@163.com Collapse << |
| NCT02921984 | Salivary Gland Tumors ... more >> Head and Neck Cancer Collapse << | Phase 1 | Completed | - | China, Shanghai ... more >> Shanghai ninth people's hospital Shanghai, Shanghai, China, 200011 Collapse << |
| NCT02603003 | Non-small Cell Lung Cancer(NSC... more >>LC) Collapse << | Phase 1 | Active, not recruiting | December 2019 | - |
| NCT01395758 | Metastatic Non-Small Cell Lung... more >> Cancer Collapse << | Phase 2 | Completed | - | United States, California ... more >> Stanford, California, United States, 94305 United States, District of Columbia Washington, District of Columbia, United States, 20057 United States, Florida Weston, Florida, United States, 33331 United States, Georgia Atlanta, Georgia, United States, 30341 United States, Illinois Chicago, Illinois, United States, 60611 United States, Kansas Kansas City, Kansas, United States, 66160 United States, Maryland Baltimore, Maryland, United States, 21205 United States, Massachusetts Boston, Massachusetts, United States, 02114 Burlington, Massachusetts, United States, 01805 United States, New York New York, New York, United States, 10016 United States, Pennsylvania Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Dallas, Texas, United States, 75390 Collapse << |
| NCT03307785 | Metastatic Cancer ... more >> Advanced Cancer Solid Tumor Non Small Cell Lung Cancer Metastatic Non Small Cell Lung Cancer Stage IIIB Non Small Cell Lung Cancer Collapse << | Phase 1 | Recruiting | March 2020 | United States, Arizona ... more >> Honor Health Recruiting Scottsdale, Arizona, United States, 85258 Principal Investigator: Jasgit Sachdev, MD United States, California California Cancer Associates for Research and Excellence (cCare) Recruiting Encinitas, California, United States, 92024 Principal Investigator: Alberto Bessudo, MD United States, Florida Florida Cancer Specialist Recruiting Sarasota, Florida, United States, 34232 Principal Investigator: Manish Patel, MD United States, Ohio Gabrail Cancer Center Research Recruiting Canton, Ohio, United States, 44718 Principal Investigator: Nashat Gabrail, MD United States, Tennessee Tennessee Oncology Recruiting Nashville, Tennessee, United States, 37203 Principal Investigator: Erika Hamilton, MD United States, Texas MD Anderson Recruiting Houston, Texas, United States, 77030 Principal Investigator: Timothy Yap, MD Collapse << |
| NCT02795884 | NSCLC | Phase 3 | Withdrawn(Because of reconside... more >>ration of using erlotinib(EGFR Tyrosine kinase inhibitor) as adjuvant aim) Collapse << | November 2020 | - |
| NCT01358968 | Cancer | Phase 1 | Completed | - | United States, Tennessee ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States, 38120 Collapse << |
| NCT01358968 | - | - | Completed | - | - |
| NCT02784171 | Mesothelioma | Phase 2 | Recruiting | December 2019 | Canada, Alberta ... more >> Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Desiree Hao 403 521-3706 Cross Cancer Institute Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Quincy Chu 780 432-8248 Canada, British Columbia BCCA - Cancer Centre for the Southern Interior Recruiting Kelowna, British Columbia, Canada, V1Y 5L3 Contact: Delia Sauciuc 250 712-3900 ext 683930 BCCA - Fraser Valley Cancer Centre Recruiting Surrey, British Columbia, Canada, V3V 1Z2 Contact: Christopher Lee 604 930-4017 Canada, Manitoba CancerCare Manitoba Recruiting Winnipeg, Manitoba, Canada, R3E 0V9 Contact: David Dawe 204 787-8644 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Recruiting Hamilton, Ontario, Canada, L8V 5C2 Contact: John Goffin 905 387-9495 London Regional Cancer Program Recruiting London, Ontario, Canada, N6A 5W9 Contact: Mark D. Vincent 519 685-8640 Ottawa Hospital Research Institute Recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: Paul Wheatley-Price 613 737-7700 ext 79859 University Health Network Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Penelope A. Bradbury 416 946-4501 ext 3544 Canada, Quebec CHUM-Centre Hospitalier de l'Universite de Montreal Recruiting Montreal, Quebec, Canada, H2X 3E4 Contact: Marie Florescu 514 890-8444 The Research Institute of the McGill University Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Scott Owen 514 398-8307 University Institute of Cardiology and Recruiting Quebec City, Quebec, Canada, G1V 4G5 Contact: Catherine Labbe 418 656-8711 ext 5504 Canada, Saskatchewan Allan Blair Cancer Centre Recruiting Regina, Saskatchewan, Canada, S4T 7T1 Contact: Mussawar Iqbal 306 766-2691 Italy Oncologia SS Antonio e Biagio Alessandria Recruiting Alessandria, AL, Italy, 15121 Contact: Federica Grosso Azienda Ospedaliera San Giuseppe Moscati Recruiting Avellino, AV, Italy, 83100 Contact: Gridelli Cesare Oncologia Medica Humanitas Gavazzeni Bergamo Not yet recruiting Bergamo, BG, Italy, 24125 Contact: Giovanni Luca Ceresoli Azienda Ospedaliera Garibaldi Nesima Recruiting Catania, CT, Italy, 95123 Contact: Roberto Bordonaro Oncologia Medica IRCCS Arcispedale Maria Recruiting Reggio Emilia, RE, Italy, 42123 Contact: Maria Pagano Istituti Fisioterapici Ospitalieri IFO Istituto Recruiting Rome, RM, Italy, 00144 Contact: Fabiana Letizia Cecere PO A Perrino ASL Brindisi - UOC Oncologia Medica Recruiting Brindisi, Italy, 72100 Contact: Saverio Cinieri AOU Policlinico Vittorio Emanuele UOC di Oncologia Recruiting Catania, Italy, 95125 Contact: Hector Jose Soto Parra 2 8224-4459 U.O. di Oncologia Ospedale Villa Scassi Recruiting Genova, Italy, 16149 Contact: Manlio Mencoboni 010 410-2639 Intstituto Scientifico Romangnolo Recruiting Meldola, Italy, 47014 Contact: Marco Angelo Burgio 054 373-9100 Instituto Nazionale Tumori Recruiting Milan, Italy Contact: Maria Chiara Garassino U.O.C. di Oncologia U.L.S.S. 13 Recruiting Mirano, Italy, 30035 Contact: Francesco Rosetti 3904 1579-4002 Azienda Ospedaliera di Rilievo Nazionale Not yet recruiting Napoli, Italy, 80131 Contact: Giacomo Carteni Dott. Fortunato Ciardiello,Cattedra Oncologia Medica Recruiting Napoli, Italy, 80131 Contact: Fortunato Ciardiello 081 566-6745 Unita Sperimentazioni Cliniche Istituto per lo Recruiting Napoli, Italy, 80131 Contact: Alessandro Morabito 081 590-3571 Azienda USL di Piacenza, Ospedale Gugliemimo Salieto Recruiting Piacenza, Italy, 29100 Contact: Luigi Cavanna 052 330-2697 Collapse << |
| NCT03762018 | Pleural Mesothelioma Malignant... more >> Advanced Collapse << | Phase 3 | Not yet recruiting | December 31, 2024 | - |
| NCT01443078 | - | - | Completed | - | - |
| NCT01746277 | Non Small Cell Lung Cancer | Phase 2 | Unknown | June 2016 | China ... more >> Department of Respiratory Medicne, Peking Union Medical Hospital Recruiting Beijing, China, 100730 Contact: Mengzhao Wang, MD 010-69155039 mengzhaowang@sina.com Contact: Jing Zhao, MD 010-69158206 zhaojing0@163.com Sub-Investigator: Wei Zhong, MD Collapse << |
| NCT01447225 | Solid Tumors | Phase 1 | Completed | - | United States, Indiana ... more >> Lafayette, Indiana, United States, 47905 United States, New York Buffalo, New York, United States, 14263 United States, Ohio Cincinnati, Ohio, United States, 45267 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19111 France Villejuif, France Collapse << |
| NCT01443078 | Lung Cancer | Phase 2 | Completed | - | United States, New Jersey ... more >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Collapse << |
| NCT01958372 | Adenocarcinoma of the Lung ... more >> Adenosquamous Cell Lung Cancer Bronchoalveolar Cell Lung Cancer Large Cell Lung Cancer Recurrent Non-small Cell Lung Cancer Squamous Cell Lung Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Collapse << | Phase 1 | Active, not recruiting | June 30, 2018 | United States, Michigan ... more >> Karmanos Cancer Institute at McLaren Bay Region Bay City, Michigan, United States, 48706 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Karmanos Cancer Institute at McLaren Lapeer Region Lapeer, Michigan, United States, 48446 Karmanos Cancer Institute at McLaren Central Michigan Mount Pleasant, Michigan, United States, 48858 Karmanos Cancer Institute at McLaren Northern Petoskey, Michigan, United States, 49770 Collapse << |
| NCT01447225 | - | - | Completed | - | - |
| NCT01982955 | Non-small Cell Lung Cancer | Phase 1 Phase 2 | Active, not recruiting | October 16, 2018 | Germany ... more >> Please contact the Merck KGaA Communication Center located in Darmstadt, Germany Collapse << |
| NCT01784549 | Non Small Cell Lung Cancer | Phase 2 | Unknown | December 2015 | Italy ... more >> IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro Recruiting Genoa, Italy, 16132 Contact: Francesco Grossi, MD +393355255484 fg1965@libero.it Collapse << |
| NCT00454649 | Neoplasms | Phase 1 | Completed | - | United States, Georgia ... more >> Pfizer Investigational Site Augusta, Georgia, United States, 30909 Pfizer Investigational Site Augusta, Georgia, United States, 30912 United States, Illinois Pfizer Investigational Site Harvey, Illinois, United States, 60426-4265 Pfizer Investigational Site Harvey, Illinois, United States, 60426 Pfizer Investigational Site Tinley Park, Illinois, United States, 60477 United States, Indiana Pfizer Investigational Site Hobart, Indiana, United States, 46342 Pfizer Investigational Site Munster, Indiana, United States, 46321 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111 United States, Texas Pfizer Investigational Site Houston, Texas, United States, 77030-4009 United States, Washington Pfizer Investigational Site Kennewick, Washington, United States, 99336 Poland Pfizer Investigational Site Warszawa, Poland, 02-781 Spain Pfizer Investigational Site Barcelona, Spain, 08003 Pfizer Investigational Site Madrid, Spain, 28046 Collapse << |
| NCT02296671 | Esophagogastric Cancer | Phase 2 | Withdrawn(Was unable to accrue... more >> any patients) Collapse << | February 2022 | - |
| NCT02276560 | - | - | Terminated(This study was term... more >>inated due to lack of funding.) Collapse << | - | - |
| NCT02264990 | Non-squamous Non-small Cell Lu... more >>ng Cancer Collapse << | Phase 3 | Active, not recruiting | July 26, 2019 | - |
| NCT02001168 | Non-small Cell Lung Cancer | Phase 3 | Active, not recruiting | October 2022 | China, Xinjiang ... more >> Cancer Hospital of Xinjiang Medical University Urumqi, Xinjiang, China, 830011 Collapse << |
| NCT03137771 | Recurrent Non-Small Cell Lung ... more >>Carcinoma Stage IV Non-Small Cell Lung Cancer Collapse << | Phase 2 | Recruiting | April 2022 | - |
| NCT01781988 | Lung Cancer C... more >>arboplatin Adverse Reaction Collapse << | Phase 2 | Completed | - | China, Guangdong ... more >> The first affiliated hospital of Guangzhou MC Guangzhou, Guangdong, China, 510120 Collapse << |
| NCT01707329 | Non-small Cell Lung Cancer | Phase 2 | Unknown | December 2016 | China, Hunan ... more >> Hunan Province Tumor Hospital Active, not recruiting Changsha, Hunan, China, 410205 China, Zhejiang Sir Run Run Shaw Hospital Active, not recruiting Hangzhou, Zhejiang, China, 310000 The First Affiliated Hospital of Medical School of Zhejiang University Active, not recruiting Hangzhou, Zhejiang, China, 310000 The Second Affiliated Hospital of Zhejiang University School of Medicine Active, not recruiting Hangzhou, Zhejiang, China, 310000 Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310000 Contact: Zhang Yi Ping, M.D. 0086-13750881678 zyp@medmail.com.cn Principal Investigator: Zhang Yi Ping, M.D. The First Affiliated Hospital of Wenzhou Medical College Active, not recruiting Wenzhou, Zhejiang, China, 325000 Collapse << |
| NCT01336543 | Stage III Non-small Cell Lung ... more >>Cancer Collapse << | Phase 2 | Withdrawn(Low accrual, small p... more >>atient population at center.) Collapse << | - | United States, Louisiana ... more >> LSU Health Sciences Center, 1501 Kings Highway Shreveport, Louisiana, United States, 71103 Collapse << |
| NCT00003706 | Unspecified Adult Solid Tumor,... more >> Protocol Specific Collapse << | Phase 1 | Completed | - | United States, Texas ... more >> San Antonio Cancer Institute San Antonio, Texas, United States, 78229-3264 Collapse << |
| NCT00454649 | - | - | Completed | - | - |
| NCT02117167 | Non-small Cell Lung Cancer Met... more >>astatic Collapse << | Phase 2 | Recruiting | February 2022 | France ... more >> Centre Hospitalier Henri Duffau Recruiting Avignon, France Contact: Nicolas CLOAREC, MD nicolas.cloarec@ch-avignon.fr Principal Investigator: Nicolas CLOAREC, MD Centre Hospitalier Universitaire de Besancon - Hopital Jean Minjoz Recruiting Besancon, France Contact: Virginie WESTEEL, MD virginie.westeel@univ.fcomte.fr Principal Investigator: Virginie WESTEEL, MD Hôpital Avicenne Recruiting Bobigny, France Contact: Boris DUCHEMANN, MD boris.duchemann@aphp.fr Principal Investigator: Boris DUCHEMANN, MD Institut Bergonié Recruiting Bordeaux, France Contact: François Chomy, MD f.chomy@bordeaux.unicancer.fr Principal Investigator: François Chomy, MD Hôpital Ambroise Paré Recruiting Boulogne Billancourt, France Contact: Etienne GIROUX LEPRIEUR, MD etienne.giroux-leprieur@aphp.fr Principal Investigator: Etienne GIROUX LEPRIEUR, MD Hospices Civils de Lyon- Hôpital Louis Pradel Recruiting Bron, France Contact: Nicolas Girard, MD nicolas.girard@chu-lyon.fr Principal Investigator: Nicolas Girard, MD Centre François Baclesse Recruiting Caen, France Contact: Radj Gervais, MD r.gervais@baclesse.unicancer.fr Principal Investigator: Radj Gervais, MD CHU Caen Recruiting Caen, France Contact: Gérard Zalcman, MD zalcman-g@chu-caen.fr Principal Investigator: Gérard Zalcman, MD Chu de Caen - Hopital Cote de Nacre Recruiting Caen, France Contact: Jeannick MADELAINE, MD madelaine-j@chu-caen.fr Principal Investigator: Jeannick MADELAINE, MD Hôpital Louis Pasteur Recruiting Chartres, France Contact: Claire Lethrosne, MD clethrosne@ch-chartres.fr Principal Investigator: Claire Lethrosne, MD centre Jean Perrin Recruiting Clermont-Ferrand, France Contact: Xavier Durando, MD xavier.durando@cjp.fr Principal Investigator: Xavier Durando, MD CHU Clermont Ferrand - Hôpital Gabriel Montpied Recruiting Clermont-Ferrand, France Contact: Henri Janicot, MD hjanicot@chu-clermontferrand.fr Principal Investigator: Henri Janicot, MD Hopitaux Civils de Colmar Recruiting Colmar, France Contact: Lionel MOREAU, MD lionel.moreau@ch-colmar.fr Principal Investigator: Lionel MOREAU, MD Centre Hopsitalier Intercommunal de Créteil Recruiting Créteil, France Contact: Isabelle Monnet, MD isabelle.monnet@chicreteil.fr Principal Investigator: Isabelle Monnet, MD Centre Georges François Leclerc Recruiting Dijon, France Contact: Bruno Coudert, MD bcoudert@cgfl.fr Principal Investigator: Bruno Coudert, MD CHU Grenoble Recruiting Grenoble, France Contact: Denis Moro-Sibilot, MD Dmoro-Sibilot@chu-grenoble.fr Principal Investigator: Denis Moro-Sibilot, MD Chd Vendee Recruiting La Roche Sur Yon, France Contact: Tifenn L'HARIDON, MD Principal Investigator: Tifenn L'HARIDON, MD CH du Mans Recruiting Le Mans, France Contact: Olivier Molinier, MD omolinier@ch-lemans.fr Principal Investigator: Olivier Molinier, MD Centre Oscar Lambret Recruiting Lille, France Contact: Eric Dansin, MD e-dansin@o-lambret.fr Principal Investigator: Eric Dansin, MD CHRU de Lille Recruiting Lille, France Contact: Alexis Cortot, MD Alexis.CORTOT@CHRU-LILLE.FR Principal Investigator: Alexis Cortot, MD Centre Léon Bérard Recruiting Lyon, France Contact: Maurice Pérol, MD maurice.perol@lyon.unicancer.fr Principal Investigator: Maurice Pérol, MD Hôpital Nord Recruiting Marseille, France Contact: Fabrice Barlesi, MD fabrice.barlesi@ap-hm.fr Principal Investigator: Fabrice Barlési, MD Institut Paoli Calmettes Recruiting Marseille, France Contact: Anne MADROSZYK, MD madroszyka@ipc.unicancer.fr Principal Investigator: Anne MADROSZYK, MD Institut de cancérologie de l'Ouest Recruiting Nantes, France Contact: Jaafar Bennouna, MD jaafar.bennouna@ico.unicancer.fr Principal Investigator: Jaafar Bennouna, MD Centre Antoine Lacassagne Recruiting Nice, France Contact: Josiane OTTO, MD josiane.otto@nice.unicancer.fr Principal Investigator: Josiane OTTO, MD Chr Orleans Recruiting Orleans, France Contact: Hugues MOREL, MD hugues.morel@chr-orleans.fr Contact: , MD Principal Investigator: Hugues MOREL AH-HP Hôpital Saint Louis Recruiting Paris, France Contact: Damien Pouessel, MD damien.pouessel@sls.aphp.fr Principal Investigator: Damien Pouessel, MD AP-HP Hôpital Cochin Recruiting Paris, France Contact: Jeanne Chapron, MD jeanne.chapron@cch.aphp.fr Principal Investigator: Jeanne Chapron, MD AP-HP Hôpital Européen Georges Pompidou Withdrawn Paris, France AP-HP Hôpital Tenon Recruiting Paris, France Contact: Marie Wislez, MD marie.wislez@tnn.aphp.fr Principal Investigator: Marie Wislez, MD Institut Curie Recruiting Paris, France Contact: Catherine Daniel, MD catherine.daniel@curie.fr Principal Investigator: Catherine Daniel, MD Centre Hospitalier de Pau Recruiting PAU, France Contact: Aldo RENAULT, MD aldo.renault@ch-pau.fr Principal Investigator: Aldo RENAULT, MD Centre Hospitalier Lyon Sud Recruiting Pierre Bénite, France Contact: Jean-Pierre Souquet, MD pierre-jean.souquet@chu-lyon.fr Principal Investigator: Jean-Pierre Souquet, MD CHR Pontchailloux Withdrawn Rennes, France Chru Strasbourg - Nouvel Hopital Civil Recruiting Strasbourg, France Contact: Philippe BARTHELEMY, MD Principal Investigator: Philippe BARTHELEMY, MD CHI de Toulon - Hôpital Sainte-Musse Recruiting Toulon, France Contact: Xavier TCHIKNAVORIAN, MD Principal Investigator: Xavier TCHIKNAVORIAN, MD CHU Toulouse -Hôpital Larrey Recruiting Toulouse, France Contact: Julien Mazières, MD mazieres.j@chu-toulouse.fr Principal Investigator: Julien Mazières, MD Hôpital Bretonneau Recruiting Tours, France Contact: Eric Pichon, MD e.pichon@chu-tours.fr Principal Investigator: Eric Pichon, MD Gustave Roussy Recruiting Villejuif, France Contact: Benjamin Besse, MD Benjamin.BESSE@gustaveroussy.fr Principal Investigator: Benjamin Besse, MD Sub-Investigator: Jean-Charles Soria, MD Collapse << |
| NCT02276560 | Stage IIIA Non-Small Cell Lung... more >> Cancer Collapse << | Phase 2 | Terminated(This study was term... more >>inated due to lack of funding.) Collapse << | - | United States, Florida ... more >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Emory - Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Kansas University of Kansas Cancer Center Kansas City, Kansas, United States, 66160 United States, Louisiana Ochsner Cancer Institute New Orleans, Louisiana, United States, 70121 United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Rex Cancer Center and Rex of Wakefield Raleigh, North Carolina, United States, 27607 United States, Ohio Case Western Reserve University - Seidman Cancer Center Cleveland, Ohio, United States, 44106 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 United States, Washington Swedish Cancer Institute Seattle, Washington, United States, 98104 Collapse << |
| NCT01263782 | Lung Cancer | Phase 2 | Completed | - | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
| NCT02591615 | Non-Small Cell Lung Cancer | Phase 2 | Recruiting | December 2019 | United States, California ... more >> UCSD Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Contact: Lyudmila Bazhenova, MD Principal Investigator: Lyudmila Bazhenova United States, Illinois The University of Chicago Medical Center Recruiting Chicago, Illinois, United States, 60637 Contact: Jyoti Patel, MD Principal Investigator: Jyoti Patel NorthShore University HealthSystem Recruiting Evanston, Illinois, United States, 60201 Contact: Thomas Hensing, MD Principal Investigator: Thomas Hensing United States, Iowa Medical Oncology & Hematology Associates Recruiting Des Moines, Iowa, United States, 50309 Contact: Robert Behrens, MD Principal Investigator: Robert Behrens United States, Maine EMMC Cancer Care Recruiting Brewer, Maine, United States, 04412 Contact: Antoine Harb, MD Principal Investigator: Antoine Harb United States, Maryland University of Maryland, Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Katherine Scilla, MD Principal Investigator: Katherine Scilla United States, Minnesota Metro MN Community Oncology Research Consortium Recruiting Minneapolis, Minnesota, United States, 55416 Contact: Arkadiusz Dudek, MD Principal Investigator: Arkadiusz Dudek United States, Missouri University of Missouri - Ellis Fischel Cancer Center Recruiting Columbia, Missouri, United States, 65212 Contact: Puja Nistala, MD Principal Investigator: Puja Nistala Missouri Baptist Medical Center Recruiting Saint Louis, Missouri, United States, 63131 Contact: Bryan Faller, MD Principal Investigator: Bryan Faller United States, Nebraska Nebraska Methodist Hospital Recruiting Omaha, Nebraska, United States, 68114 Contact: Robert Langdon, MD Principal Investigator: Robert Langdon United States, New Hampshire NH Oncology (Concord) Recruiting Concord, New Hampshire, United States, 03301 Contact: Douglas Weckstein, MD Principal Investigator: Douglas Weckstein NH Oncology Recruiting Hooksett, New Hampshire, United States, 03106 Contact: Douglas Weckstein, MD Principal Investigator: Douglas Weckstein Dartmouth Hitchcock Medical Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Konstantin Dragnev, MD Principal Investigator: Konstantin Dragnev United States, New York Hematology Oncology Associates of Central New York, PC Recruiting East Syracuse, New York, United States, 13057 Contact: Jeffrey Kirshner, MD Principal Investigator: Jeffrey Kirshner SUNY Upstate Medical University Recruiting Syracuse, New York, United States, 13210 Contact: Stephen Graziano, MD Principal Investigator: Stephen Graziano United States, North Carolina Wake Forest Baptist Health Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: William Petty, MD Principal Investigator: William Petty United States, Ohio The Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: Gregory Otterson, MD Principal Investigator: Gregory Otterson United States, Oklahoma University of Oklahoma Health Sciences Center Stephenson Cancer Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Raid Aljumaily, MD Principal Investigator: Raid Aljumaily United States, South Carolina Lexington Oncology/ Lexington Medical Center Recruiting West Columbia, South Carolina, United States, 29169 Contact: James Wells, MD Principal Investigator: James Wells Collapse << |
| NCT01003964 | Non Small Cell Lung Cancer | Phase 2 | Unknown | December 2014 | Korea, Republic of ... more >> National Cancer Center, Korea Goyang-si, Gyeonggi-do, Korea, Republic of Collapse << |
| NCT02439450 | Non-small Cell Lung Cancer | Phase 1 Phase 2 | Recruiting | December 2021 | - |
| NCT03664024 | Non-Small Cell Lung Cancer | Phase 2 | Recruiting | March 4, 2022 | United States, Maryland ... more >> Harry & Jeanette Weinberg Cancer Institute ( Site 0901) Recruiting Baltimore, Maryland, United States, 21237 Contact: Study Coordinator 443-777-7364 Canada, Quebec CISSS de la Monteregie-Centre ( Site 0801) Recruiting Greenfield Park, Quebec, Canada, J4V 2H1 Contact: Study Coordinator 45046650003226 Hungary Orszagos Koranyi TBC es Pulmonologiai Intezet ( Site 0400) Recruiting Budapest, Hungary, 1121 Contact: Study Coordinator +36302005233 Petz Aladar Megyei Oktato Korhaz ( Site 0402) Recruiting Gyor, Hungary, 9024 Contact: Study Coordinator +3696418244 Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet ( Site 0401) Recruiting Szolnok, Hungary, 5900 Contact: Study Coordinator +36209323256 Israel Meir Medical Center ( Site 0501) Recruiting Kfar-Saba, Israel, 4428132 Contact: Study Coordinator +97297472414 Chaim Sheba Medical Center ( Site 0500) Recruiting Ramat Gan, Israel, 5262000 Contact: Study Coordinator +97235307096 Spain Hospital Universitario Insular de Gran Canaria ( Site 0700) Recruiting Las Palmas de Gran Canaria, Gran Canaria, Spain, 35001 Contact: Study Coordinator +34928441738 H.U. Vall de Hebron ( Site 0701) Recruiting Barcelona, Spain, 08035 Contact: Study Coordinator +34932746085 Hospital General Universitario 12 de Octubre ( Site 0703) Recruiting Madrid, Spain, 28041 Contact: Study Coordinator +34914692313 Hospital Universitario Central de Asturias ( Site 0704) Recruiting Oviedo, Spain, 33011 Contact: Study Coordinator +34609804227 Collapse << |
| NCT01544179 | Non-Small Cell Lung Cancer | Phase 3 | Active, not recruiting | December 31, 2018 | - |
| NCT01102231 | Stage III Non-small Cell Lung ... more >>Cancer Collapse << | Phase 2 | Completed | - | France ... more >> Clinique de l'Europe Amiens, France Centre Hospitalier Annemasse, France CHU Besancon - Pneumologie Besancon, France, 25000 Bordeaux - Polyclinique Nord Bordeaux, France, 33300 Caen - Centre François Baclesse Caen, France, 14000 Caen - CHU Côte de Nacre Caen, France, 14000 CH Chartres, France CH Cholet, France CHU Clermont-Ferrand, France CH Colmar, France Clinique des Cèdres Cornebarrieu, France Dijon - CAC Dijon, France, 21000 CHU Grenoble Grenoble, France, 38000 Institut d'Oncologie Hartmann Levallois, France CHU (Hôpital Calmette) - Pneumologie Lille, France, 59000 CH Longjumeau, France Clinique des 4 Pavillons Lormont, France Hôpital Louis Pradel Lyon, France Hôpital Nord Marseille, France Centre Hospitalier Montélimar, France CHU Nancy, France CH Nevers, France Centre Hospitalier Niort, France APHP - Hopital Tenon - Pneumologie Paris, France, 75020 Hôpital du Val de Grâce Paris, France Hôpital Saint-Joseph Paris, France Perpignan - Centre Catalan d'Oncologie Perpignan, France, 66000 HCL - Lyon Sud Pierre Bénite, France, 69495 CHU Poitiers, France Centre Hospitalier Rambouillet, France Reims - CHU Reims, France, 51092 Institut Jean Godinot Reims, France Centre Frederic Joliot Rouen, France Centre Etienne Dolet Saint-Nazaire, France Hôpitaux Universitaires - Nouvel Hôpital Civil Strasbourg, France, 63000 Suresnes - Hopital Foch Suresnes, France, 92151 Tours - CHU Tours, France, 37000 Institut Gustave Roussy Villejuif, France, 94800 Collapse << |
| NCT03589950 | Lung Neoplasms ... more >> Docetaxel Pemetrexed S-1 Anlotinib Collapse << | Phase 2 | Not yet recruiting | August 1, 2021 | China, Jiangsu ... more >> The Affiliated Lianyungang Hospital of Xuzhou Medical University Not yet recruiting Lianyungang, Jiangsu, China, 222002 Contact: xiaodong jiang, MD 18961326201 jxdysy1970@163.com Sub-Investigator: lijun liang, MM Sub-Investigator: yixuan wen, MM Collapse << |
| NCT01544179 | - | - | Active, not recruiting | - | - |
| NCT01708993 | Non Small Cell Lung Cancer | Phase 2 | Completed | - | Canada, Alberta ... more >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Canada, British Columbia BCCA - Abbotsford Centre Abbotsford, British Columbia, Canada, V2S 0C2 BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada, V3V 1Z2 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada, K7L 5P9 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Lakeridge Health Oshawa Oshawa, Ontario, Canada, L1G 2B9 Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Collapse << |
| NCT02944396 | Non-Small Cell Lung Cancer | Phase 1 Phase 2 | Active, not recruiting | January 2, 2019 | United States, Alabama ... more >> University of Alabama /ID# 155135 Birmingham, Alabama, United States, 35233 United States, California Icri /Id# 155593 Whittier, California, United States, 90603 United States, Colorado Univ of Colorado Cancer Center /ID# 153820 Aurora, Colorado, United States, 80045 United States, Illinois University of Chicago /ID# 153824 Chicago, Illinois, United States, 60637-1443 United States, Indiana Goshen Center for Cancer Care /ID# 153822 Goshen, Indiana, United States, 46526 United States, North Carolina Duke Univ Med Ctr /ID# 153821 Durham, North Carolina, United States, 27710 Collapse << |
| NCT02662504 | Malignant Pleural Mesothelioma | Phase 2 | Completed | - | France ... more >> CHRU de Lille Hôpital Calmette Lille, France Collapse << |
| NCT02964013 | Neoplasms | Phase 1 | Recruiting | June 3, 2022 | United States, Arizona ... more >> Call for Information (Investigational Site 0013) Recruiting Gilbert, Arizona, United States, 85234 United States, California Call for Information (Investigational Site 0012) Recruiting Duarte, California, United States, 91010 United States, Colorado Call for Information (Investigational Site 0006) Recruiting Aurora, Colorado, United States, 80045 United States, Connecticut Call for Information (Investigational Site 0003) Recruiting New Haven, Connecticut, United States, 06511 United States, Michigan Call for Information (Investigational Site 0009) Recruiting Detroit, Michigan, United States, 48201 United States, New Jersey Call for Information (Investigational Site 0005) Recruiting Hackensack, New Jersey, United States, 07601 United States, North Carolina Call for Information (Investigational Site 0011) Recruiting Charlotte, North Carolina, United States, 28204 United States, Pennsylvania Call for Information (Investigational Site 0010) Recruiting Pittsburgh, Pennsylvania, United States, 15232 United States, Tennessee Call for Information (Investigational Site 0004) Recruiting Nashville, Tennessee, United States, 37203 United States, Texas Call for Information (Investigational Site 0001) Recruiting San Antonio, Texas, United States, 78229 Australia Merck Sharp & Dohme Recruiting North Ryde, Australia Contact: Australian Medical Information Centre 61 2 8988 8428 Israel Merck Sharp & Dohme Co. Ltd. Recruiting Hod Hasharon, Israel Contact: Dan Goldstaub 972-9-9533326 Korea, Republic of MSD Korea LTD Recruiting Seoul, Korea, Republic of, 4130 Contact: TaeYoun Jo 8223312313 Collapse << |
| NCT02124148 | Neoplasm Metastasis ... more >> Colorectal Neoplasms Breast Cancer Collapse << | Phase 1 | Recruiting | February 27, 2020 | United States, Florida ... more >> Florida Cancer Specialists Recruiting Sarasota, Florida, United States, 34232 Contact 9413779993 Principal Investigator: Manish Rajni Patel United States, Oklahoma University of Oklahoma Health Sciences Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact 405-271-4022 Principal Investigator: Kathleen Moore United States, Tennessee Sarah Cannon Research Institute SCRI Recruiting Nashville, Tennessee, United States, 37203 Contact 615-329-7615 Principal Investigator: SMO Sarah Cannon Research Inst. Tennessee Oncology PLLC Recruiting Nashville, Tennessee, United States, 37203 Contact 6153297274 Principal Investigator: Johanna Chock Bendell United States, Texas University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact 713-563-5844 Principal Investigator: David S Hong Collapse << |
| NCT01590160 | Lung Cancer - Malignant Pleura... more >>l Mesothelioma Collapse << | Phase 1 Phase 2 | Active, not recruiting | November 2018 | United Kingdom ... more >> UCL Cancer Trials Centre London, United Kingdom, W1T 4TJ Collapse << |
| NCT02947113 | Non-Small Cell Lung Cancer | Phase 2 | Withdrawn(New studies availabl... more >>e with immunotherapy so recruitment is no longer acceptable.) Collapse << | November 2017 | - |
| NCT03472053 | Non Small Cell Lung Cancer Sta... more >>ge IIIB Collapse << | Phase 2 | Active, not recruiting | June 30, 2019 | India ... more >> Vardhman Mahavir Medical College & Hospital New Delhi, Delhi, India, 110029 Unique Hospital and Research Institute Surat, Gujarat, India, 395002 Aadhar Health Institute Hisar, Hariyana, India, 125005 HCG Manavata Cancer Center Nashik, Maharashtra, India, 422004 Deenanath Mangeshkar Hospital & Research Center Pune, Maharashtra, India, 411004 Tata Memorial Hospital Mumbai, Maharastra, India, 400012 Navsanjeevani Hospital Nashik, Maharastra, India, 422002 Chirayu Cancer Hospital Bhopal, MP, India, 462030 Sparsh Hospitals and Critical Care Bhubaneswar, Odisa, India, 751007 SMS Medical College & Hospital Jaipur, Rajasthan, India, 302016 Nehru Hospital & Post Graduate Institute of Medical Education Chandigarh, India, 160012 Collapse << |
| NCT00003711 | Unspecified Adult Solid Tumor,... more >> Protocol Specific Collapse << | Phase 1 | Completed | - | United States, Texas ... more >> Brooke Army Medical Center Fort Sam Houston, Texas, United States, 78234 San Antonio Cancer Institute San Antonio, Texas, United States, 78229 Collapse << |
| NCT01860040 | - | - | Terminated(Poor accrual, no da... more >>ta to analyze) Collapse << | - | - |
| NCT01860040 | Non-squamous Cell Non-Metastat... more >>ic Non-Small Cell Lung Cancer Squamous Cell Non-Metastatic Non-Small Cell Lung Cancer Collapse << | Phase 2 | Terminated(Poor accrual, no da... more >>ta to analyze) Collapse << | - | United States, Arizona ... more >> Western Regional Medical Center Goodyear, Arizona, United States, 85338 Collapse << |
| NCT01185847 | Non-Squamous Non-Small Cell Lu... more >>ng Cancer Collapse << | Phase 2 | Completed | - | Belgium ... more >> Charleroi, Belgium, B6000 Leuven, Belgium, 3000 Liège, Belgium, 4000 France Caen, France, 14033 Marseille, France, 13915 Saint Herblain, France, 44805 Toulouse, France, 31400 Germany Bad Berka, Germany, 99437 Gauting, Germany, 82131 Grosshansdorf, Germany, 22927 Heidelberg, Germany, 69126 Köln, Germany, 51109 Mainz, Germany, 55131 Mannheim, Germany, 68167 Italy Milano, Lombardia, Italy, 20162 Milan, Lombardia, Italy, 20132 Ancona, Marche, Italy Lido Di Camaiore, Toscana, Italy, 55043 Livorno, Toscana, Italy, 57100 Perugia, Umbria, Italy, 06156 Poland Lodz, Poland, 93-509 Otwock, Poland, 05-400 Warszawa, Poland, 02-781 Spain Barcelona, Spain, 08003 Barcelona, Spain, 08035 Madrid, Spain, 28040 Madrid, Spain, 28041 Madrid, Spain, 28046 Madrid, Spain, 28050 Malaga, Spain, 29010 Sevilla, Spain, 41013 United Kingdom London, United Kingdom, SE1 9RT Collapse << |
| NCT03706703 | Lung Cancer | Phase 2 | Recruiting | September 1, 2020 | China, Guangdong ... more >> Affiliated Cancer Hospital & Institute of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510000 Contact: Chuan Jin, post-graduate 020-66673666 18302078099@163.com Collapse << |
| NCT00034593 | Urologic Neoplasms | Phase 2 | Completed | - | Finland ... more >> "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Helsinki, Finland "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Pikonlinna, Finland "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Turku, Finland France "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Bordeaux Cedex, France For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Lille Cedex, France "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Marseille Cedex 09, France "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Montpellier, France "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Paris Cedex 14, France Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Homburg/Saar, Germany Collapse << |
| NCT03201146 | Lung Cancer N... more >>on Small Cell Lung Cancer Combination Chemotherapy Apatinib Collapse << | Phase 1 Phase 2 | Recruiting | August 1, 2020 | China, Sichuan ... more >> West China Hospital, Sichuan University Recruiting Chengdu, Sichuan, China, 610041 Contact: You Lu, MD 86-028-85422114 radyoulu@hotmail.com Contact: Meijuan Huang, MD 86-028-85422114 hmj107@163.com Collapse << |
| NCT02707666 | Pleural Mesothelioma | Phase 1 | Recruiting | September 2018 | United States, Illinois ... more >> University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Mehwish Ahmad 773-834-1472 mahmad3@medicine.bsd.uchicago.edu Contact: Buerkley Rose, RN 773 834 4002 brose@medicine.bsd.uchicago.edu Principal Investigator: Hedy Kindler, M.D. Collapse << |
| NCT03381066 | Completely Resected NSCLC With... more >> Common EGFR Mutations Collapse << | Phase 3 | Not yet recruiting | December 2023 | Korea, Republic of ... more >> Department of Oncology, Yonsei University College of Medicine Not yet recruiting Seoul, Korea, Republic of, 03722 Contact: Byoung Chul Cho, MD 82 2 2228 0880 cbc1971@yuhs.ac Collapse << |
| NCT01569919 | Malignant Ple... more >>ural Mesothelioma Collapse << | Phase 2 | Unknown | December 2014 | United Kingdom ... more >> Velindre Cancer Centre Recruiting Cardiff, South Wales, United Kingdom, CF14 2TL Sub-Investigator: Mick Button Collapse << |
| NCT01296113 | Non-small Cell Lung Cancer ... more >> Hiv-positive Collapse << | Phase 2 | Completed | - | France ... more >> Centre Hospitalier du Pays d'Aix Aix-en-Provence, France Annemasse - CH Ambilly, France, 74100 Annecy - CH Annecy, France, 74374 Avignon - CH Avignon, France CH de la Côte Basque Bayonne, France CHU Besancon - Pneumologie Besancon, France, 25000 Caen - CHU Côte de Nacre Caen, France, 14000 CH Cahors Cahors, France CHU Clermont-Ferrand, France CH Colmar, France CH Compiègne - Pneumologie Compiègne, France Créteil - CHI Créteil, France, 94000 CHU Grenoble - pneumologie Grenoble, France, 38000 Le Mans - Centre Hospitalier Le Mans, France, 72000 CH Longjumeau, France Hôpital de la Croix Rousse Lyon, France Hôpital Louis Pradel Lyon, France APHM - Hôpital Nord Marseille, France, 13000 Montpellier - CHRU Montpellier, France, 34295 Nevers - CH Nevers, France, 58033 Centre Antoine Lacassagne Nice, France CHR d'Orléans La Source Orléans, France APHP - Hopital Tenon - Pneumologie Paris, France, 75020 GH Paris Saint-Joseph Paris, France Hôpital Saint Antoine Paris, France Paris - Pitié-salpêtrière Paris, France Pau - CH Pau, France, 64046 Centre François Magendie - hôpital du Haut-Lévèque Pessac, France HCL - Lyon Sud (Pneumologie) Pierre Bénite, France, 69495 Reims - CHU Reims, France, 51092 Rennes - CHU Rennes, France, 35033 Saint Brieuc - CHG Saint Brieuc, France, 22000 NHC - Pneumologie Strasbourg, France, 63000 Suresnes - Hopital Foch Suresnes, France, 92151 Thonon les bains - CH Thonon les bains, France, 74200 Toulon - CHI Toulon, France, 83000 CHU Toulouse - Pneumologie Toulouse, France Tourcoing - CH Tourcoing, France, 59208 Tours - CHU Tours, France, 37000 CH Valence Valence, France Collapse << |
| NCT00402883 | - | - | Terminated(Terminated due to b... more >>evacizumab and chemoradiotherapy toxicity) Collapse << | - | - |
| NCT03709147 | Advanced LKB1-inactive Lung Ad... more >>enocarcinoma Collapse << | Phase 2 | Not yet recruiting | September 10, 2023 | Italy ... more >> Marina Chiara Garassino Not yet recruiting Milan, Italy, 20133 Contact: MARINA CHIARA GARASSINO, MD 0223903813 ext +39 marina.garassino@istitutotumori.mi.it Collapse << |
| NCT00402883 | Lung Cancer | Phase 2 | Terminated(Terminated due to b... more >>evacizumab and chemoradiotherapy toxicity) Collapse << | - | United States, Florida ... more >> Gainsville Hematology Oncology Associates Gainesville, Florida, United States, 32605 Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States, 33805 United States, Georgia Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Associates in Hematology Oncology Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Collapse << |
| NCT03041181 | Non-Squamous Non-Small Cell Lu... more >>ng Cancer (NSCLC) Adenocarcinoma of the Lung Lung Cancer Squamous Cell Lung Cancer Collapse << | Phase 2 | Recruiting | September 2020 | United States, Indiana ... more >> St. Vincent Anderson Regional Hospital Recruiting Anderson, Indiana, United States, 46016 Contact: Kellie Ballman 765-648-4106 kellie.ballman@ascension.org Principal Investigator: Praveen Ranaganath, MD Indiana University Melvin and Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Nasser Hanna, M.D. nhanna@iu.edu Contact: Maggie Uhrich 317-274-4505 muhrich@iu.edu IU Health Central Indiana Cancer Center Recruiting Indianapolis, Indiana, United States, 46219 Contact: Melody Sands 317-678-2700 MSands1@iuhealth.org Principal Investigator: Andrew Greenspan, MD Community Regional Cancer Care Recruiting Indianapolis, Indiana, United States, 46256 Contact: Kelly Verel 317-497-2836 KVerel@ecommunity.com Principal Investigator: Radhika Walling, MD IU Health Ball Memorial Hospital Cancer Center Recruiting Muncie, Indiana, United States, 47303 Contact: Stacey Cadogan 765-281-2030 scadogan@iuhealth.org Principal Investigator: William Fisher, MD Community Healthcare System Recruiting Munster, Indiana, United States, 46321 Contact: Mary Shields 219-836-6879 mshields@comhs.org Principal Investigator: Mohamad Kassar, MD United States, Minnesota HealthPartners Institute Recruiting Minneapolis, Minnesota, United States, 55440 Contact: Jennifer Collier 651-254-3391 Jennifer.Collier@parknicollet.com Principal Investigator: Arkadiusz Dudek, MD, PhD United States, Texas University of Texas Medical Branch at Galveston Recruiting Galveston, Texas, United States, 77555 Contact: Renee Brown 409-772-9583 renbrown@utmb.edu Principal Investigator: Maurice Willis, MD United States, Virginia University of Virginia Health System Recruiting Charlottesville, Virginia, United States, 22908 Contact: Marian Abdelmalek 434-924-5834 MKA6S@hscmail.mcc.virginia.edu Principal Investigator: Richard Hall, MD Collapse << |
| NCT01154140 | - | - | Completed | - | - |
| NCT01154140 | Non Squamous Lung Cancer | Phase 3 | Completed | - | - |
| NCT03498222 | Carcinoma, Non-Small-Cell Lung | Phase 1 | Not yet recruiting | December 31, 2021 | - |
| NCT00998166 | Non-Small Cell Lung Cancer | Phase 2 | Terminated(Poor enrollment) | - | United States, New York ... more >> North Shore University Hospital Lake Success, New York, United States, 11042 Columbia University Medical Center New York, New York, United States, 10032 Collapse << |
| NCT00109096 | Ovarian Neoplasms ... more >> Primary Peritoneal Cancer Collapse << | Phase 2 | Completed | - | Belgium ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bruxelles, Belgium For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leuven, Belgium Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Erlangen, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Homburg/Saar, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jena, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Magdeburg, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munchen, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wolfsburg, Germany Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jaen, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Malaga, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palma De Mallorca, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sabadell, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leeds, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Newcastle-Upon-Tyne, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sutton, United Kingdom Collapse << |
| NCT00035061 | Urologic Neoplasms ... more >> Metastases, Neoplasm Collapse << | Phase 2 | Completed | - | United States, California ... more >> Los Angeles, California, United States Palo Alto, California, United States United States, Florida Boca Raton, Florida, United States Tampa, Florida, United States United States, Illinois Decatur, Illinois, United States United States, Indiana Indianapolis, Indiana, United States Lafayette, Indiana, United States Muncie, Indiana, United States South Bend, Indiana, United States United States, Kansas Lenexa, Kansas, United States United States, Kentucky Saint Mathews, Kentucky, United States United States, Massachusetts Boston, Massachusetts, United States United States, Nebraska Omaha, Nebraska, United States United States, Ohio Cleveland, Ohio, United States United States, Pennsylvania Philadelphia, Pennsylvania, United States Pittsburgh, Pennsylvania, United States United States, Tennessee Nashville, Tennessee, United States United States, Texas Fort Worth, Texas, United States Houston, Texas, United States United States, Washington Seattle, Washington, United States Collapse << |
| NCT02607592 | Carcinoma，Non-Small-Cell Lung | Phase 3 | Recruiting | August 2020 | China, Guangdong ... more >> Sun Yat-sen University of cancer center Recruiting Guangzhou, Guangdong, China, 510000 Contact: li-kun chen, doctor 13798019964 Collapse << |
| NCT01017874 | - | - | Completed | - | - |
| NCT00377520 | Neoplasms Neo... more >>plasms by Site Urogenital Neoplasms Genital Neoplasms, Female Uterine Neoplasms Endometrial Neoplasms Cancer of Endometrium Endometrial Cancer Cancer of the Endometrium Endometrium Cancer Neoplasms, Endometrial Collapse << | Phase 2 | Completed | - | United States, Pennsylvania ... more >> Gynecologic Oncology Group 215-854-0770 Philadelphia, Pennsylvania, United States, 19103 Collapse << |
| NCT00377520 | - | - | Completed | - | - |
| NCT00079872 | Colorectal Cancer | Phase 2 | Completed | - | Australia, Victoria ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician NSW, QLD, South Australia, Victoria, Australia Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Woodville, Australia Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Frankfurt/Main, Germany Greece For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Krete, Greece Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Amsterdam, Netherlands Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Sevilla, Spain Collapse << |
| NCT00402051 | Non-Small-Cell Lung Cancer | Phase 2 | Completed | - | Germany ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Coswig, Germany, D-01640 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, 65929 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Großhansdorf, Germany, D-22927 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Halle, Germany, D-06120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, D-21075 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hofheim, Germany, D-65719 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Homburg/Saar, Germany, 66421 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Immenhausen, Germany, D-34376 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leipzig, Germany, 04207 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Luebeck, Germany, 23538 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, 55131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Muenchen, Germany, 81664 Collapse << |
| NCT02804646 | Adenocarcinoma of Lung | Phase 4 | Unknown | December 2018 | China, Anhui ... more >> Anhui provincial hospital Recruiting Hefei, Anhui, China, 230000 Contact: Lejie Cao, prefessor sycaolejie@163.com Contact: Nana Hu 493305821@qq.com Collapse << |
| NCT02531854 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Not yet recruiting | - | - |
| NCT00351039 | Non-Small Cell Lung Cancer | Phase 1 Phase 2 | Terminated(slow accrual) | - | United States, Florida ... more >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Collapse << |
| NCT02657434 | Non-Small Cell Lung Cancer | Phase 3 | Recruiting | November 30, 2019 | - |
| NCT00351039 | - | - | Terminated(slow accrual) | - | - |
| NCT00383266 | - | - | Terminated(Low accrual) | - | - |
| NCT00402051 | - | - | Completed | - | - |
| NCT00383266 | Esophageal Neoplasms | Phase 2 | Terminated(Low accrual) | - | United States, Missouri ... more >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Collapse << |
| NCT01490437 | Urothelial Carcinoma | Phase 2 | Completed | - | Korea, Republic of ... more >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Collapse << |
| NCT03526900 | Non-small Cell Lung Cancer Sta... more >>ge IV Collapse << | Phase 2 | Recruiting | December 15, 2022 | Spain ... more >> Hospital General Universitario de Elche Not yet recruiting Elche, Alicante, Spain, 03203 Contact: María Guirado, MD Principal Investigator: María Guirado, MD Hospital Universitari Germans Tries i Pujol Recruiting Badalona, Barcelona, Spain, 08916 Contact: Enric Carcereny, PhD + 93 430 20 06 ecarcereny@iconcologia.net Principal Investigator: Enric Carcereny Hospital Universitari de Bellvitge Recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08908 Contact: Ernest Nadal, phD +34 32607744 esnadal@iconcologia.net Principal Investigator: Ernest Nadal Complejo Hospitalario de la Coruña Recruiting La Coruña, Coruña, Spain, 15006 Contact: Rosario García Campelo, MD-phD Principal Investigator: Rosario García Campelo Hospital Insular de Gran Canaria Not yet recruiting Las Palmas de Gran Canaria, Las Palmas, Spain Contact: Delvys Rodríguez, MD +34 93 430 20 06 delvysra@yahoo.com Principal Investigator: Delvys Rodríguez, MD Complexo Hospitalario Universitario de Vigo Recruiting Vigo, Pontevedra, Spain, 36036 Contact: Gerardo Huidobro Principal Investigator: Gerardo Huidobro, MD Hospital General de Alicante Not yet recruiting Alicante, Spain, 03010 Contact: Bartomeu Massutí, MD-phD Principal Investigator: Bartomeu Massutí H.U.Vall D´Hebrón Recruiting Barcelona, Spain, 08035 Contact: Enriqueta Felip, MD +34932746085 efelip@vhebron.net Principal Investigator: Enriqueta Felip, MD Hospital de Santa Creu i Sant Pau Recruiting Barcelona, Spain, 08041 Contact: Ivana Sullivan, MD Principal Investigator: Ivana Sullivan, MD Hospital Dr. Josep Trueta Recruiting Girona, Spain, 17007 Contact: Joaquim Bosch, MD Principal Investigator: Joaquim Bosch, MD Hospital Fundación Jiménez Díaz Not yet recruiting Madrid, Spain, 28040 Contact: Manuel Dómine, MD Principal Investigator: Manuel Dómine H. La Paz Recruiting Madrid, Spain Contact: Javier de Castro, MD Principal Investigator: Javier de castro, MD Hospital General Universitario de Valencia Recruiting Valencia, Spain, 46014 Contact: Ana Blasco Cordellat, MD Principal Investigator: Ana Blasco, MD Hospital La Fe Not yet recruiting Valencia, Spain, 46026 Contact: Óscar Juan, MD Principal Investigator: Óscar Juan, MD Hospital Clínico Universitario de Valladolid Recruiting Valladolid, Spain, 47003 Contact: Rafael López, MD Principal Investigator: Rafael López, MD Collapse << |
| NCT00530621 | Non-small Cell Lung Cancer | Phase 2 | Completed | - | - |
| NCT00106002 | Breast Cancer ... more >> Breast Neoplasms, Male Carcinoma, Ductal Collapse << | Phase 2 | Completed | - | United States, Texas ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75204 Collapse << |
| NCT00106002 | - | - | Completed | - | - |
| NCT00192088 | Advanced Gastric Carcinoma | Phase 2 | Completed | - | Italy ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ancona, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bari, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bergamo, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brescia, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Firenze, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gorgonzola, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mantova, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Padova, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Parma, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Roma, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Varese, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Verona, Italy Collapse << |
| NCT00769600 | Recurrent Non Small Cell Lung ... more >>Cancer Collapse << | Phase 2 | Terminated(Low accrual.) | - | United States, Maryland ... more >> Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 Singapore Singapore General Hospital Jalan Tan Tock Seng, Singapore, 308433 Collapse << |
| NCT02498860 | Adenocarcinoma ... more >> Lung Neoplasm Collapse << | Phase 2 | Unknown | December 2018 | Korea, Republic of ... more >> Chonnam National University Hwasun Hospital Recruiting Hwasun, Jeonnam, Korea, Republic of, 519-763 Contact: Young-Chul Kim, MD, PhD 82-61-379-7614 kyc0923@jnu.ac.kr Contact: In-Jae Oh, MD, PhD 82-61-379-7617 droij@jnu.ac.kr Sub-Investigator: Cheol-Kyu Park, MD Kyungpook National University Medical Center Recruiting Daegu, Kyungpook, Korea, Republic of Contact: Seung Soo Yoo, MD, PhD 82-10-9133-0641 007md@hanmail.net Principal Investigator: Seung Soo Yoo, MD, PhD Chungnam National University Hospital Recruiting Daejeon, Korea, Republic of Contact: Jeong Eun Lee, MD, PhD 82-42-280-7035 vov-x@hanmail.net Contact: Chaeuk Chung, MD, PhD 82-42-280-7247 universe7903@gmail.com Pusan National University Hospital Recruiting Pusan, Korea, Republic of, 602-739 Contact: Min-Ki Lee, MD, PhD leemk@pusan.ac.kr Principal Investigator: Min-Ki Lee, MD, PhD Kosin University Gospel Hospital Recruiting Pusan, Korea, Republic of Contact: Taewon Jang, MD, PhD jangtw@ns.kosinmed.or.kr Principal Investigator: Tae-Won Jang, MD, PhD Sub-Investigator: Maan-Hong Jung, MD, PhD Sub-Investigator: Chulho Oak, MD, PhD Korea university Guro hospital Recruiting Seoul, Korea, Republic of Contact: Sung Yong Lee syl0801@korea.ac.kr Severance hospital Recruiting Seoul, Korea, Republic of Contact: Eun Young Kim, MD, PhD 82-2-2228-2267 NARAE97@yuhs.ac Collapse << |
| NCT03134872 | Lung Neoplasms ... more >> Carcinoma, Non-Small-Cell Lung Respiratory Tract Neoplasms Thoracic Neoplasms Lung Diseases Respiratory Tract Disease Neoplasms by Site Neoplasm, Bronchial Carcinoma, Bronchogenic Collapse << | Phase 3 | Recruiting | December 31, 2019 | China, Shanghai ... more >> Tongji University, Shanghai Pulmonary Hospital Recruiting Shanghai, Shanghai, China, 200433 Contact: Caicun Zhou, MD,PhD 86-021-65115006 ext 3050 caicunzhoudr@126.com Collapse << |
| NCT00193414 | - | - | Completed | - | - |
| NCT00898820 | - | - | Completed | - | United States, Minnesota ... more >> Mayo Clinic Rochester, Minnesota, United States, 55905 Collapse << |
| NCT01187615 | Small Cell Lung Carcinoma | Phase 1 | Terminated | - | United States, Connecticut ... more >> New Haven, Connecticut, United States, 06519 United States, Nevada Las Vegas, Nevada, United States, 89135-3011 United States, New York New York, New York, United States, 10065 United States, North Carolina Chapel Hill, North Carolina, United States, 27599 Collapse << |
| NCT00061477 | Mesothelioma | Phase 2 | Completed | - | United States, Colorado ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampa, Florida, United States United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States United States, Massachusetts For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Boston, Massachusetts, United States United States, Michigan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Detroit, Michigan, United States United States, New Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Albuquerque, New Mexico, United States United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New York, New York, United States United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cleveland, Ohio, United States United States, Pennsylvania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Philadelphia, Pennsylvania, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pittsburgh, Pennsylvania, United States Collapse << |
| NCT00191191 | Non-small Cell Lung Cancer | Phase 2 | Completed | - | Japan ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Chiba, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Ehime, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Fukuoka, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Gifu, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Gunma, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Hokkaido, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Hyogo, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Kanagawa, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Kumamoto, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Miyagi, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Niigata, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Okayama, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Osaka, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Saitama, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Shizuoka, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Tokyo, Japan Collapse << |
| NCT02639767 | Malignant Pleural Mesothelioma | Phase 1 | Withdrawn(Lack of accrual) | - | United States, New Jersey ... more >> Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center at Phelps Sleepy Hollow, New York, United States, 10591 Memorial Sloan Kettering West Harrison West Harrison, New York, United States, 10604 Collapse << |
| NCT00193414 | Lung Cancer | Phase 2 | Completed | - | United States, Tennessee ... more >> Tennessee Oncology Nashville, Tennessee, United States, 37203 Collapse << |
| NCT00691301 | Cervical Cancer | Phase 2 | Completed | - | United States, California ... more >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange, California, United States, 92868 United States, Mississippi University of Mississippi Cancer Clinic Jackson, Mississippi, United States, 39216 United States, Nevada Women's Cancer Center - La Canada Las Vegas, Nevada, United States, 89169 United States, Ohio MetroHealth Cancer Care Center at MetroHealth Medical Center Cleveland, Ohio, United States, 44109 United States, Oklahoma Oklahoma University Cancer Institute Oklahoma City, Oklahoma, United States, 73104 Cancer Care Associates - Saint Francis Campus Tulsa, Oklahoma, United States, 74136-1929 United States, Texas Parkland Memorial Hospital Dallas, Texas, United States, 75235 Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Lyndon B. Johnson General Hospital Houston, Texas, United States, 77026-1967 M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 United States, Virginia Carilion Gynecologic Oncology Associates Roanoke, Virginia, United States, 24016 Collapse << |
| NCT00191191 | - | - | Completed | - | - |
| NCT00691301 | - | - | Completed | - | - |
| NCT00111839 | Lung Cancer N... more >>on Small Cell Lung Carcinoma Collapse << | Phase 2 | Completed | - | - |
| NCT00794417 | Advanced Carcinoma ... more >> Non-small Cell Lung Cancer Collapse << | Phase 1 Phase 2 | Completed | - | United States, Arizona ... more >> Arizona Cancer Institute, LLC Tucson, Arizona, United States, 85715 United States, Arkansas University of Arkansas for Medical Science Little Rock, Arkansas, United States, 72205 United States, California Stanford University Medical Center Stanford, California, United States, 94305 United States, Florida Palm Beach Institute of Hematology and Oncology Boynton Beach, Florida, United States, 33435 United States, Illinois Edward Hines Jr. VA Medical Center Hines, Illinois, United States, 60141 United States, Kentucky Kentucky Cancer Clinic Hazard, Kentucky, United States, 41701 United States, Maryland Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231-1000 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, New Mexico UNM Cancer Clinic Albuquerque, New Mexico, United States, 87131 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, North Carolina Presbyterian Hospital Center for Cancer Research Charlotte, North Carolina, United States, 28204 United States, Pennsylvania Erie Regional Cancer Center Erie, Pennsylvania, United States, 16505 United States, West Virginia Schiffler Cancer Center - Medical Oncology Division Wheeling, West Virginia, United States, 26003 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Collapse << |
| NCT03193788 | Bladder Cancer ... more >> Ureter Cancer Transitional Cell Carcinoma Collapse << | Phase 3 | Recruiting | June 2020 | Korea, Republic of ... more >> Hallym University Medical Center, Hallym University College of Medicine Recruiting Anyang, Korea, Republic of Contact: Ho Young Kim ksfam@daum.net Keimyeong University Dongsan Medical Center Recruiting Daegu, Korea, Republic of, 700-712 Contact: Jin Young Kim, MD takgu@dsmc.or.kr Fatima Hospital Recruiting Daegu, Korea, Republic of Contact: Jung Lim Lee junglim3@gmail.com Chungnam University Hospital Recruiting Daejeon, Korea, Republic of, 301-721 Contact: Hyo Jin Lee, MD, PhD. cymed@cnu.ac.kr National Health Insurance Service Ilsan Hospital Recruiting Goyang, Korea, Republic of Contact: Soo Jung Hong suzzy901@nhimc.or.kr Hallym University Dongtan Sacred Heart Hospital Recruiting Hwaseong-si, Korea, Republic of Contact: Hyun Ae Jung hyunaejung@hallym.or.kr Gil Medical Center Recruiting Incheon, Korea, Republic of, 21565 Contact: Inkeun Park, MD ingni79@hanmail.net Dong-A University Medical Center Recruiting Pusan, Korea, Republic of Contact: Suee Lee Inje University Haeundae Paik Hospital Recruiting Pusan, Korea, Republic of Contact: Il-Hwan Kim onelement@daum.net Pusan National University Hospital, Pusan National University School of Medicine Recruiting Pusan, Korea, Republic of Contact: Hyo Jung Kim leonkim80@naver.com Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Jae-Lyun Lee, MD, PhD 82 2 3010 5977 jaelyun@amc.seoul.kr Chung Ang University Hospital Recruiting Seoul, Korea, Republic of, 156-755 Contact: Hee Joon Kim, MD heejun.dino11@gmail.com Inje University Sanggye Paik Hospital Recruiting Seoul, Korea, Republic of Contact: Byeong Seok Sohn imbs@paik.ac.kr Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine Recruiting Seoul, Korea, Republic of Contact: Yun-Gyoo Lee gosciny@gmail.com Korea University Anam Hospital Recruiting Seoul, Korea, Republic of Contact: Yoon Ji Choi yoonji23@hanmail.net Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine Recruiting Seoul, Korea, Republic of Contact: Bhum Suk Keam Contact bhumsuk@snu.ac.kr Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea Recruiting Seoul, Korea, Republic of Contact: In-Ho Kim ihkmd@naver.com Yonsei Cancer Center Recruiting Seoul, Korea, Republic of Contact: Sang Joon Shin ssj338@yuhs.ac St. Vincent's Hospital, The Catholic University of Korea Recruiting Suwon, Korea, Republic of Contact: Byoung Yong Shim shimby@catholic.ac.kr Uijeongbu St Mary's hospital, Catholic university of Korea Recruiting Uijeongbu, Korea, Republic of Contact: Yoon Ho Ko koyoonho@catholic.ac.kr Pusan National University Yangsan Hospital Recruiting Yangsan, Korea, Republic of Contact: Kwonoh Park parkkoh@hanmail.net Collapse << |
| NCT01951469 | Non-small Cell Lung Cancer ... more >> Brain Metastases EGFR Mutation Collapse << | Phase 2 | Recruiting | June 2019 | China, Guangdong ... more >> Sun Yat-sen University of Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: li-kun Chen, doctor 13798019964 chenlk@sysucc.org.cn Principal Investigator: li-kun Chen, doctor Collapse << |
| NCT01336192 | Non Small Cell Lung Cancer | Phase 4 | Unknown | April 2013 | China, Shanghai ... more >> Shanghai Pulmonary Hospital Medical Oncology Department Recruiting Shanghai, Shanghai, China, 200433 Contact: Ying Xu, MD 86-21-65115006 ext 1053 xuying2186@hotmail.com Principal Investigator: Di Zheng, MD Collapse << |
| NCT02284308 | NSCLC | Not Applicable | Recruiting | July 2023 | Belgium ... more >> University Hospital Gent Not yet recruiting Gent, Belgium, 9000 Contact: Veerle Surmont Netherlands Radiotherepiegroep Recruiting Arnhem, Gelderland, Netherlands, 6815 AD Principal Investigator: Marcel Stam Caniusius-Wilhelmina Hospital Recruiting Nijmegen, Gelderland, Netherlands, 6532 SZ Principal Investigator: Yvonne Berk Ziekenhuisgroep Twente Recruiting Almelo, Overijssel, Netherlands, 7609 PP Principal Investigator: Jeske Staal Deventer Hospital Recruiting Deventer, Overijssel, Netherlands, 7416 SE Principal Investigator: Suzy Samii Radiotherapiegroep Recruiting Deventer, Overijssel, Netherlands, 7416 SE Principal Investigator: Ernest Vonk Gelre ziekenhuis Recruiting Apeldoorn, Netherlands Contact: N Pronk, Dr. Principal Investigator: N Pronk Rijnstate Ziekenhuis Recruiting Arnhem, Netherlands, 6815 AD Contact: Niels Claessens Amphia Ziekenhuis Not yet recruiting Breda, Netherlands, 4818 CK Contact: Joachim Aerts Medical Centre Haaglanden Recruiting Den Haag, Netherlands, 2512 VA Contact: Klaar Maas Catharina Hospital Eindhoven Recruiting Eindhoven, Netherlands, 5623 EJ Contact: Ben van den Borne Zuyderland Recruiting Heerlen, Netherlands, 6419 PC Principal Investigator: Gerben Bootsma Leiden University Medical Centre Not yet recruiting Leiden, Netherlands, 2333 ZC Contact: Rajen Ramai MAASTRO clinic Recruiting Maastricht, Netherlands, 6229 ET Contact: Judith van Loon, MD, PhD +31 88 44 55 666 judith.vanloon@maastro.nl Contact: Nadja Drummen +31 88 44 55 817 nadja.drummen@maastro.nl Principal Investigator: Judith van Loon Maastricht University Medical Center Recruiting Maastricht, Netherlands, 6229 HX Contact: Anne-Marie Dingemans, MD, PhD +31 43 387 65 43 a.dingemans@maastro.nl Principal Investigator: Anne-Marie Dingemans University Medical Centre Nijmegen Recruiting Nijmegen, Netherlands, 6525 GA Principal Investigator: Olga Schuurbiers Laurentius Hospital Recruiting Roermond, Netherlands, 6043 VC Contact: Cordula Pitz VieCuri Medical Centre Recruiting Venlo, Netherlands, 5912 BL Contact: Marcel Westenend Collapse << |
| NCT03470350 | Colorectal Cancer Metastatic | Phase 1 Phase 2 | Recruiting | June 1, 2020 | Netherlands ... more >> Antoni van Leeuwenhoek (NKI-AVL) Recruiting Amsterdam, Noord-Holland, Netherlands, 1066 CX Contact: S Huijberts, MD +31 (0)20-5129111 s.huijberts@nki.nl Contact: N Steeghs, MD +31 (0)20-5129111 n.steeghs@nki.nl Principal Investigator: N Steeghs, Dr. Sub-Investigator: S Huijberts, MD Collapse << |
| NCT01802021 | Carcinoma, Non-Small-Cell Lung | Phase 2 Phase 3 | Unknown | February 2014 | Taiwan ... more >> Center for traditional chinese medicine, Chang Gung Memorial Hospital Recruiting Gueishan Township, Taoyuan County, Taiwan, 33378 Contact: Tse-Hung Huang, M.D. +886-3196200 ext 2613 tsehunghuang_1089@yahoo.com.tw Principal Investigator: Tse-Hung Huang, M.D. Collapse << |
| NCT03304093 | Non Small Cell Lung Cancer Met... more >>astatic Non Small Cell Lung Cancer Stage IIIB HIV/AIDS Collapse << | Phase 2 | Recruiting | September 2020 | France ... more >> CH d'Avignon Recruiting Avignon, France Contact: Nicolas CLOAREC, Dr contact@ifct.fr CH de la Côte Basque Recruiting Bayonne, France Contact: Sophie SCHNEIDER contact@ifct.fr CH Cahors Recruiting Cahors, France Contact: Patricia BARRE contact@ifct.fr CH Recruiting Colmar, France Contact: Lionel MOREAU CHI Créteil Not yet recruiting Créteil, France Contact: Isabelle MONNET contact@ifct.fr Centre Hospitalier - Pneumologie Recruiting Le Mans, France, 72000 Contact: Olivier Molinier, Dr Hôpital de la Croix Rousse Not yet recruiting Lyon, France Contact: Lize KIAKOUAMA-MALEKA, MD contact@ifct.fr AP-HM Hôpital Nord Not yet recruiting Marseille, France Contact: Laurent GREILLIER Montpellier - CHRU Recruiting Montpellier, France, 34295 Contact: Benoit ROCH, Dr contact@ifct.fr Montpellier - ICM Not yet recruiting Montpellier, France Contact: Xavier QUANTIN, MD, PhD APHP - Hopital Tenon - Pneumologie Recruiting Paris, France, 75020 Contact: Armelle LAVOLE, MD contact@ifct.fr Paris - APHP Bichat Not yet recruiting Paris, France Contact: Solenn Brosseau, Dr contact@ifct.fr Principal Investigator: Valérie Gounant, Dr Paris - Pitié-salpêtrière Not yet recruiting Paris, France Contact: Jean-Philippe SPANO, MD-PhD contact@ifct.fr CH de Pau Recruiting Pau, France Contact: Aldo RENAULT, Dr contact@ifct.fr Saint Brieuc - CHG Not yet recruiting Saint Brieuc, France, 22000 Contact: Gwenaëlle Le Garff, Dr contact@ifct.fr NHC - Pneumologie Recruiting Strasbourg, France, 63000 Contact: Philippe Fraisse, Dr contact@ifct.fr Suresnes - Hopital Foch Not yet recruiting Suresnes, France, 92151 Contact: Hélène Doubre, Dr contact@ifct.fr CHU Toulouse - Pneumologie Recruiting Toulouse, France Contact: Julien Mazieres, Pr Collapse << |
| NCT00801736 | Lung Cancer | Phase 3 | Terminated(The antibody used d... more >>id not appear prognostic/predictive based on interim results.) Collapse << | - | United Kingdom ... more >> University College London Hospitals London, United Kingdom Collapse << |
| NCT03063450 | Mesothelioma | Phase 3 | Recruiting | July 2021 | United Kingdom ... more >> Aberdeen Royal Infirmary Recruiting Aberdeen, United Kingdom Contact: Gillian Price Belfast City Hospital Not yet recruiting Belfast, United Kingdom Contact: Gerry Hanna Royal Bournemouth Hospital Recruiting Bournemouth, United Kingdom Contact: Tom Geldart Addenbrooke's Hospital Not yet recruiting Cambridge, United Kingdom Contact: David Gilligan Velindre Cancer Centre Recruiting Cardiff, United Kingdom Contact: Jason Lester Ninewells Hospital Not yet recruiting Dundee, United Kingdom Contact: Angela Scott Beatson West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom Contact: Nicola Steele Harrogate District Hospital Recruiting Harrogate, United Kingdom Contact: Samuel Chan University Hospitals Morecambe Bay Recruiting Lancaster, United Kingdom Contact: Amy Ford Leicester Royal Infirmary Recruiting Leicester, United Kingdom Contact: Dean Fennell Barts Cancer Institute Not yet recruiting London, United Kingdom Contact: Peter Szlosarek University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom Contact: Dionysis Papadatos-Pastos Wythenshawe Hospital Recruiting Manchester, United Kingdom Contact: Raffaele Califano Mount Vernon Cancer Centre Recruiting Northwood, United Kingdom Contact: Andreas Polychronis Churchill Hospital Not yet recruiting Oxford, United Kingdom Contact: Denis Talbot Southampton General Hospital Recruiting Southampton, United Kingdom Contact: Christian Ottensmeier Southend Hospital Recruiting Southend-on-Sea, United Kingdom Contact: Gairin Dancey Lister Hospital Recruiting Stevenage, United Kingdom Contact: Andreas Polychronis Musgrove Park Hospital Recruiting Taunton, United Kingdom Contact: Petra Jankowska Collapse << |
| NCT03158129 | Non-Small Cell Lung Cancer | Phase 2 | Recruiting | June 2022 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact tcascone@mdanderson.org Collapse << |
| NCT00111839 | - | - | Completed | - | - |
| NCT02178397 | NSCLC Patients With EGFR Activ... more >>ating Mutation Collapse << | Phase 3 | Terminated(lack of recruitment... more >>) Collapse << | - | France ... more >> CH Aix En Provence, France CH Amiens, France CHRU Angers, France, 49933 CH Annecy, France, 74374 CHU Brest, France, 29609 Centre François BACLESSE Caen, France, 14000 CHIC Creteil, France, 94000 CH Draguignan, France, 83007 CH Elbeuf, France CHIC GAP, France, 05007 Ch La Roche/Yon La Roche/yon, France Centre Hospitalier Le MANS, France, 72037 Centre Oscar Lambret Lille, France, 59020 CHU Limoges, France, 87042 CH Longjumeau, France, 91160 CH Lorient, France, 35632 CH Macon, France, 71018 CH Mantes La Jolie, France, 78201 Institut Paoli Calmettes Marseille, France, 13273 AP-HM - Hôpital Nord Marseille, France CH Meaux, France, 77104 Centre Hospitalier Intercommunal Meulan, France, 78250 CH PAU, France Centre Catalan Perpignan, France CHU Rennes, France, 35033 CH Roanne, France CHU Rouen, France CH Salon de Provence, France CH Sens, France, 89100 CH St BRIEUC, France Institut de Cancérologie de la Loire St ETIENNE, France, 42271 Centre Paul Strauss Strasbourg, France, 67065 CH Tarbes, France Hôpital d'instruction des Armées Sainte-Anne Toulon, France, 83041 CH Villefranche, France, 69655 Collapse << |
| NCT01870609 | Malignant Pleural Mesothelioma | Phase 2 | Terminated(Interim analysis-DS... more >>MB stated good safety profile but lack of efficacy) Collapse << | - | - |
| NCT02353936 | Squamous Cell Carcinoma of Eso... more >>phagus Collapse << | Phase 2 | Recruiting | January 2019 | Korea, Republic of ... more >> Severance hospital Recruiting Seoul, Korea, Republic of, 120-752 Contact: Hye Ryun Kim, MD 82-2-2228-8125 nobelg@yuhs.ac Collapse << |
| NCT01749072 | Non-small Cell Lung Cancer ... more >> Effects of Chemotherapy Collapse << | Phase 2 | Unknown | December 2017 | China, Beijing ... more >> Department of Respiratory Medicine, Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Mengzhao Wang, MD 010-69155039 ext +86 mengzhaowang@sina.com Contact: Jing Zhao, MD 010-69158206 ext +86 pumchzj@sina.com Sub-Investigator: Wei Zhong, MD Sub-Investigator: Jinmei Luo, MD Collapse << |
| NCT03267654 | Non-small-cell Lung Cancer | Phase 2 | Recruiting | August 20, 2019 | China, Shanghai ... more >> Shanghai Pulmonary Hospital; Recruiting Shanghai, Shanghai, China, 200000 Contact: Caicun Zhou, MD Collapse << |
| NCT00989690 | Lung Cancer | Phase 3 | Unknown | - | Italy ... more >> Istituto Scientifico H. San Raffaele Recruiting Milan, Italy, 20132 Contact: Vanesa Gregor, MD 39-02-2643-7623 Collapse << |
| NCT00828841 | Non-Small Cell Lung Cancer | Phase 2 | Completed | - | - |
| NCT02661659 | Malignant Pleural Mesothelioma... more >> (MPM) Collapse << | Phase 1 | Withdrawn(PI stopped study due... more >> to inability to accrue.) Collapse << | - | United States, Illinois ... more >> University of Chicago Chicago, Illinois, United States, 60637 Collapse << |
| NCT03631199 | Non-small Cell Lung Cancer | Phase 3 | Not yet recruiting | October 21, 2022 | - |
| NCT01803282 | Tumors Pancre... more >>atic Cancer Non-small Cell Lung Cancer Esophagogastric Cancer Colorectal Cancer Breast Cancer Collapse << | Phase 1 | Active, not recruiting | February 2019 | United States, Alabama ... more >> Alabama Oncology Birmingham, Alabama, United States, 35213 United States, Arizona Pinnacle Oncology Hematology Scottsdale, Arizona, United States, 85258 United States, California Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309 San Diego Pacific Oncology and Hematology Associates, Inc. Encinitas, California, United States, 92024 University of Southern California (USC) Los Angeles, California, United States, 90033 California Pacific Medical Center San Francisco, California, United States, 94115 UCLA Medical Center Santa Monica, California, United States, 90404 United States, Florida Florida Cancer Specialists Sarasota, Florida, United States, 34232 United States, Indiana Parkview Research Center Fort Wayne, Indiana, United States, 46845 Indiana University Health Goshen Center for Cancer Care Goshen, Indiana, United States, 46526 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Cornell University New York, New York, United States, 10021 United States, South Carolina Greenville Health System, Institute for Translational Oncology Research Greenville, South Carolina, United States, 29605 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Vanderbilt Nashville, Tennessee, United States, 37212 United States, Texas UT Southwestern Dallas, Texas, United States, 75390 United States, Utah University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Northwest Medical Specialties Tacoma, Washington, United States, 98405 Collapse << |
| NCT03663166 | Carcinoma, Non-Small-Cell Lung | Phase 1 Phase 2 | Recruiting | March 1, 2027 | United States, Florida ... more >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Austin Lannon 813-745-2169 Austin.Lannon@moffitt.org Principal Investigator: Bradford Perez, MD Sub-Investigator: Scott Antonia, MD, PhD Sub-Investigator: Alberto Chiappori, MD Sub-Investigator: Benjamin Creelan, MD Sub-Investigator: Thomas Dilling, MD Sub-Investigator: Jhanelle Gray, MD Sub-Investigator: Eric Haura, MD Sub-Investigator: Stephen Rosenberg, MD, MS Sub-Investigator: Michael Shafique, MD Sub-Investigator: Tawee Tanvetyanon, MD, MPH Collapse << |
| NCT00828841 | - | - | Completed | - | - |
| NCT00391586 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Terminated(PI left institution... more >>.) Collapse << | - | United States, New Mexico ... more >> Lovelace Medical Group Albuquerque, New Mexico, United States, 87102 Hematology Oncology Associates NM Albuquerque, New Mexico, United States, 87106 Presbyterian Medical Group Albuquerque, New Mexico, United States, 87110 University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87131 New Mexico Cancer Care Associates Santa Fe, New Mexico, United States, 87505 Collapse << |
| NCT00391586 | - | - | Terminated(PI left institution... more >>.) Collapse << | - | - |
| NCT03337711 | - | - | Recruiting | May 31, 2020 | China, Guangdong ... more >> Sun Yat-Sen university cancer center Recruiting Guangzhou, Guangdong, China, 510000 Contact: Hao Long, Prof +86 2087343261 longhao@sysucc.org.cn Contact: Ruping Xing +86 2087343736 xingrp@sysucc.org.cn Collapse << |
| NCT02705820 | Metastatic Non Small Cell Lung... more >> Cancer Collapse << | Phase 2 | Recruiting | July 2020 | Cyprus ... more >> Bank of Cyprus Oncology Centre Recruiting Nicosia, Strovolos, Cyprus, 2006 Contact: Haris Charalambous, BM MRCP FRCR 0035722847403 haris.charalambous@bococ.org.cy Contact: Ioannis Stylianou, BSc RN 0035722847446 ioannis.stylianou@bococ.org.cy Collapse << |
| NCT01553942 | Lung Cancer | Phase 2 | Recruiting | December 2020 | United States, Massachusetts ... more >> Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Geoffrey Oxnard, MD 617-632-6049 goxnard@partners.org Principal Investigator: Geoffrey Oxnard, MD Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Lecia V Sequist, MD MPH 617-724-4000 lvsequist@partners.org Principal Investigator: Lecia V Sequist, MD MPH Collapse << |
| NCT03178552 | Non-Small Cell Lung Cancer | Phase 2 Phase 3 | Recruiting | January 2, 2022 | - |
| NCT03337698 | Carcinoma, Non-Small-Cell Lung | Phase 1 Phase 2 | Recruiting | April 20, 2022 | United States, Connecticut ... more >> Smilow Cancer Hospital at Yale New Haven Recruiting New Haven, Connecticut, United States, 06510 United States, Massachusetts Massachusetts General Hospital Not yet recruiting Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 United States, New York Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749 Recruiting New York, New York, United States, 10032 United States, Tennessee Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Australia, Victoria Peter Mac Callum Cancer Center Recruiting East Melbourne, Victoria, Australia, 3002 France Centre Léon Bérard Recruiting Lyon, France, 69008 Hôpital Nord Not yet recruiting Marseille, France, 13915 Institut Universitaire du Cancer de Toulouse-Oncopole; PHARMACIE Recruiting Toulouse, France, 31100 Korea, Republic of Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Severance Hospital, Yonsei University Health System; Pharmacy Recruiting Seoul, Korea, Republic of, 03722 University of Ulsan College of Medicine - Asan Medical Center (AMC) - Asan Cancer Center (ACC) Recruiting Songpa-gu, Korea, Republic of, 05505 Spain Clínica Universidad de Navarra Recruiting Pamplona, Navarra, Spain, 31620 Hospital Universitari Vall d'Hebron Recruiting Barcelona, Spain, 08035 Fundación Jimenez Díaz Recruiting Madrid, Spain, 28040 South Texas Accelerated Research Therapeutics Madrid - CIOCC - Universitario Sanchinarro Recruiting Madrid, Spain, 28050 United Kingdom Barts Cancer Institute Recruiting London, United Kingdom, E1 2AT Royal Marsden Hospital; Institute of Cancer Research Recruiting Sutton, United Kingdom, SM2 5PT Collapse << |
| NCT01416961 | Lung Cancer | Phase 1 | Withdrawn(Neutron therapy has ... more >>become unavailable) Collapse << | - | - |
| NCT03769805 | Nonsmall Cell Lung Cancer | Not Applicable | Not yet recruiting | December 31, 2020 | - |
| NCT02876081 | SMALL CELL LUNG CARCINOMA | Phase 2 | Withdrawn(medical decision) | December 2018 | France ... more >> Groupe Hospitalier Paris Saint Joseph Paris, Ile-de-France, France, 75014 Collapse << |
| NCT02716272 | Mesothelioma | Phase 2 | Active, not recruiting | December 2018 | France ... more >> Angers - CHU Angers, France, 49000 Avignon - Institut Sainte-Catherine Avignon, France, 84918 CHU Clermont-Ferrand, France Dijon - CHU Dijon, France, 63000 Grenoble - CHU Grenoble, France, 38000 Centre Hospitalier - Pneumologie Le Havre, France, 76600 Centre Hospitalier - Pneumologie Le Mans, France, 72000 CHRU Lille - Hopital Calmette Lille, France AP-HM Hôpital Nord Marseille, France Mulhouse - CH Mulhouse, France, 68000 AP-HP Hopital Tenon - Pneumologie Paris, France, 75020 AP-HP Hôpital Bichat Paris, France HCL Lyon Sud Pierre Bénite, France, 69495 Pontoise - CH Pontoise, France Rennes - CHU Rennes, France Rouen - CHU Rouen, France, 76000 Centre Etienne Dolet Saint-Nazaire, France CHU Strasbourg Strasbourg, France Toulon - CHI Toulon, France, 83000 Toulouse - CHU Larrey Toulouse, France CHU Tours - Pneumologie Tours, France Gustave Roussy Villejuif, France, 94800 Collapse << |
| NCT01878617 | Medulloblastoma | Phase 2 | Recruiting | December 2026 | - |
| NCT03057106 | Lung Cancer Metastatic | Phase 2 | Active, not recruiting | December 2019 | - |
| NCT00705549 | Non-Small-Cell Lung Cancer | Phase 2 | Terminated(Due to poor accrual... more >>) Collapse << | - | Greece ... more >> University General Hospital of Alexandroupolis, Dept. of Medical Oncology Alexandroupolis, Greece "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece 401 Military Hospital, Medical Oncology Unit Athens, Greece Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece Sismanogleio General Hospital, 1st, 2nd Dep of Pulmonary Diseases Athens, Greece Sotiria" General Hospital, 1st, 3rd, 8th Dep of Pulmonary Diseases Athens, Greece "Metaxa's" Anticancer Hospital of Piraeus,1st Dep of Medical Oncology Piraeus, Greece "Theagenion" Anticancer Hospital of Thessaloniki Thessaloniki, Greece Collapse << |
| NCT01383148 | Non-Small-Cell Lung Carcinoma | Phase 2 Phase 3 | Terminated | - | - |
| NCT03061058 | Stomach Neoplasms ... more >> Chemotherapy Effect Chemotherapeutic Toxicity Collapse << | Phase 3 | Recruiting | December 2019 | China, Anhui ... more >> Ma'anshan People's Hospital Recruiting Ma'anshan, Anhui, China Contact: Fenglin Zhang, MD Contact: Fangbo Cui, MD China, Jiangsu Jiangyin People's Hospital Recruiting Jiangyin, Jiangsu, China Contact: Weisheng Shen, MD Contact: Lei Xi, MD Nanjing Gaochun People's Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Rongfu Wei, MD Contact: Yajun Xin, MD Nanjing Lishui People's Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Chunlan Nie, MD Contact: Hui Xu, MD The Comprehensive Cancer Center of Nanjing Drum Tower Hospital Recruiting Nanjing, Jiangsu, China, 210008 Contact: Yang Yang, MD,PhD,MSCR 0086-18602568379 wing_young7@hotmail.com Contact: Baorui Liu, MD, PhD 0086-13770621908 baoruiliu07@163.com Suqian People's Hospital Recruiting Suqian, Jiangsu, China Contact: Chuanwen You, MD Contact: Qing Zhu, MD Xuzhou Central Hospital Recruiting Xuzhou, Jiangsu, China Contact: Sanyuan Sun, MD Contact: Yuan Yuan, MD Affiliated Hospital of Jiangsu University Recruiting Zhenjiang, Jiangsu, China Contact: Xiaoqing Li, MD Contact: Meilian Cheng, MD Collapse << |
| NCT02419495 | Advanced Malignant Neoplasm ... more >> Recurrent Malignant Neoplasm Refractory Malignant Neoplasm Collapse << | Phase 1 | Recruiting | December 31, 2019 | United States, Texas ... more >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Aung Naing 713-563-1930 Principal Investigator: Aung Naing MD Anderson Regional Care Center-Katy Recruiting Houston, Texas, United States, 77094 Contact: Aung Naing 713-563-1930 Principal Investigator: Aung Naing MD Anderson Regional Care Center-Bay Area Recruiting Nassau Bay, Texas, United States, 77058 Contact: Aung Naing 713-563-1930 Principal Investigator: Aung Naing MD Anderson Regional Care Center-Sugar Land Recruiting Sugar Land, Texas, United States, 77478 Contact: Aung Naing 713-563-1930 Principal Investigator: Aung Naing MD Anderson Regional Care Center-The Woodlands Recruiting The Woodlands, Texas, United States, 77384 Contact: Aung Naing 713-563-1930 Principal Investigator: Aung Naing Collapse << |
| NCT03432598 | Locally Advanced or Metastatic... more >> Lung Cancer Collapse << | Phase 2 | Recruiting | July 2019 | China, Beijing ... more >> Chinese Academy of Medical Sciences Tumor Hospital Recruiting Beijing, Beijing, China, 100021 Contact: Lijuan Zhao 861087788495 cancergcp@163.com Principal Investigator: Jie Wang, MD Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Jun Huang 861088196023 hj19840804@163.com Principal Investigator: Jun Zhao, MD Beijing Chest Hospital Recruiting Beijing, Beijing, China, 133500 Contact: Jing Liu 861089509157 liujingworkbj@126.com Principal Investigator: Zhe Liu, MD China, Henan Henan Cancer Hospital Recruiting Zhengzhou, Henan, China, 450008 Contact: Hongxia Li 8637165588007 51lihongxia@sina.com Principal Investigator: Zhiyong Ma, MD China, Jiangsu Jaingsu People's Hospital Recruiting Nanjing, Jiangsu, China, 210029 Contact: Mingmin Sun 862568136221 jsphkj@163.com Principal Investigator: Yongqian Shu, MD China, Jilin Jilin University First Hospital Recruiting Changchun, Jilin, China, 130021 Contact: Fei Wang 8643188786014 wangfei5780@126.com Principal Investigator: Ying Cheng, MD Jilin Cancer Hospital Recruiting Changchun, Jilin, China, 132000 Contact: Yan Xi 8643185879120 417064629@qq.com Principal Investigator: Ying Cheng, MD Collapse << |
| NCT03631784 | Non-small Cell Lung Cancer | Phase 2 | Recruiting | January 12, 2022 | United States, California ... more >> St Joseph Heritage Healthcare ( Site 1403) Recruiting Santa Rosa, California, United States, 95403 Contact: Study Coordinator 707-521-3830 United States, Indiana Parkview Cancer Institute ( Site 1415) Recruiting Fort Wayne, Indiana, United States, 46845 Contact: Study Coordinator 833-724-8356 United States, Massachusetts UMass Memorial Medical Center ( Site 1417) Recruiting Worcester, Massachusetts, United States, 01655 Contact: Study Coordinator 508-334-5539 United States, Michigan Henry Ford Hospital ( Site 1418) Recruiting Detroit, Michigan, United States, 48202 Contact: Study Coordinator 313-916-2635 United States, Nebraska St. Francis Cancer Treatment Center ( Site 1421) Recruiting Grand Island, Nebraska, United States, 68803 Contact: Study Coordinator 308-398-5450 United States, New Jersey Rutgers Cancer Institute of New Jersey ( Site 1422) Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Study Coordinator 732-235-6048 United States, Oklahoma CTCA Southwestern ( Site 1428) Recruiting Tulsa, Oklahoma, United States, 74133 Contact: Study Coordinator 918-286-5448 Australia, New South Wales Blacktown Hospital Western Sydney Local Health District ( Site 0204) Recruiting Blacktown, New South Wales, Australia, 2148 Contact: Study Coordinator +61403170371 MNCCI Port Macquarie Base Hospital ( Site 0200) Recruiting Port Macquarie, New South Wales, Australia, 2444 Contact: Study Coordinator +61265801818 Australia, Victoria Ballarat Health Services ( Site 0206) Recruiting Ballarat, Victoria, Australia, 3350 Contact: Study Coordinator +61353204735 Korea, Republic of Chungbuk National University Hospital ( Site 1003) Recruiting Cheongju si, Chungcheongbuk Do, Korea, Republic of, 28644 Contact: Study Coordinator +82432696015 Samsung Medical Center ( Site 1001) Recruiting Seoul, Korea, Republic of, 06351 Contact: Study Coordinator +82234103459 Ulsan University Hospital ( Site 1000) Recruiting Ulsan, Korea, Republic of, 44033 Contact: Study Coordinator +82522508832 Poland Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 0811) Recruiting Bydgoszcz, Poland, 85-796 Contact: Study Coordinator +48523743029 Osrodek Badan Klinicznych przy Szpitalu Specjalistycznym ( Site 0802) Recruiting Krakow, Poland, 31-826 Contact: Study Coordinator +48721295010 Centrum Onkologii Instytut im. Marii Sklodowskiej Curie ( Site 0800) Recruiting Warszawa, Poland, 02-781 Contact: Study Coordinator +48225463066 Russian Federation Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 0910) Recruiting Kazan, Russian Federation, 420029 Contact: Study Coordinator +79172662851 N.N. Blokhin National Medical Oncology Research Centre ( Site 0902) Recruiting Moscow, Russian Federation, 115478 Contact: Study Coordinator +79031990755 National Medical Research Center of Oncology n.a. N. N. Petrov ( Site 0904) Recruiting St. Petersburg, Russian Federation, 197758 Contact: Study Coordinator +79117500005 Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 0903) Recruiting Ufa, Russian Federation, 450054 Contact: Study Coordinator +79050058625 Spain Hospital Universitari Vall d Hebron ( Site 1101) Recruiting Barcelona, Spain, 08035 Contact: Study Coordinator +34934894158 Hospital Clinic de Barcelona ( Site 1100) Recruiting Barcelona, Spain, 08036 Contact: Study Coordinator +34932275402 Clinica Universitaria de Navarra ( Site 1102) Recruiting Madrid, Spain, 28027 Contact: Study Coordinator +349135319027502 Collapse << |
| NCT02064491 | Non-small Cell Lung Cancer | Phase 2 | Completed | - | Finland ... more >> Helsinki University Hospital Espoo, Finland Helsinki University Hospital Helsinki, Finland Oulu University Hospital Oulu, Finland Pori Central Hospital Pori, Finland Tampere University Hospital Tampere, Finland Turku University Hopital Turku, Finland Vaasa Central Hospital Vaasa, Finland Collapse << |
| NCT02951897 | Lung Adenocarcinoma, Stage I ... more >> Diagnoses Diseases Circulating Tumor Cells Treatment Collapse << | Not Applicable | Recruiting | December 2019 | China ... more >> Daping hospital Recruiting Chongqing, China Contact: Bo Deng +86-13637782166 deng.bo@dphospital.tmmu.edu.cn Collapse << |
| NCT02579564 | Malignant Hydrothorax ... more >> Non Small Cell Lung Cancer Collapse << | Phase 3 | Unknown | December 2018 | - |
| NCT03215706 | Non-Small Cell Lung Cancer | Phase 3 | Recruiting | May 20, 2020 | - |
| NCT03760575 | Mesotheliomas Pleural | Phase 1 | Not yet recruiting | November 2021 | United States, Pennsylvania ... more >> Abramson Cancer Center of the University of Pennsylvania Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Evan W Alley 588-216-0098 penncancertrials@emergingmed.com Collapse << |
| NCT02906150 | Non-Small Cell Lung Cancer | Phase 2 | Not yet recruiting | July 2019 | Italy ... more >> Azienda Sanitaria Locale Frosinone Not yet recruiting Frosinone, Italy Contact: Dott.ssa Teresa Gamucci Principal Investigator: Dott.ssa Teresa Gamucci Istituto Nazionale dei Tumori Not yet recruiting Milan, Italy Contact: Dott.ssa Marina Chiara Garassino Principal Investigator: Dott.ssa Marina Chiara Garassino Roma_Campus Bio-Medico Not yet recruiting Rome, Italy Contact: Prof. Daniele Santini Principal Investigator: Prof. Daniele Santini Roma_Gemelli Not yet recruiting Rome, Italy Contact: Prof. Carlo Antonio Mario Barone Principal Investigator: Prof. Carlo Antonio Mario Barone Roma_Regina Apostolorum Not yet recruiting Rome, Italy Contact: Dott. Francesco Angelini Principal Investigator: Dott. Francesco Angelini Roma_Tor Vergata Not yet recruiting Rome, Italy Contact: Prof. Mario Roselli Principal Investigator: Prof. Mario Roselli Sant'Andrea Hospital Not yet recruiting Rome, Italy Contact: Prof. Paolo Marchetti Principal Investigator: Prof. Paolo Marchetti Presidio Sanitario San Camillo Not yet recruiting Torino, Italy Contact: Dott.ssa Maria Rita Migliorino Principal Investigator: Dott.ssa Maria Rita Migliorino Collapse << |
| NCT01672229 | Graft Versus Host Disease | Phase 1 | Active, not recruiting | December 2019 | United States, California ... more >> University of California Comprehensive Cancer Center Sacramento, California, United States, 95817 Collapse << |
| NCT02940990 | NSCLC SBRT ... more >> GM-CSF Collapse << | Phase 2 | Not yet recruiting | - | China, Shanghai ... more >> Shanghai Chest Hospital Not yet recruiting Shanghai, Shanghai, China Contact: Xiaolong Fu, PhD +862122200000 ext 3602 xlfu1964@126.com Collapse << |
| NCT02142738 | - | - | Active, not recruiting | - | - |
| NCT02013453 | Cancer of Head and Neck | Phase 2 | Withdrawn(Lack of funding) | - | United States, Michigan ... more >> University of Michigan Hospital Ann Arbor, Michigan, United States, 48109 Collapse << |
| NCT02142738 | Non-Small Cell Lung Carcinoma | Phase 3 | Active, not recruiting | May 31, 2019 | - |
| NCT02039674 | Non-small Cell Lung Carcinoma | Phase 1 Phase 2 | Active, not recruiting | October 18, 2021 | United States, California ... more >> Call for Information (Investigational Site 0018) La Jolla, California, United States, 92037 Call for Information (Investigational Site 0010) San Francisco, California, United States, 94115 United States, Indiana Call for Information (Investigational Site 0019) Indianapolis, Indiana, United States, 46202 United States, Massachusetts Call for Information (Investigational Site 0017) Boston, Massachusetts, United States, 02114 Call for Information (Investigational Site 0002) Boston, Massachusetts, United States, 02215 Call for Information (Investigational Site 0016) Boston, Massachusetts, United States, 02215 United States, Nebraska Call for Information (Investigational Site 0023) Omaha, Nebraska, United States, 68130 United States, New Jersey Call for Information (Investigational Site 0055) Hackensack, New Jersey, United States, 07601 United States, New York Call for Information (Investigational Site 0056) Lake Success, New York, United States, 11042 United States, Pennsylvania Call for Information (Investigational Site 0009) Philadelphia, Pennsylvania, United States, 19104 Call for Information (Investigational Site 0015) Philadelphia, Pennsylvania, United States, 19104 Call for Information (Investigational Site 0004) Philadelphia, Pennsylvania, United States, 19111 United States, Texas Call for Information (Investigational Site 0007) Houston, Texas, United States, 77030 Call for Information (Investigational Site 0003) San Antonio, Texas, United States, 78229 Taiwan Merck Sharp & Dohme (I.A.) Corp. Taipei, Taiwan Collapse << |
| NCT03456076 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Recruiting | September 30, 2026 | - |
| NCT03088540 | Carcinoma，Non-Small-Cell Lung ... more >> Lung Carcinomas, Non-Small-Cell Non-small-cell Lung Carcinoma Nonsmall Cell Lung Cancer Collapse << | Phase 3 | Recruiting | September 20, 2022 | - |
| NCT02486718 | Non-Small Cell Lung Cancer | Phase 3 | Active, not recruiting | September 25, 2026 | - |
| NCT02039674 | - | - | Active, not recruiting | - | - |
| NCT02055144 | - | - | Recruiting | March 2018 | Italy ... more >> IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro Recruiting Genoa, Italy, 16132 Contact: Francesco Grossi, MD +393355255484 fg1965@libero.it Collapse << |
| NCT02576574 | First Line Non-Small Cell Lung... more >> Cancer Collapse << | Phase 3 | Active, not recruiting | September 5, 2024 | - |
| NCT03351361 | Advanced Non Small Cell Lung C... more >>ancer Collapse << | Phase 3 | Not yet recruiting | June 2022 | France ... more >> CH du Pays d'Aix Not yet recruiting Aix-en-Provence, France Contact: Jacques Letreut CHU d'Angers Not yet recruiting Angers, France Contact: Thierry Urban CH de la Côte Basque Not yet recruiting Bayonne, France Contact: Marielle Sabatini CH de Beauvais Not yet recruiting Beauvais, France Contact: Jacky Crequit CHU de Brest Not yet recruiting Brest, France Contact: Gilles Robinet Centre Francois Baclesse Not yet recruiting Caen, France Contact: Radj Gervais CH René Dubos Not yet recruiting Cergy-Pontoise, France Contact: Gislaine Fraboulet CH de Charleville-Mézières Not yet recruiting Charleville-Mézières, France Contact: Stéphane Chouabe CH Intercommunal Not yet recruiting Créteil, France Contact: Isabelle Monnet CH Intercommunal des Alpes du Sud Not yet recruiting Gap, France Contact: Pascal Thomas CH Départemental Vendée Not yet recruiting La Roche-sur-Yon, France Contact: Marie Marcq CH de Versailles Not yet recruiting Le Chesnay, France Contact: Cécile Dujon CH Robert Boulin Not yet recruiting Libourne, France Contact: Menouar-Samir Abdiche CHU de Limoges Not yet recruiting Limoges, France Contact: Alain Vergnenegre CH Régional Not yet recruiting Longjumeau, France Contact: Gérard Oliviero CH de Bretagne Sud Not yet recruiting Lorient, France Contact: Régine Lamy Centre Léon Bérard Not yet recruiting Lyon, France Contact: Maurice Perol CH François Quesnay Not yet recruiting Mantes-la-Jolie, France Contact: Jean-Bernard Auliac APHM Hôpital Nord Not yet recruiting Marseille, France Contact: Laurent Greillier Institut Paoli-Calmette Not yet recruiting Marseille, France Contact: Anne Madroszyk-Flandin CH de Meaux Not yet recruiting Meaux, France Contact: Chrystèle Locher CH de la Région d'Annecy Pringy, France CHU de Rennes Not yet recruiting Rennes, France Contact: Hervé Léna Sub-Investigator: Romain Corre Principal Investigator: Hervé Léna CHU de Rouen Not yet recruiting Rouen, France Contact: Luc Thiberville CH de Saint-Brieuc Not yet recruiting Saint-Brieuc, France Contact: Gwenaëlle Le Garff CHU de Saint-Etienne Not yet recruiting Saint-Priest-en-Jarez, France Contact: Pierre Fournel CLCC Paul Strauss Not yet recruiting Strasbourg, France Contact: Roland Schott CH Intercommunal Toulon-La Seyne-sur-Mer Not yet recruiting Toulon, France Contact: Clarisse Audigier-Valette HIA Saint-Anne Not yet recruiting Toulon, France Contact: Henri Berard CH de Villefranche sur Saône Not yet recruiting Villefranche-sur-Saône, France Contact: Lionel Falchero Collapse << |
| NCT00969098 | - | - | Unknown | September 2015 | Italy ... more >> Istituto Clinico Humanitas Rozzano, Milano, Italy, 20089 Collapse << |
| NCT02041533 | Stage IV or Recurrent Non-Smal... more >>l Cell Lung Cancer Collapse << | Phase 3 | Active, not recruiting | October 1, 2018 | - |
| NCT03269162 | NSCLC | Phase 3 | Active, not recruiting | September 30, 2019 | - |
| NCT02862457 | Neoplasms Car... more >>cinoma, Non-Small-Cell Lung Collapse << | Phase 1 | Recruiting | November 30, 2020 | Japan ... more >> MSD K.K. Recruiting Chiyoda-Ku, Tokyo, Japan, 102-8667 Contact: Japan Call Center 81-3-6272-1957 Collapse << |
| NCT02083679 | Carcinoma, Non-Small-Cell Lung | Phase 1 | Terminated(Sponsor the return ... more >>rights of the compound to the collaboration partner for further clinical development) Collapse << | - | United States, Massachusetts ... more >> Please Contact U.S. Medical Information Located in Rockland, Massachusetts, United States Germany Please contact the Merck KGaA Communication Center located in Darmstadt, Germany Collapse << |
| NCT02041533 | - | - | Active, not recruiting | - | - |
| NCT02974426 | Non-small Cell Lung Cancer Sta... more >>ge IIIA Radiotherapy Collapse << | Phase 3 | Recruiting | December 2020 | China, Shanghai ... more >> Shanghai Chest Hospital Recruiting Shanghai, Shanghai, China Contact: Xiaolong Fu, PhD +862122200000 ext 3602 xlfu1964@126.com Collapse << |
| NCT02083679 | - | - | Terminated(Sponsor the return ... more >>rights of the compound to the collaboration partner for further clinical development) Collapse << | - | - |
| NCT02610140 | Mesothelioma | Phase 2 | Active, not recruiting | July 29, 2019 | - |
| NCT02117024 | Non Small Cell Lung Cancer | Phase 2 | Active, not recruiting | September 2018 | United States, Arkansas ... more >> Highlands Oncology Group Rogers, Arkansas, United States, 72758 United States, California University of California San Diego La Jolla, California, United States, 92093 University of California at Los Angeles Los Angeles, California, United States, 90029 University of California Davis Sacramento, California, United States, 95817 United States, Georgia Georgia Regents University Augusta, Georgia, United States, 30912 United States, Maryland University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Massachusetts University of Massachusetts Worcester, Massachusetts, United States, 01655 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York SUNY Syracuse Syracuse, New York, United States, 13210 United States, Ohio Gabrail Cancer Center Canton, Ohio, United States, 44718 United States, Oregon Providence Portland Medical Center- Providence Lung Cancer Clinic Portland, Oregon, United States, 97213 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas Texas Oncology PA Texas Cancer Center Abilene, Texas, United States, 79606 Mary Crowley Cancer Center Dallas, Texas, United States, 75201 United States, Washington Cancer Care Northwest Spokane, Washington, United States, 99216 United States, Wisconsin Aurora Research Institute Green Bay, Wisconsin, United States, 54311 Collapse << |
| NCT03530397 | Selected Advanced Solid Tumors | Phase 1 | Recruiting | March 27, 2023 | Australia ... more >> Research Site Recruiting Melbourne, Australia, 3000 Research Site Recruiting Melbourne, Australia, 3004 Research Site Recruiting Randwick, Australia, 2031 Italy Research Site Not yet recruiting Milano, Italy, 20133 Korea, Republic of Research Site Not yet recruiting Incheon, Korea, Republic of, 21565 Research Site Recruiting Seoul, Korea, Republic of, 03080 Research Site Recruiting Seoul, Korea, Republic of, 03722 Research Site Recruiting Seoul, Korea, Republic of, 05505 Research Site Recruiting Seoul, Korea, Republic of, 06351 Taiwan Research Site Not yet recruiting Taichung, Taiwan, 40705 Research Site Not yet recruiting Tainan, Taiwan, 70403 Research Site Not yet recruiting Taipei, Taiwan, 10048 Collapse << |
| NCT01993810 | Stage II Non-Small Cell Lung C... more >>ancer AJCC v7 Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 Stage III Non-Small Cell Lung Cancer AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Collapse << | Phase 3 | Recruiting | December 31, 2025 | United States, Florida ... more >> University of Florida Health Science Center - Jacksonville Recruiting Jacksonville, Florida, United States, 32209 Contact: Site Public Contact 412-339-5294 Roster@nrgoncology.org Principal Investigator: Bradford S. Hoppe United States, Illinois Northwestern Medicine Cancer Center Warrenville Suspended Warrenville, Illinois, United States, 60555 United States, Maryland Maryland Proton Treatment Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Site Public Contact 410-369-5226 info@mdproton.com Principal Investigator: Charles B. Simone University of Maryland/Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Site Public Contact 800-888-8823 Principal Investigator: Charles B. Simone Upper Chesapeake Medical Center Recruiting Bel Air, Maryland, United States, 21014 Contact: Site Public Contact 443-643-3010 Principal Investigator: Jack J. Hong Central Maryland Radiation Oncology in Howard County Recruiting Columbia, Maryland, United States, 21044 Contact: Site Public Contact 443-546-1300 Principal Investigator: Charles B. Simone Tate Cancer Center Recruiting Glen Burnie, Maryland, United States, 21061 Contact: Site Public Contact 410-553-8100 Principal Investigator: Charles B. Simone United States, Massachusetts Massachusetts General Hospital Cancer Center Suspended Boston, Massachusetts, United States, 02114 Mass General/North Shore Cancer Center Suspended Danvers, Massachusetts, United States, 01923 United States, Missouri Siteman Cancer Center at West County Hospital Recruiting Creve Coeur, Missouri, United States, 63141 Contact: Site Public Contact 800-600-3606 info@siteman.wustl.edu Principal Investigator: Jeffrey D. Bradley Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Site Public Contact 800-600-3606 info@siteman.wustl.edu Principal Investigator: Jeffrey D. Bradley United States, New Jersey Memorial Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Site Public Contact 212-639-7592 Principal Investigator: Abraham J. Wu ProCure Proton Therapy Center-Somerset Suspended Somerset, New Jersey, United States, 08873 United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Site Public Contact 212-639-7592 Principal Investigator: Abraham J. Wu Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Site Public Contact 212-639-7592 Principal Investigator: Abraham J. Wu Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Site Public Contact 212-639-7592 Principal Investigator: Abraham J. Wu Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Site Public Contact 212-639-7592 Principal Investigator: Abraham J. Wu Memorial Sloan Kettering Sleepy Hollow Suspended Sleepy Hollow, New York, United States, 10591 United States, Pennsylvania University of Pennsylvania/Abramson Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Site Public Contact 800-474-9892 Principal Investigator: Samuel Swisher-McClure Thomas Jefferson University Hospital Active, not recruiting Philadelphia, Pennsylvania, United States, 19107 United States, Tennessee Tennessee Cancer Specialists-Dowell Springs Recruiting Knoxville, Tennessee, United States, 37909 Contact: Site Public Contact 865-244-3209 Principal Investigator: J. B. Wilkinson United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Site Public Contact 877-312-3961 Principal Investigator: Quynh-Nhu Nguyen MD Anderson Regional Care Center-Katy Suspended Houston, Texas, United States, 77094 MD Anderson Regional Care Center-Bay Area Suspended Nassau Bay, Texas, United States, 77058 MD Anderson Regional Care Center-Sugar Land Suspended Sugar Land, Texas, United States, 77478 MD Anderson Regional Care Center-The Woodlands Suspended The Woodlands, Texas, United States, 77384 United States, Washington ProCure Proton Therapy Center-Seattle Recruiting Seattle, Washington, United States, 98133 Contact: Site Public Contact 412-339-5294 Roster@nrgoncology.org Principal Investigator: Ramesh Rengan University of Washington Medical Center Recruiting Seattle, Washington, United States, 98195 Contact: Site Public Contact 800-804-8824 Principal Investigator: Ramesh Rengan Collapse << |
| NCT01356368 | Non-Small Cell Lung Cancer | Phase 2 | Terminated(slow accrual rate) | - | Saudi Arabia ... more >> King Abdul Aziz Medical City for National Guard Health Affairs Riyadh, Saudi Arabia Collapse << |
| NCT01969955 | Squamous Cell Carcinoma of Lun... more >>g Collapse << | Phase 2 | Unknown | June 2015 | China, Beijing ... more >> Cancer institute and hospital, Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 100021 Contact: Junling Li drlijunling@vip.163.com Principal Investigator: Junling Li Collapse << |
| NCT00324805 | Stage IB Non-Small Cell Lung C... more >>arcinoma Stage IIA Non-Small Cell Lung Carcinoma Stage IIB Non-Small Cell Lung Carcinoma Stage IIIA Non-small Cell Lung Cancer Collapse << | Phase 3 | Active, not recruiting | October 16, 2023 | - |
| NCT00324805 | - | - | Active, not recruiting | - | - |
| NCT02607423 | Stage IIIA Non-Small Cell Lung... more >> Cancer Collapse << | Phase 2 | Withdrawn(The study failed to ... more >>meet its accrual targets.) Collapse << | - | United States, Pennsylvania ... more >> ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States, 19103 Collapse << |
| NCT02777788 | Cancer | Phase 2 Phase 3 | Active, not recruiting | December 2019 | - |
| NCT01192230 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Unknown | - | China, Shanghai ... more >> Cancer hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Jianhua Chang, MD,PhD 13916619284 changjianhua@hotmail.com Collapse << |
| NCT00775385 | Carcinoma, Non-Small-Cell Lung | Phase 2 Phase 3 | Completed | - | France ... more >> Centre Hospitalier Aix en Provence, France Clinique de L'Europe Amiens, France Angers - CHU Angers, France, 49000 Centre Hospitalier Béziers, France Centre F. Baclesse Caen, France, 14000 CHU - Pneumologie Caen, France, 14000 Centre Hospitalier Chauny, France Chevilly Larue - CH Chevilly Larue, France Hôpital Percy-Armées - Pneumologie Clamart, France, 92140 Clermont Ferrand - CHU Clermont Ferrand, France, 63000 Colmar - CH Colmar, France, 68000 Dax - CH Dax, France, 40107 Ermont - Clinique Claude Bernard Ermont, France CHU Grenoble - pneumologie Grenoble, France, 38000 Le Mans - CHG Le Mans, France Centre Léon Bérard Lyon, France, 69000 Lyon - Hôpital Louis Pradel (Pneumologie) Lyon, France Mantes La Jolie - CH Mantes La Jolie, France, 78200 APHM - Hôpital Sainte Marguerite Marseille, France, 13000 Institut Paoli Calmette Marseille, France Metz - Belle Isle Metz, France Mont de Marsan - CH Mont de Marsan, France, 40000 Montpellier - Clinique Clémentville Montpellier, France, 34070 Mulhouse - CH Mulhouse, France, 68000 Nancy - Polyclinique Gentilly Nancy, France Nevers - CH Nevers, France, 58033 Paris - Saint Louis Paris, France, 75000 APHP - Hopital Tenon - Pneumologie Paris, France, 75020 Pau - CH Pau, France, 64046 HCL - Lyon Sud (Pneumologie) Pierre Bénite, France, 69495 Reims - CHU Reims, France, 51092 Rennes - CHU Rennes, France Centre Hospitalier Saint-Quentin, France Nouvel Hopital Civil Strasbourg, France, 63000 Hôpital Foch Suresnes, France Centre Hospitalier Intercommunal Toulon, France CHU Toulouse - Pneumologie Toulouse, France Clinique Pasteur Toulouse, France Tours - CHU Tours, France, 37000 Nancy - CHU Vandoeuvre lès Nancy, France, 54500 Institut Gustave Roussy Villejuif, France, 94805 Centre Hospitalier Intercommunal Villeneuve-Saint-Georges, France Collapse << |
| NCT02367781 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Active, not recruiting | December 28, 2019 | - |
| NCT03519971 | Non-Small Cell Lung Cancer | Phase 3 | Recruiting | August 1, 2022 | - |
| NCT02129699 | Lung Cancer Non-small Cell Sta... more >>ge IV Collapse << | Phase 3 | Active, not recruiting | September 2020 | - |
| NCT02662634 | Non-small Cell Lung Cancer (NS... more >>CLC) Collapse << | Phase 2 | Unknown | March 2018 | United States, Nebraska ... more >> Cancer Research Network of Nebraska / Oncology Associates Recruiting Omaha, Nebraska, United States, 68118 Contact: Tony Romero, MS, CCRC 402-697-2229 tromero@gucancer.com Principal Investigator: Stephen Lemon, MD Collapse << |
| NCT01840579 | Solid Tumor N... more >>on-small Cell Lung Cancer Small Cell Lung Cancer Collapse << | Phase 1 | Active, not recruiting | April 17, 2020 | - |
| NCT01809210 | Locally Advanced or Metastatic... more >> NSCL Cancer Stage IIIB IV Collapse << | Phase 1 | Completed | - | United Kingdom ... more >> Research Site Glasgow, United Kingdom, G12 0YN Research Site London, United Kingdom, W1G 6AD Research Site Manchester, United Kingdom, M20 4BX Research Site Newcastle upon Tyne, United Kingdom, NE7 7DN Collapse << |
| NCT01059552 | Locally Advanced Non-small Cel... more >>l Lung Cancer Collapse << | Phase 1 | Active, not recruiting | December 1, 2018 | United States, Florida ... more >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 Collapse << |
| NCT02195453 | Non-Small Cell Lung Cancer | Phase 4 | Unknown | December 2016 | - |
| NCT02031601 | Non-Small-Cell Lung Cancer | Phase 4 | Unknown | December 2017 | China, Shandong ... more >> Yu Li Recruiting Jinan, Shandong, China, 250012 Contact: Yu Li Collapse << |
| NCT01809210 | - | - | Completed | - | - |
| NCT03562871 | NSCLC | Phase 1 Phase 2 | Recruiting | February 2022 | Spain ... more >> Servicio de Oncología-El médico del Virgen de la Victoria Recruiting Málaga, Andalusia, Spain, 29010 Contact: José M Trigo Pérez, Dr Insituto Oncologico Dr Rosell. Hospital Universitario Quiron Dexeus Not yet recruiting Barcelona, Catalonia, Spain, 08028 Contact: Santiago Viteri, Prof Hospital Universitario de Vall d'Hebron Recruiting Barcelona, Catalonia, Spain, 08035 Contact: Enriqueta Felip, Dr Hospital Universitari de Girona Doctor Josep Trueta Recruiting Girona, Catalonia, Spain, 17007 Contact: Joaquim Bosch, Dr Hospital Universitario 12 Octubre Recruiting Madrid, Community Of Madrid, Spain, 28041 Contact: Luis Paz-Ares, Dr Centro Integral Oncologico Clara Campal, Hospital Universitario HM Sanchinarro Not yet recruiting Madrid, Community Of Madrid, Spain, 28050 Hospital Universitario Ramón y Cajal Not yet recruiting Madrid, Community Of Madrid, Spain, 28134 Contact: Pilar Garrido, Dr Hospital Puerta del Hierro Majadahonda Recruiting Madrid, Community Of Madrid, Spain Contact: Mariano Provencio, Dr Hospital Clinico Universitario de València Not yet recruiting València, Horta De València, Spain, 46010 Contact: Amelia Insa, Dr Hospital Universitario La Paz Recruiting Madrid, Spain, 28050 Contact: Javier de Castro Carpeno, DR +34917277000 javier.decastro@salud.madrid.org Collapse << |
| NCT01063478 | Non-Small Cell Lung Cancer | Phase 1 | Terminated(Poor accrual) | - | United States, Illinois ... more >> University of Chicago Medical Center Chicago, Illinois, United States, 60637 Collapse << |
| NCT01633970 | Cancer | Phase 1 | Active, not recruiting | December 31, 2018 | United States, Colorado ... more >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, Connecticut Yale University New Haven, Connecticut, United States, 06511 United States, District of Columbia Georgetown University Medical Center Lombardi Cancer Center Washington, District of Columbia, United States, 20007 United States, Illinois Uni of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts Massachusetts General Hospital. Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States, 02215 Dana Farber Can Ins Boston, Massachusetts, United States, 02215 United States, New York Laura and ISAAC Perlmutter Cancer Center at NYU Langone. New York, New York, United States, 10016 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 Carolina BioOncology Institute; Can Therapy & Res Ctr Huntersville, North Carolina, United States, 28078 United States, Tennessee Sarah Cannon Research Inst. Nashville, Tennessee, United States, 37203 Collapse << |
| NCT03083808 | Non-Small-Cell Lung Cancer | Phase 2 | Recruiting | December 2019 | United States, Illinois ... more >> University of Illinois Cancer Center Recruiting Chicago, Illinois, United States, 60612 Contact: Margaret Gavor 312-355-4200 mgavor2@uic.edu Principal Investigator: Lawrence Feldman, MD United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Greg Durm, MD 317-656-4260 gdurm@iu.edu Contact: Ashley Hudson 317-278-5638 ashnhuds@iu.edu United States, Iowa University of Iowa Hospital Clinics Recruiting Iowa City, Iowa, United States, 52242 Contact: Sarah Heady 319-384-4241 sarah-heady@uiowa.edu Principal Investigator: Muhammad Furgan, MD United States, Minnesota University of Minnesota Medcical Center Recruiting Minneapolis, Minnesota, United States, 55455 Principal Investigator: Naomi Fujioka, MD United States, Wisconsin University of Wisconsin Recruiting Madison, Wisconsin, United States, 53705 Contact: Hilary Hernan 608-263-2079 hernan@wisc.edu Principal Investigator: Ticiana Leal, MD Collapse << |
| NCT02368990 | - | - | Withdrawn(Since the conception... more >> of the study, the competitive environment has developed and as a result this study is no longer able to generate the necessary information.) Collapse << | June 2018 | - |
| NCT01828099 | Non-Small Cell Lung Cancer | Phase 3 | Active, not recruiting | April 11, 2022 | - |
| NCT02568033 | Non Small Cell Lung Cancer | Early Phase 1 | Unknown | October 2017 | United States, New Jersey ... more >> MD Anderson Cancer Center at Cooper Recruiting Camden, New Jersey, United States, 08103 Contact: Kim Krieger 856-735-6237 Collapse << |
| NCT01828099 | - | - | Active, not recruiting | - | - |
| NCT00560573 | Carcinoma, Non-Small-Cell Lung | Phase 1 | Completed | - | Belgium ... more >> Pfizer Investigational Site Charleroi, Belgium, 6000 Ireland Pfizer Investigational Site Dublin, Ireland, 8 Spain Pfizer Investigational Site Madrid, Spain, 28041 Pfizer Investigational Site Sevilla, Spain, 41013 Collapse << |
| NCT01454934 | - | - | Completed | - | - |
| NCT02930954 | Non-small-cell Lung Cancer | Phase 2 | Unknown | December 2018 | China ... more >> Department of Oncology, Shanghai pulmonary hospital Shanghai, China, 200433 Collapse << |
| NCT02103257 | EGFR Positive Non-small Cell L... more >>ung Cancer Adenocarcinoma Collapse << | Phase 4 | Unknown | September 2017 | China, Gansu ... more >> First Hospital of Lanzhou University Active, not recruiting Lanzhou, Gansu, China, 730000 Lanzhou military region general hospital Active, not recruiting Lanzhou, Gansu, China, 730050 China, Guangdong General Hospital of Guangzhou Military Command Active, not recruiting Guangzhou, Guangdong, China, 510010 Cancer Hospital of Sun Yat-sen Active, not recruiting Guangzhou, Guangdong, China, 510060 First Affiliated Hospital of Guangzhou Medical College Active, not recruiting Guangzhou, Guangdong, China, 510120 Jiangmen central hospital Active, not recruiting Jiangmen, Guangdong, China, 529030 The university of Hong Kong-Shenzhen Hospital Active, not recruiting Shenzhen, Guangdong, China, 518000 Shenzhen People's Hospital Active, not recruiting Shenzhen, Guangdong, China, 518020 Medical Oncology,Shenzhen Second People's Hospital Active, not recruiting Shenzhen, Guangdong, China, 518035 Thoracic Surgery,Shenzhen Second People's Hospital Active, not recruiting Shenzhen, Guangdong, China, 518035 Peking University Shenzhen Hospital Active, not recruiting Shenzhen, Guangdong, China, 518036 Guangdong Agribusiness Center Hospital Active, not recruiting Zhanjiang, Guangdong, China, 524009 China, Guangxi First Affiliated Hospital of Guangxi Medical University Active, not recruiting Nanning, Guangxi, China, 530021 China, Hainan Hainan Provincal Nong Ken Hospital Active, not recruiting Haikou, Hainan, China, 570311 Hainan Provincial People's Hospital Active, not recruiting Haikou, Hainan, China, 570311 China, Henan First Affiliated Hospital of Zhengzhou University Active, not recruiting Zhengzhou, Henan, China, 450052 China, Ningxia Medical Oncology，General Hospital of Ningxia Medical University Active, not recruiting Yinchuan, Ningxia, China, 750004 Radiation Oncology，General Hospital of Ningxia Medical University Active, not recruiting Yinchuan, Ningxia, China, 750004 Respiratory medicine，General Hospital of Ningxia Medical University Active, not recruiting Yinchuan, Ningxia, China, 750004 China, Shanxi Baoji Central Hospital Active, not recruiting Baoji, Shanxi, China, 721008 3201 Hospital, Hanzhong, Shanxi Active, not recruiting Hanzhong, Shanxi, China, 723000 Shaanxi province people's hospital Active, not recruiting Xi'an, Shanxi, China, 710000 Second Affiliated Hospital of Xi'an Jiaotong University Active, not recruiting Xi'an, Shanxi, China, 710004 Xi'an Chang'an Hospital Active, not recruiting Xi'an, Shanxi, China, 710018 Tangdu Hospital，Fourth Military Medical University Recruiting Xi'an, Shanxi, China, 710038 Contact: Helong Zhang, MD 13709202616 Principal Investigator: Helong Zhang, MD First Affiliated Hospital of Xi'an Jiaotong University Active, not recruiting Xi'an, Shanxi, China, 710061 Shanxi Cancer Hospital Active, not recruiting Xi'an, Shanxi, China, 710061 China, Xinjiang Urumqi General Hospital of Lanzhou Military Region General Hospital Active, not recruiting Urumqi, Xinjiang, China, 830000 Xinjiang medical university affiliated tumor hospital Active, not recruiting Urumqi, Xinjiang, China, 830000 First Affiliated Hospital of Xinjiang Medical University Active, not recruiting Urumqi, Xinjiang, China, 830054 Autonome Region Xinjiang Uygur Chinese medicine hospital Active, not recruiting Urumqi, Xinjiang, China, 830099 Collapse << |
| NCT00560573 | - | - | Completed | - | - |
| NCT01454934 | Non-Small Cell Lung Cancer (NS... more >>CLC) Collapse << | Phase 3 | Completed | - | - |
| NCT02977169 | Non-small Cell Lung Cancer Sta... more >>ge IIIA Radiotherapy Collapse << | Phase 2 | Recruiting | December 2019 | China, Shanghai ... more >> Shanghai Chest Hospital Recruiting Shanghai, Shanghai, China Contact: Xiaolong Fu, PhD +862122200000 ext 3602 xlfu1964@126.com Collapse << |
| NCT00715611 | Mesothelioma | Phase 2 | Recruiting | July 2019 | United States, Florida ... more >> Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Bradford Perez, MD 888-663-3488 Principal Investigator: Bradford Perez, MD United States, Massachusetts Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Raymond Mak, MD 617-632-3591 United States, Minnesota Mayo Clinic Cancer Center Recruiting Rochester, Minnesota, United States, 55905 Contact: Nina Garces, MD 507-538-3270 United States, New Jersey Memorial Sloan Kettering at Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Andreas Rimner, MD 212-639-6025 Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Andreas Rimner, MD 212-639-6025 Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Andreas Rimner, MD 212-639-6025 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: Andreas Rimner, MD 212-639-6025 Memorial Sloan Kettering West Harrison Recruiting Harrison, New York, United States, 10604 Contact: Andreas Rimner, MD 212-639-6025 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Andreas Rimner, MD 212-639-6025 Contact: Valerie Rusch, MD 212-639-5873 Principal Investigator: Andreas Rimner, MD Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: Andreas Rimner, MD 212-639-6025 Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Recruiting Sleepy Hollow, New York, United States, 10591 Contact: Andreas Rimner, MD 212-639-6025 United States, Texas Md Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Daniel Gomez, MD Principal Investigator: Daniel Gomez, MD Collapse << |
| NCT02937116 | Cancer, Solid Tumor | Phase 1 | Unknown | December 2018 | - |
| NCT01351415 | Non-Squamous Non-Small Cell Lu... more >>ng Cancer Collapse << | Phase 3 | Completed | - | - |
| NCT02886195 | EGFR Gene Mutation | Phase 3 | Enrolling by invitation | July 2019 | - |
| NCT01351415 | - | - | Completed | - | - |
| NCT02649829 | Malignant Pleural Mesothelioma | Phase 1 Phase 2 | Recruiting | November 2021 | Belgium ... more >> Antwerp University Hospital Recruiting Edegem, Antwerp, Belgium, 2650 Contact: Zwi N Berneman, MD, PhD zwi.berneman@uza.be Contact: Sébastien Anguille, MD, PhD sebastien.anguille@uza.be Sub-Investigator: Paul Germonpré, MD Sub-Investigator: Koen Deschepper, MD AZ Middelares Recruiting Ghent, Belgium, 9000 Contact: Local investigator: Paul Germonpré, MD, PhD AZ Nikolaas Recruiting Sint-Niklaas, Belgium, 9100 Contact: Local investigator: Koen Deschepper, MD Collapse << |
| NCT01783197 | Non Small Cell Lung Cancer | Phase 1 | Active, not recruiting | December 2018 | Canada, British Columbia ... more >> BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada, K7L 5P9 Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Collapse << |
| NCT02621333 | Lung Adenocarcinoma | Phase 2 | Unknown | September 2018 | China, Henan ... more >> Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university Recruiting ZhengZhou, Henan, China, 450008 Contact: Quanli Gao, M.D. +8615038171966 guaoquanli2015@126.com Contact: Lingdi Zhao, M.D. +8637165587483 lingdi1010@sohu.com Principal Investigator: Quanli Gao, M.D. Collapse << |
| NCT03228537 | Biphasic Mesothelioma ... more >> Epithelioid Mesothelioma Stage I Pleural Malignant Mesothelioma AJCC v7 Stage IA Pleural Malignant Mesothelioma AJCC v7 Stage IB Pleural Malignant Mesothelioma AJCC v7 Stage II Pleural Malignant Mesothelioma AJCC v7 Stage III Pleural Malignant Mesothelioma AJCC v7 Collapse << | Phase 1 | Recruiting | June 1, 2020 | - |
| NCT00301808 | Lung Cancer | Phase 2 | Completed | - | United States, Michigan ... more >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Veterans Affairs Medical Center - Detroit Detroit, Michigan, United States, 48201 Collapse << |
| NCT00301808 | - | - | Completed | - | - |
| NCT02076477 | Oligo-metastatic Stage IV Non-... more >>small Cell Lung Cancer Collapse << | Phase 3 | Unknown | - | China, Sichuan ... more >> Sichuan Cancer Hospital & Institute Recruiting Chengdu, Sichuan, China, 610041 Contact: TAO LI, MD, PhD 86-18908178818 litaoxmf@163.com Principal Investigator: TAO LI, MD, PhD Sub-Investigator: XIAOHU WANG, MD, PhD Sub-Investigator: XIAOBO DU, MD, PhD Sub-Investigator: BING LU, MD, PhD Collapse << |
| NCT01700400 | Non Small Cell Lung Cancer | Phase 1 | Completed | - | United States, Arizona ... more >> University of Arizona Cancer Center Tuscon, Arizona, United States, 85724 United States, Kentucky University of Kentucky Markey Cancer Center Lexington, Kentucky, United States, 40536 United States, Oregon Providence Cancer Center Portland, Oregon, United States, 97213 United States, Washington Cancer Research And Biostatistics Clinical Trials Consortium Seattle, Washington, United States, 98101 Collapse << |
| NCT03190239 | Advanced Non-squamous Non-smal... more >>l-cell Lung Cancer Collapse << | Phase 2 | Not yet recruiting | December 30, 2019 | China ... more >> Xinqiao Hospital of Chongqing Chongqing, China, 400000 Collapse << |
| NCT02347917 | Malignant Pleural Mesothelioma... more >> Non-Small Cell Lung Cancer Collapse << | Phase 1 Phase 2 | Completed | - | Japan ... more >> National Cancer Center Hospital East Chiba, Japan National Cancer Center Hospital Tokyo, Japan Collapse << |
| NCT02399566 | Lung Adenocarcinoma | Phase 4 | Not yet recruiting | January 2019 | - |
| NCT00191984 | Metastatic Colorectal Cancer | Phase 2 | Completed | - | France ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Angers, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Lille, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Montfermeil, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Paris, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Suresnes, France Collapse << |
| NCT00394147 | Head and Neck Cancer | Phase 2 | Terminated(stopped for lack of... more >> efficacy) Collapse << | - | United States, Pennsylvania ... more >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Collapse << |
| NCT01579630 | NSCLC | Phase 2 Phase 3 | Unknown | June 2014 | Taiwan ... more >> Veterans General Hospital -Taipei Taipei, Taiwan, 112 Collapse << |
| NCT00191984 | - | - | Completed | - | - |
| NCT02185690 | Lungcancer | Phase 1 | Recruiting | April 2019 | Canada, Alberta ... more >> Cross Cancer Institute Recruiting Edmonton, Alberta, Canada, T6G1Z2 Contact: Quincy Chu, MD 780-432-8248 quincy.chu@albertahealthservices.ca Sub-Investigator: Quincy Chu, MD Canada, Ontario Juravinski Cancer Centre Recruiting Hamilton, Ontario, Canada, L8V 5C2 Contact: Peter Ellis, MD 905-387-9711 ext 64609 Peter.Ellis@jcc.hhsc.ca Sub-Investigator: Peter Ellis, MD The Ottawa Hospital Regional Cancer Centre Recruiting Ottawa, Ontario, Canada, K1G 3Y9 Contact: Scott Laurie, MD 613-737-7700 ext 70175 slaurie@ottawahospital.on.ca Sub-Investigator: Scott Laurie, MD Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G2M9 Contact: Natasha Leighl, MD 416-946-4645 Natasha.Leighl@uhn.ca Contact: Maggie Sawczak, CRA 416-946-4501 ext 5444 Maggie.Sawczak@uhn.ca Principal Investigator: Natasha Leighl, MD Collapse << |
| NCT02308020 | Breast Cancer ... more >> Non-small Cell Lung Cancer Melanoma Brain Metastases Collapse << | Phase 2 | Active, not recruiting | November 8, 2019 | - |
| NCT00612677 | Lung Cancer | Phase 2 | Terminated(slow accrual - the ... more >>1 patient accrued did not go on treatment) Collapse << | - | United States, Florida ... more >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Collapse << |
| NCT01548144 | Advanced Cancers | Phase 1 | Active, not recruiting | April 2019 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
| NCT03322566 | Lung Cancer | Phase 2 | Active, not recruiting | September 2021 | - |
| NCT01951586 | - | - | Completed | - | - |
| NCT01703910 | Adenocarcinoma of Colon ... more >> Adenocarcinoma of Rectum Metastatic Disease Collapse << | Phase 2 | Completed | - | Spain ... more >> Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain, 28950 Hospital Madrid Norte Sanchinarro Madrid, Spain, 28050 Collapse << |
| NCT02998528 | Non Small Cell Lung Cancer | Phase 3 | Recruiting | November 8, 2028 | - |
| NCT02805530 | Carcinoma, Non-Small-Cell Lung... more >> Synchronous Neoplasms Collapse << | Not Applicable | Recruiting | December 2017 | Mexico ... more >> Instituto Nacional de Cancerologia Recruiting Mexico City, Mexico, 14080 Contact: Oscar Arrieta 015556280400 ogarrieta@gmail.com Collapse << |
| NCT03319316 | Squamous Non-small Cell Lung C... more >>ancer Non-Squamous Non-small Cell Lung Cancer Collapse << | Phase 2 | Not yet recruiting | November 2022 | - |
| NCT02701231 | Lung Neoplasms | Not Applicable | Recruiting | December 2020 | China, Beijing ... more >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Liang-An Chen, MD, phD 8610-55499027 chenla301@263.net Principal Investigator: Liang-An Chen, MD, phD China, Shandong Affiliated hospital of Shandong University of traditional Chinese medicine Not yet recruiting Jinan, Shandong, China, 250011 Shandong Provincial Hospital Not yet recruiting Jinan, Shandong, China, 250021 China, Shanxi Xijing Hospital affiliated to the Fourth Military Medical University Not yet recruiting Xi'an, Shanxi, China, 710032 Collapse << |
| NCT02883543 | Non-small Cell Lung Cancer | Phase 3 | Active, not recruiting | June 2019 | - |
| NCT01209520 | - | - | Completed | - | - |
| NCT01951586 | Non-Small Cell Lung Cancer | Phase 2 | Completed | - | - |
| NCT02477826 | Non-Small Cell Lung Cancer | Phase 3 | Recruiting | December 31, 2020 | - |
| NCT02453282 | Non-Small-Cell Lung Carcinoma ... more >>NSCLC Collapse << | Phase 3 | Active, not recruiting | December 31, 2019 | - |
| NCT03064854 | Non-small Cell Lung Cancer | Phase 1 | Recruiting | February 15, 2022 | - |
| NCT03164616 | Non Small Cell Lung Cancer NSC... more >>LC Collapse << | Phase 3 | Recruiting | September 24, 2021 | - |
| NCT03257267 | Recurrent or Metastatic, Plati... more >>num-refractory Cervical Cancer Collapse << | Phase 3 | Recruiting | June 7, 2023 | - |
| NCT01209520 | Lung Cancer N... more >>on Small Cell Lung Carcinoma Hypermethylation Collapse << | Not Applicable | Completed | - | United States, Florida ... more >> University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 Collapse << |
| NCT01725165 | Lung Cancer | Phase 2 | Active, not recruiting | November 2019 | United States, Colorado ... more >> University of Colorado Denver, Colorado, United States, 80204 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Ontario London Health Sciences Centre London, Ontario, Canada, N6A 5W9 Collapse << |
| NCT03348904 | Lung Cancer | Phase 3 | Terminated(Study halted premat... more >>urely and will not resume; participants are no longer being examined or receiving intervention.) Collapse << | - | United States, California ... more >> Pacific Cancer Medical Center, Inc Anaheim, California, United States, 92801 United States, Kansas Cancer Center of Kansas Wichita, Kansas, United States, 67214 Collapse << |
| NCT03775486 | Non-small Cell Lung Cancer NSC... more >>LC Collapse << | Phase 2 | Not yet recruiting | May 23, 2022 | - |
| NCT03509012 | Carcinoma, Squamous Cell of He... more >>ad and Neck Carcinoma, Non-Small-Cell Lung Small Cell Lung Carcinoma Collapse << | Phase 1 | Recruiting | April 4, 2022 | United States, Arizona ... more >> Research Site Recruiting Tucson, Arizona, United States, 85719 United States, Colorado Research Site Recruiting Aurora, Colorado, United States, 80045 United States, Missouri Research Site Not yet recruiting Saint Louis, Missouri, United States, 63110 United States, New Jersey Research Site Withdrawn Middletown, New Jersey, United States, 07748 Japan Research Site Recruiting Koto-ku, Japan, 135-8550 Research Site Recruiting Sunto-gun, Japan, 411-8777 Korea, Republic of Research Site Recruiting Seoul, Korea, Republic of, 03080 Research Site Recruiting Seoul, Korea, Republic of, 03722 Research Site Recruiting Seoul, Korea, Republic of, 05505 Research Site Recruiting Seoul, Korea, Republic of, 135-710 Taiwan Research Site Not yet recruiting Kaohsiung, Taiwan, 807 Research Site Not yet recruiting Taipei, Taiwan, 10002 Collapse << |
| NCT03353675 | NSCLC | Phase 2 | Recruiting | September 2020 | United States, North Carolina ... more >> Charlotte Recruiting Charlotte, North Carolina, United States, 28204 United States, Tennessee Nashville Recruiting Nashville, Tennessee, United States, 37203 Belgium Libramont Recruiting Libramont, Belgium Denmark Herlev Recruiting Herlev, Denmark France Créteil Recruiting Créteil, France Mulhouse Recruiting Mulhouse, France Rennes Recruiting Rennes, France Strasbourg Recruiting Strasbourg, France Hungary Budapest Recruiting Budapest, Hungary Szekesfehervar Recruiting Szekesfehervar, Hungary Collapse << |
| NCT03770299 | Non-Small Cell Lung Cancer ... more >> Non-Small-Cell Lung Carcinoma Circulating Tumor DNA Collapse << | Phase 2 | Not yet recruiting | March 14, 2024 | United States, Florida ... more >> Local Institution Not yet recruiting Jacksonville, Florida, United States, 32224 Contact: Site 0015 United States, Kentucky Local Institution Not yet recruiting Lexington, Kentucky, United States, 40503-1489 Contact: Site 0014 United States, South Carolina Local Institution Not yet recruiting Charleston, South Carolina, United States, 29414 Contact: Site 0010 United States, Texas Local Institution Not yet recruiting Tyler, Texas, United States, 75701 Contact: Site 0013 Germany Local Institution Not yet recruiting Gauting, Germany, 82131 Contact: Site 0005 Local Institution Not yet recruiting Grosshansdorf, Germany, 22927 Contact: Site 0006 Local Institution Not yet recruiting Heidelberg, Germany, 69126 Contact: Site 0007 Switzerland Local Institution Not yet recruiting Lausanne, Switzerland, 1011 Contact: Site 0009 Local Institution Not yet recruiting Zuerich, Switzerland, 8091 Contact: Site 0008 United Kingdom Local Institution Not yet recruiting London, United Kingdom, NW1 2BU Contact: Site 0001 Collapse << |
| NCT00312728 | Non-Small Cell Lung Cancer ... more >> Brain Neoplasms Collapse << | Phase 2 | Completed | - | - |
| NCT01067794 | - | - | Completed | - | - |
| NCT02045446 | Stage IV Non-Small Cell Lung C... more >>ancer Collapse << | Phase 2 | Active, not recruiting | December 2020 | United States, Texas ... more >> UT Southwestern Medical Center Dallas, Texas, United States, 75235 Collapse << |
| NCT01241682 | Malignant (Pleural) Mesothelio... more >>ma Collapse << | Phase 1 | Completed | - | Netherlands ... more >> Erasmus Medical Center Rotterdam, Zuid-Holland, Netherlands, 3000 CA Collapse << |
| NCT00312728 | - | - | Completed | - | - |
| NCT01770418 | Lung Neoplasms | Phase 1 Phase 2 | Recruiting | - | United States, Florida ... more >> University of Florida Proton Therapy Institute Recruiting Jacksonville, Florida, United States, 32206 Contact: Samantha Sago 904-588-1529 SSago@floridaproton.org Principal Investigator: Brad Hoppe, MD United States, Illinois Northwestern Medicine Chicago Proton Center Recruiting Warrenville, Illinois, United States, 60555 Contact: Megan Boroczk 630-315-1797 Megan.Boroczk@nm.org Principal Investigator: John Chang, MD United States, Maryland Maryland Proton Treatment Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Carl Brown 410-364-5353 CarlBrown@umm.edu Principal Investigator: Pranshu Mohindra, MD United States, New Jersey Princeton ProCure Management LLC Recruiting Somerset, New Jersey, United States, 08873 Contact: Heba Darwish 732-357-2676 heba.darwish@nj.procure.com Principal Investigator: Brian Chon, MD United States, Oklahoma ProCure Proton Therapy Center Recruiting Oklahoma City, Oklahoma, United States, 73142 Contact: Kayla Tarrant 405-773-6775 research@okc.procure.com Principal Investigator: Gary Larson, MD United States, Virginia Hampton University Proton Therapy Institute Recruiting Hampton, Virginia, United States, 23666 Contact: Donna Sternberg, RN, BSN, OCN 757-251-6839 Donna.Sternberg@hamptonproton.org Principal Investigator: Christopher Sinesi, MD Collapse << |
| NCT01510990 | Non-small Cell Lung Cancer | Phase 2 | Unknown | November 2015 | Korea, Republic of ... more >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Sang-We Kim, M.D. 82-2-3010-3215 swkim@amc.seoul.kr Principal Investigator: Sang-We Kim, M.D. Collapse << |
| NCT02723955 | Cancer | Phase 1 | Recruiting | May 18, 2020 | United States, California ... more >> GSK Investigational Site Recruiting Duarte, California, United States, 91010 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, New York GSK Investigational Site Recruiting New York, New York, United States, 10016 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting New York, New York, United States, 10032 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Pennsylvania GSK Investigational Site Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Tennessee GSK Investigational Site Recruiting Nashville, Tennessee, United States, 37203 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Nashville, Tennessee, United States, 37232-6307 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Australia, Victoria GSK Investigational Site Recruiting Heidelberg, Victoria, Australia, 3084 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Melbourne, Victoria, Australia, 3000 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Australia, Western Australia GSK Investigational Site Recruiting Nedlands, Western Australia, Australia, 6009 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Canada, Ontario GSK Investigational Site Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com France GSK Investigational Site Not yet recruiting Bordeaux Cedex, France, 33076 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Lyon cedex 08, France, 69373 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Paris, France, 75005 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Villejuif cedex, France, 94805 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Italy GSK Investigational Site Recruiting Siena, Toscana, Italy, 53100 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Netherlands GSK Investigational Site Recruiting Amsterdam, Netherlands, 1066 CX Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Spain GSK Investigational Site Recruiting Barcelona, Spain, 08035 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Barcelona, Spain, 08036 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Madrid, Spain, 28040 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Málaga, Spain, 29010 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Sevilla, Spain, 41009 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Collapse << |
| NCT02542293 | Non Small Cell Lung Carcinoma ... more >>NSCLC Collapse << | Phase 3 | Active, not recruiting | March 29, 2019 | - |
| NCT02574078 | Non-Small Cell Lung Cancer | Phase 1 Phase 2 | Active, not recruiting | April 15, 2019 | - |
| NCT02151981 | Anticancer Treatment | Phase 3 | Active, not recruiting | December 30, 2020 | - |
| NCT02151981 | - | - | Active, not recruiting | - | - |
| NCT01899989 | Non-small Cell Lung Cancer | Phase 1 | Recruiting | July 2019 | United States, New Jersey ... more >> Memorial Sloan Kettering Cancer Center at Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Andreas Rimner, MD 212-639-6025 Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Andreas Rimner, MD 212-639-6025 Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Andreas Rimner, MD 212-639-6025 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: Andreas Rimner, MD 212-639-6025 Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Andreas Rimner, MD 212-639-6025 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Andreas Rimner, MD 212-639-6025 Contact: Jamie Chaft, MD 646-888-4545 Principal Investigator: Andreas Rimner, MD Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: Andreas Rimner, MD 212-639-6025 Contact: Jamie Chaft, MD 646-888-4545 Principal Investigator: Andreas Rimner, MD Collapse << |
| NCT03003962 | Non Small Cell Lung Carcinoma ... more >>NSCLC Collapse << | Phase 3 | Recruiting | December 31, 2020 | - |
| NCT03085914 | Solid Tumors ... more >>Colorectal Cancer (CRC) Adenocarcinoma (PDAC) Lung Cancer UC (Urothelial Cancer) Head and Neck Cancer Collapse << | Phase 1 Phase 2 | Active, not recruiting | January 2020 | United States, Arizona ... more >> Mayo Clinic Arizona Phoenix, Arizona, United States, 85054 United States, California University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States, 92093 The Angeles Clinic and Research Institute Los Angeles, California, United States, 90025 United States, Florida Mayo Clinic Jacksonville, Florida, United States, 32224 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Carolina Bio-Oncology Institute, PLLC Huntersville, North Carolina, United States, 28078 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Pennsylvania University of Pennsylvania Health System Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15237 United States, Tennessee Tennessee Oncology - Nashville; The Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Vanderbilt University; Henry Joyce Cancer Clinic Nashville, Tennessee, United States, 37232 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States, 84112 Collapse << |
| NCT02455843 | Non Small Cell Lung Cancer | Phase 3 | Recruiting | May 2018 | China, Shandong ... more >> Binzhou Medical University Hospital Recruiting Binzhou, Shandong, China, +86 256600 Contact: Shao shui Chen, M.D +86 15169959936 byfychenss@126.com Dezhou People's Hospital Recruiting Dezhou, Shandong, China, +86 253000 Contact: Yu ting Dong +86 13969286066 dyt1963@163.com The Second People's Hospital of Dezhou Recruiting Dezhou, Shandong, China, +86 253000 Contact: Chun tang Wang, M.D +86 13181378288 dzeyxwct@sina.com Jinan Military General Hospital Recruiting Jinan, Shandong, China, +83 250001 Contact: Jing wang Bi, M.D +86 15963119538 jingwangbi@outlook.com Affliated Hospital of Shandong Academy of Medical Sciences Recruiting Jinan, Shandong, China, +86 250001 Contact: Ya hong Sun, M.D 13606415915 sunyahong0915@163.com Shandong Provincial Hospital Recruiting Jinan, Shandong, China, +86 250001 Contact: Xin Ye, M.D +86 0531-68773171 yexintaian2014@163.com Affliated Hospital of Jining Medical University Recruiting Jining, Shandong, China, +86 272000 Contact: Jun ye Wang, M.D +86 13563771996 jiningwangjunye@163.com Liaocheng Cancer Hospital Recruiting Liaocheng, Shandong, China, +86 252000 Contact: Qing liang Feng, M.D +86 15339949567 fql-123@sohu.com The People's Hospital of Pingyi Country Recruiting Linyi, Shandong, China, +86 276000 Contact: Xing lu Xu, M.D +86 18265398816 xlk2082@126.com Affliated Hospital of Taishan Medical University Recruiting Taian, Shandong, China, +86 271000 Contact: Ben hua Zhang, M.D +86 15169887577 zhangbenhua1964@163.com The People's Liberation Army 88 Hospital Recruiting Taian, Shandong, China, +86 271000 Contact: Li cheng Zhang, M.D +86 13605383651 zhanglc88@aliyun.com Weifang People's Hospital Recruiting Weifang, Shandong, China, +86 262000 Contact: Guo hua Yu, M.D +86 13685368817 ghyry@126.com Yantai Yuhuangding Hospital Recruiting Yantai, Shandong, China, +86 264000 Contact: Liang ming Zhang, M.D +86 18660079893 zhanglmdr@163.com Tengzhou center of people's hospital Recruiting Zaozhuang, Shandong, China, +86 277000 Contact: Kai xian Zhang, M.D +86 18663069829 kaixianzhang@aliyun.com Collapse << |
| NCT01997775 | Non-small Cell Lung Cancer | Phase 2 | Terminated(Difficult enrollmen... more >>t) Collapse << | - | Taiwan ... more >> National Cheng-Kung Uni. Hosp. Tainan, Taiwan, 704 Collapse << |
| NCT02383212 | Advanced Cancer ... more >> Advanced Malignancies Collapse << | Phase 1 | Active, not recruiting | December 20, 2019 | - |
| NCT01376310 | Cancer | Phase 2 | Completed | - | - |
| NCT01665417 | EGFR Positive Non-small Cell L... more >>ung Cancer Adenocarcinoma Collapse << | Phase 4 | Recruiting | December 2017 | China, Beijing ... more >> Chinese People's Liberation Army (PLA) General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Jiao Shunchang, MD 0086-13801380677 Principal Investigator: Jiao Shunchang, MD Collapse << |
| NCT01119664 | Mesothelioma | Phase 1 Phase 2 | Unknown | - | United States, Pennsylvania ... more >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Collapse << |
| NCT01850147 | Cancer Lung C... more >>ancer Collapse << | Phase 2 | Unknown | December 2014 | China ... more >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, China, 100021 Collapse << |
| NCT02489903 | Small Cell Carcinoma ... more >> Carcinoma, Non-Small-Cell Lung Neuroendocrine Tumors Ovarian Epithelial Cancer Collapse << | Phase 2 | Recruiting | July 2020 | United States, California ... more >> Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Melanie San Pedro-Salcedo 650-724-1388 msanpedro@stanford.edu Principal Investigator: Sukhmani Padda, MD United States, Connecticut VA Connecticut Cancer Center Recruiting West Haven, Connecticut, United States, 06516 Contact: Jessica Jordan 203-932-5711 ext 3287 jessica.jordan@va.gov Principal Investigator: Michal Rose, MD United States, Indiana Memorial Hospital of South Bend Recruiting South Bend, Indiana, United States, 46601 Contact: Amie Lake 574-647-6784 ALake@beaconhealthsystem.org Contact: Mary Jane Danner 574-647-7309 MDanner@beaconhealthsystem.org Principal Investigator: Thomas J Reid, MD, PhD United States, Kentucky Baptist Health Recruiting Lexington, Kentucky, United States, 40503 Contact: Stephanie Cason 859-260-3197 stephanie.cason@bhsi.com Contact: Micheal F Stephens 859-260-6456 micheal.stephens@BHSI.com Principal Investigator: Arvinda Padmanabhan, MD United States, Maryland Walter Reed National Military Medical Center Recruiting Bethesda, Maryland, United States, 20889 Contact: Sonja Skeete 301-319-4599 sonja.t.skeete.ctr@mail.mil Principal Investigator: Karen Zeman, MD United States, Michigan Henry Ford Allegiance Health Recruiting Jackson, Michigan, United States, 49201 Contact: Kris Strzalkowski, RN 517-205-1522 KSTRZAL1@hfhs.org Contact: Natalie Peterson, RN OCN (517) 205-1549 npeters8@hfhs.org Principal Investigator: Malcolm Trimble, MD United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Dan Blume 314-362-0872 dan.blume@wustl.edu Principal Investigator: Daniel Morgensztern, MD United States, Ohio University of Cincinnati Cancer Institute Recruiting Cincinnati, Ohio, United States, 45267 Contact: Lauren Hendricks 513-584-5725 hendrilu@ucmail.uc.edu Principal Investigator: John C Morris, MD United States, Tennessee University of Tennessee Medical Center Withdrawn Knoxville, Tennessee, United States, 37920 United States, Virginia Virginia Cancer Specialists Recruiting Fairfax, Virginia, United States, 22031 Contact: Karin Choquette, MSN, RN 703-208-9268 Karin.Choquette@USONCOLOGY.COM Principal Investigator: Alexander Spira, MD United States, West Virginia West Virginia University Recruiting Morgantown, West Virginia, United States, 26506 Contact: Carla Ross, RN 304-581-1158 cjross@hsc.wvu.edu Principal Investigator: Patrick Ma, MD Collapse << |
| NCT01564329 | Advanced Primary Lung Adenocar... more >>cinoma Collapse << | Phase 2 | Unknown | July 2013 | China, Sichuan ... more >> The Department of Thoracic Oncology in West China Hospital of Sichuan University Recruiting Chengdu, Sichuan, China, 610041 Contact: Meijuan Huang, MD Contact: You Lu, MD Collapse << |
| NCT02891733 | - | - | Recruiting | December 31, 2018 | France ... more >> Groupe Hospitalier Paris Saint Joseph Recruiting Paris, Ile-de-France, France, 75014 Contact: BEAUSSIER Helene, PhD, PharmD +33 1 44 12 70 38 hbeaussier@hpsj.fr Contact: Mohamed CHERIFI, PharmD +33 1 44 12 70 84 mcherifi@hpsj.fr Collapse << |
| NCT02679963 | Non Small Cell Lung Cancer | Phase 2 | Recruiting | January 2021 | France ... more >> Gustave Roussy Cancer Campus Recruiting Villejuif, Val de Marne, France, 94805 Contact: Valérie Mairot 0142113730 ext +33 Valerie.mairot@gustaveroussy.fr Collapse << |
| NCT01533727 | Non-small Cell Lung Cancer | Phase 2 | Withdrawn(Few patients would l... more >>ike to participate ,since CIK cell transfusion was a new treatment and its efficacy was doubted.) Collapse << | December 2020 | China, Guangdong ... more >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Collapse << |
| NCT02132143 | Lung Adenocarcinoma Patients W... more >>ith Postoperative in pN2 Collapse << | Not Applicable | Unknown | January 2017 | China ... more >> The People's Hospital of Guangxi Zhuang Autonomous Region Recruiting Nanning Shi, China, 530021 Contact: Hui Lin 8613878133266 linhui33266@sina.com Collapse << |
| NCT01869023 | Advanced Malignant Pleural Mes... more >>othelioma Collapse << | Phase 2 | Active, not recruiting | December 2017 | Mexico ... more >> Instituto Nacional de Cancerología Mexico City, Mexico Collapse << |
| NCT01262859 | Head and Neck Neoplasms | Phase 2 | Withdrawn(PI relocated to anot... more >>her institution. No subjects went on treatment.) Collapse << | - | United States, Pennsylvania ... more >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Collapse << |
| NCT00979576 | - | - | Terminated | - | - |
| NCT00320073 | Unspecified Adult Solid Tumor,... more >> Protocol Specific Collapse << | Phase 1 | Completed | - | United States, North Carolina ... more >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Collapse << |
| NCT00979576 | Carcinoma, Non-Small-Cell Lung | Phase 1 | Terminated | - | Japan ... more >> 1199.28.003 Boehringer Ingelheim Investigational Site Chiba,Kashiwa, Japan 1199.28.002 Boehringer Ingelheim Investigational Site Miyakojima-ku, Osaka, Japan 1199.28.001 Boehringer Ingelheim Investigational Site Osaka-Sayama, Osaka, Japan Collapse << |
| NCT01877902 | - | - | Unknown | - | Spain ... more >> Hospital La Línea Recruiting Algeciras, Cádiz, Spain Contact: José Carlos Roldán Hospital Punta de Europa Recruiting Algeciras, Cádiz, Spain Contact: Pablo Villanueva Jiménez Hospital Jerez de la Frontera Recruiting Jerez de la Frontera, Cádiz, Spain Contact: Rocío Gavira Moreno Hospital Costa del Sol Recruiting Marbella, Cádiz, Spain Contact: Margarita Garrido Hospital de Puerto Real Recruiting Puerto Real, Cádiz, Spain Contact: Carmen Martínez Díaz Hospital de Baza Recruiting Baza, Granada, Spain Contact: Francisco Nieto Cobo Hospital Universitario Torrecardenas Recruiting Almería, Spain Contact: Juan José Fernández Avila Hospital Universitario Puerta del Mar Recruiting Cádiz, Spain Contact: María José Martínez Bautista Hospital Universitario Reina Sofía Recruiting Córdoba, Spain Contact: Ana Isabel Gago Sánchez Hospital San Cecilio Recruiting Granada, Spain Contact: Miguel Damas Fernández Fijares Hospital Santa Ana Recruiting Granada, Spain Contact: Marcos Camacho Romera Hospital Universitario Virgen de las Nieves Recruiting Granada, Spain Contact: Inmaculada Vallejo Rodríguez Hospital Universitario Juan Ramón Jiménez Recruiting Huelva, Spain Contact: Mª Teresa Garrido Martínez Hospital Regional de Málaga Recruiting Málaga, Spain Contact: Beatriz Mora Rodríguez Hospital Universitario Virgen de la Victoria Recruiting Málaga, Spain Contact: Begoña Muros de Fuentes Hospital Universitario Virgen de Valme Recruiting Sevilla, Spain Contact: Silvia Artecho Hospital Universitario Virgen del Rocío Recruiting Sevilla, Spain Contact: Javier Bautista Paloma Hospital Universitario Virgen Macarena Recruiting Sevilla, Spain Contact: Nuria Muñoz Muñoz Collapse << |
| NCT00372788 | Non-small Cell Lung Cancer | Phase 2 | Completed | - | United States, California ... more >> Research Site Los Angeles, California, United States United States, Michigan Research Site Ann Arbor, Michigan, United States United States, New York Research Site New York, New York, United States United States, Tennessee Research Site Nashville, Tennessee, United States Bulgaria Research Site Plovdiv, Bulgaria Research Site Sofia, Bulgaria Research Site Varna, Bulgaria Romania Research Site Cluj-Napoca, Romania Collapse << |
| NCT00749346 | Non-small Cell Lung Cancer ... more >> NSCLC Collapse << | Phase 1 Phase 2 | Completed | - | Switzerland ... more >> CCRC Basel, Switzerland Kantonspital Graubunden Chur, Switzerland Kantonspital Fribourg Fribourg, Switzerland Kantonspital Winterthur Winterthur, Switzerland Collapse << |
| NCT00798603 | Lung Cancer | Phase 2 | Completed | - | - |
| NCT01742767 | NSCLC | Phase 2 | Unknown | April 2015 | Germany ... more >> University hospital essen Recruiting Essen, Northrhine westphalia, Germany, 45122 Contact: Diana Cortes-Incio 02017232011 diana.cortez-incio@uk-essen.de Collapse << |
| NCT00798603 | - | - | Completed | - | - |
| NCT03655834 | Non Small Cell Lung Cancer ... more >> Mesothelioma Collapse << | Phase 4 | Not yet recruiting | September 1, 2021 | Netherlands ... more >> Jeroen Bosch Hospital Not yet recruiting 's-Hertogenbosch, Netherlands Contact: Bonne Biesma b.biesma@jbz.nl Principal Investigator: Bonne Biesma Sub-Investigator: Jeroen Derijks Antoni van Leeuwenhoek Not yet recruiting Amsterdam, Netherlands Contact: Sjaak Burgers s.burgers@nki.nl Principal Investigator: Sjaak Burgers Sub-Investigator: Alwin Huitema Maastricht University Medical centre Not yet recruiting Maastricht, Netherlands Contact: Anne-Marie Dingemans a.dingemans@mumc.nl Principal Investigator: Anne-Marie Dingemans Radboud university medical centre Not yet recruiting Nijmegen, Netherlands Contact: Rob ter Heine R.terHeine@radboudumc.nl Principal Investigator: Rob ter Heine Sub-Investigator: Nikki de Rouw Sub-Investigator: Michel van den Heuvel Erasmus University Medical Centre Not yet recruiting Rotterdam, Netherlands Contact: Joachim Aerts j.aerts@erasmusmc.nl Principal Investigator: Joachim Aerts Sub-Investigator: Ron Mathijsen Collapse << |
| NCT02274038 | Non-small Cell Lung Cancer ... more >> Starting Pemetrexed Based Therapy Unresectable Cancer Collapse << | Not Applicable | Active, not recruiting | November 2020 | United States, Pennsylvania ... more >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Collapse << |
| NCT01088620 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Suspended(the DSMB stopped the... more >> trial due to unacceptable side effects in the experimental arm which has not yet been verified) Collapse << | January 2014 | Germany ... more >> Schwerpunktpraxis für Hämatologie und Internistische Onkologie, Gesundheitszentrum St. Marien GmbH Amberg, Germany, 92224 Universitätsklinikum Charité - Campus Mitte Berlin, Germany, 10117 Charité Campus Benjamin Franklin Medizinische Klinik m. S. Hämatologie und Onkologie Berlin, Germany, 12200 HELIOS Klinikum Emil von Behring - Lungenklinik Heckeshorn Berlin, Germany, 14165 Augusta-Kranken-Anstalt gGmbH Bochum, Germany, 44791 Johanniter-Krankenhaus Bonn Bonn, Germany, 53113 Carl-Thiem-Klinikum Cottbus gGmbH Cottbus, Germany, 03048 Medizinische Fakultät Carl Gustav Carus der Technischen Universität Dresden Medizinische Klinik 1 Dresden, Germany, 01307 Katholisches Klinikum Duisburg/St. Johannes-Hospital Duisburg, Germany, 47166 Klinikum Frankfurt (Oder) GmbH Frankfurt (Oder), Germany, 15236 Krankenhaus Großhansdorf GmbH Onkologischer Schwerpunkt Großhansdorf, Germany, 22927 Krankenhaus - Martha-Maria Halle-Dölau GmbH Halle/Saale, Germany, 06120 Universitätsklinikum Halle (Saale), Klinik und Poliklinik für Innere Medizin I Halle/Saale, Germany, 06120 Universitätsklinikum Jena, Klinik für Innere Medizin I Jena, Germany, 07740 Onkologische Schwerpunktpraxis Dr. Stauch Kronach, Germany, 96317 Kliniken der Stadt Köln, Krankenhaus Merheim Köln, Germany, 51109 UK-SH, Campus Lübeck, Med. Klinik III Lübeck, Germany, 23538 LMU-Klinikum der Universität München, Medizinische Klinik München-Innenstadt München, Germany, 80336 Oncologianova GmbH Recklinghausen, Germany, 45657 Uniklinikum Ulm, Klinik für Innere Medizin II, Pneumologie Ulm, Germany, 89081 Collapse << |
| NCT00612677 | - | - | Terminated(slow accrual - the ... more >>1 patient accrued did not go on treatment) Collapse << | - | - |
| NCT01170871 | Advanced Solid Tumors | Phase 1 | Withdrawn(Sponsor withdrew sup... more >>port) Collapse << | - | United States, California ... more >> Los Angeles County+University of Southern California Medical Center Los Angeles, California, United States, 90033 USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Collapse << |
| 靶点 | Description | IC50 |
|---|---|---|
| DHFR | Ki:7.2nM | |
| GARFT | Ki:65nM | |
| Thymidylate Synthase | Ki:1.3nM |
